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Summary 
 
Pre-competition and recovery strategies in elite sport: the use of vascular occlusion and 
ischemia 
 
Understanding competition demands and training are only two components that impact overall 
performance which have been previously established in the literature; pre-competition and 
recovery can also improve athletic performance.  However, considerably less research has been 
conducted in elite populations, investigating the effect of pre-competition and recovery strategies.  
This thesis set out to investigate a pre-competition and recovery strategy for application in elite 
sport, via a series of studies specifically focussed on vascular occlusion and limb ischemic 
preconditioning (IPC).  Common to all studies was the importance of individualising cuff pressure 
and ensuring all studies were completed with elite athletes.  Study one investigated the use of 
vascular occlusion combined with resistance exercise, performed in the morning prior to afternoon 
exercise performance.  Despite exercise with occlusion attenuating the decline in T from morning 
to afternoon, this did not translate into improved afternoon performance in strength-power athletes.  
Study two examined the use of limb IPC applied 2h and 24h prior to swimming time trial 
performance.  There were no differences in physiological (blood gases and lactate) or performance 
markers measured between conditions, when compared to a control.  Study three investigated 
vascular occlusion applied as a recovery strategy following repeated sprint exercise, in rugby union 
players.  Recovery rate, assessed through biochemical, hormonal, neuromuscular and subjective 
perception of muscle soreness were not significantly different following application of vascular 
occlusion.  This thesis successfully examined the use of vascular occlusion/limb IPC as a pre-
competition and recovery strategy within elite athletes.  Despite the absence of performance 
improvements, this thesis addressed some of the practical limitations of applying pre-determined 
protocols in sport and offered alternative protocols to be applied across a range of sports (strength-
power, anaerobic, team sports) in areas which have not previously been investigated, providing 
clear practical implications and future research to inform coaches and performance scientists. 
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Chapter 1 – General Introduction 
 
1.1 INTRODUCTION 
 
Coaches, performance scientists and athletes spend a significant amount of time trying to 
understand the demands of competition to ensure the training stimulus is appropriate and well 
planned to optimise competition performance.  However, understanding competition demands and 
training are only two components that impact overall performance; the pre-competition 
environment, a window on the day of competition in which performance can be acutely enhanced, 
and recovery strategies, are two equally important areas that can improve athletic performance.  
To date, literature has established the demands of competition along with the impact and use of 
training to improve competition performance, however considerably less research has been 
conducted in elite populations in the areas of pre-competition and recovery, specifically that can 
be applied in practice; thus this thesis aims to add to the current body of literature to inform coaches 
and performance scientists of effective pre-competition and recovery strategies available which 
will consider the constraints on the day of competition and provide practical methods to implement 
with athletes. 
 
Several pre-competition strategies have been identified that may positively impact performance, 
for instance a meta-analysis investigating the effects of warm up on physical performance 
highlighted improved performance in 79% of the criterions examined, with improvements ranging 
from 1-20% (Fradkin et al. 2010).  Despite this, 20% of studies showed either no improvement or 
a detrimental effect, however results suggest this is due to an inappropriate warm up that was either 
not suited to the performance test to follow or the intensity, duration and recovery following warm 
up was insufficient to improve performance. This highlights the importance of optimising 
strategies that are available to be used prior to competition.  More recently, Kilduff et al. (2013) 
have identified additional pre-competition strategies to optimise performance across different 
sports.  These have included passive heat maintenance, post activation potentiation, prior morning 
exercise, hormonal priming and limb ischemic preconditioning (IPC).   
 
Athletes can be susceptible to changes in their physical performance as a function of time (Cook 
et al. 2014); they need to ensure they can optimally perform at competition regardless of its timing.  
Opportunities exists on the day of competition to influence subsequent performance, T, for 
instance, is important for sports performance as it can promote increases in voluntary exercise 
(Beaven et al. 2008; Crewther et al. 2014); athlete T levels have been positively correlated to self-
selected workloads (Goto et al. 2007) whilst greater T responses to competition have been 
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associated with higher motivation to win (Hellhammer et al. 1985), thus fluctuations in T could be 
a major factor determining competition performance.  However, T exhibits circadian rhythms in 
basal levels, which are elevated in the morning with a nadir in the late afternoon (Kanaley et al. 
2001; Kraemer et al. 2001).  Previous literature has therefore investigated the use of prior morning 
exercise, aiming to reduce the circadian decline in T and optimise afternoon performance.  For 
illustration, Cook et al. (2014) have reported morning strength training was related to 
improvements in countermovement jump (CMJ) peak power output (PPO) and sprint times 6 h 
later, associated with an offset in circadian decline in testosterone (T).    
 
Limb IPC, or vascular occlusion, is another emerging strategy that has received attention for its 
use in training, however, less research has established its application as a pre-competition strategy.  
Some positive effects on performance have been identified, improving 5 km running time trial 
(TT) (Bailey et al. 2012), 50 m (Lisbôa et al. 2017) and 100 m swim time (Jean-St-Michel et al. 
2011) when used as a pre-competition strategy.  However, the majority of studies have investigated 
the use of limb IPC in un-trained participants (Marocolo et al. 2016).  Ischemia refers to the 
restriction in blood supply to a tissue, causing a shortage of oxygen (O2) required for metabolism 
(Kalogeris et al. 2012). Considering the potential application across different sports, in 
combination with the relative ease of use and minimal required equipment, limb IPC or occlusion 
provides a good option to implement as a warm up in elite sport.  The original concept of IPC 
aimed to reduce myocardial infarct size by applying brief ischemia and reperfusion to an organ or 
tissue and provide protection against subsequent lethal ischemia-reperfusion injury (IRI).  This 
was extended and is a process used to protect cardiac and skeletal muscle against IRI (Zhao & 
Vinten-Johansen 2006) (further detail see section 2.3.1).  Within sport, this strategy has involved 
applying a tourniquet, pressurised cuff or elastic band to a specific limb to restrict blood flow.  The 
aim of external pressures is to maintain partial arterial inflow to the muscle while occluding venous 
return (Pope et al. 2013) resulting in a pooling of venous blood around the exercising muscle when 
occlusion is combined with exercise (Fahs et al. 2012) or create cycles of ischemia and reperfusion 
when applied during passive rest. Typically, limb IPC involves 3-4 cycles of five min occlusion 
and five min reperfusion whilst the athlete lies in a supine position at rest (Thijssen et al. 2016).  
Whereas when vascular occlusion is combined with exercise, occlusion of the limbs occurs for the 
duration of the exercise being performed either continuous or intermittent (see section 2.5.1).  
Manipulation of the protocol differentiates the use of blood flow restriction and associated 
physiological responses, altering mechanisms for application as a pre-competition strategy with 
varying application for strength and power, anaerobic specific events or team sports. 
 
Despite previously identified benefits of completing morning exercise to improve performance 
through attenuations in the decline in T, previous resistance exercise protocols may not be 
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favourable to implement on the day of competition or for specific sports, for example, weightlifting 
would not complete 5x10 bench press in training or competition and therefore lacks practical 
application.  However, as research has proposed the importance of an intensity and volume 
threshold to cause a metabolic response to initiate an acute T response (Cumming et al. 1987) an 
alternative mechanism may be required to allow a reduced volume of repetitions but still produce 
a metabolic and hormonal response.  These sought-after strategies require investigation for 
implementation in elite sport, in which vascular occlusion provides an alternative option.  
Schoenfeld (2013) reported a greater accumulation of metabolites due to increased production in 
a more hypoxic state and limited removal due to occlusion acting as a primary moderator of 
metabolic response.  When resistance exercise is combined with vascular occlusion it has shown 
to increase strength and hypertrophy; this is achieved with lower volumes/intensity of exercise, 
but has still provided a sufficient training stimulus when compared to traditional strength training 
(Slysz et al. 2016; Scott et al. 2015).  One study of particular interest performed five sets of five 
repetitions of three resistance exercises at 70% one repetition maximum (1RM) for three weeks 
(Cook et al. 2014).  Consistent with previous research, an increase in strength was identified, but 
also an occlusion-dependent elevation in salivary T (ES 1.50 to 2.19) immediately after exposure 
was highlighted (Cook et al. 2014), potentially resulting from increased metabolic stress (Suga et 
al. 2012) of vascular occlusion combined with resistance exercise.   
 
Considering the potential role of T in mediating athletic performance, vascular occlusion has 
demonstrated use for stimulating hormone (T; Cook et al. 2014) and also muscle fibre recruitment 
(Takarada et al. 2000; Yasuda et al. 2009) with much lower volumes (25 repetitions at 70% 1RM) 
than in previous morning priming studies (i.e. 50 repetitions at 75% 1RM) (Further details see 
section 2.2.3, Table 2.1).  It has been suggested vascular occlusion with exercise causes an 
increased metabolic response due to restricted venous outflow; greater duration of metabolic 
acidosis via the trapping of and accumulation of intramuscular protocols (H+) and stimulation of 
metabaroceptors, possibly eliciting an exaggerated acute systemic hormonal response (Pope et al. 
2013).  This has not been previously investigated in males or females but as it offers application 
as a pre-competition strategy to offset the circadian decline in T and improve afternoon 
performance of strength and power sports such as weightlifting, it warrants further research. 
 
To note, the majority of research relating hormone response and resistance exercise exists within 
males, however there is evidence of elevated T and self-selected workloads in females (Cook & 
Beaven 2013); back squat performance correlated to individual T levels (r=0.7062; p=0.0103), 
especially when considering the difference in elite versus non-elite females (Cook et al. 2012).  
Cardinale & Stone (2006) observed a significant correlation between T and CMJ JH in elite 
women.  With evidence supporting the potential benefit of T on performance in females, research 
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has not previously investigated the effect of morning exercise on afternoon performance in female 
athletes and therefore warrants further examination. 
 
Alternatively, occlusion applied whilst at passive rest before competition (i.e. limb IPC) is a 
strategy receiving more attention for its use in anaerobic and endurance competition performances.  
Within athletic performance, the benefits of limb IPC have been observed in time to exhaustion 
(De Groot et al. 2010), anaerobic specific performance tests (Jean-St-Michel et al. 2011) and 
repeated sprint ability (Patterson et al. 2015).  Specifically in swimming, limb IPC has shown to 
be beneficial to performance, potentially owing to greater contribution of adenosine triphosphate 
(ATP) generated from the aerobic system following limb IPC which is important for 100 to 400m 
swimming performance as reports have suggested 54.1-61.4% aerobic contribution for 100m and 
83.2-85.5% for 400m (Rodriguez & Mader 2003).  Jean-St-Michel et al. (2011) reported five min 
ischemia followed by five min reperfusion, repeated for four cycles, resulted in 1.1% improvement 
in 100 m performance relative to personal best times.  Similarly, Marocolo et al. (2015) completed 
the same limb IPC protocol prior to performance, resulting in 1.46% improvement in 100 m TT 
(further supporting research see section 2.5.3).  It has been reported limb IPC induces acute 
vascular adaptations, due to the effect of adenosine, resulting in local vasodilation and enhanced 
blood flow (Tapuria et al. 2008).  Consequently, enhanced functional sympatholysis may speed 
and increase O2 extraction by means of matching demand with supply (Horiuchi et al. 2015) 
facilitating aerobic contribution.  Limb IPC can also cause a faster uptake of acetyl Coenzyme A 
(acetyl-CoA) by mitochondria thus maintaining lactate accumulation at a metabolically acceptable 
level due to greater contribution of aerobically generated ATP for exercise (Jean-St-Michel et al. 
2011); this may reduce metabolic fatigue impacting performance (for further mechanism see 
section 2.5.4).  Given the nature of swimming and controlled breathing, which can result in 
exercise induced hypoxemia, decreased pH and metabolic accumulation, a systemic increase in 
blood flow and O2 delivery could be speculated to be advantageous to performance. 
 
These mechanisms are associated with the early phase of limb IPC and have been implemented 
within the 3-4 h window previously reported (Kuzuya et al. 1993).  However, race day is frequently 
congested and restricted by designated warm up timings, strict marshalling regulations and 
additional factors such as race suits and psychological strategies; therefore, alternative options are 
investigated to impact swimming performance due to the marginal time differences for medal 
positions.  As reported within the clinical literature, the application of IPC to harness a second or 
late phase appearing 12-24 h after application (Kuzuya et al. 1993) may have increased practical 
application.  This has only been investigated in one previous study in sport, highlighting a protocol 
of four cycles of five min occlusion and five min reperfusion applied 1 h or 24 h prior to a 5km 
TT did not improve performance.  However, previous research in swimming has identified a 
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consistent improvement in performance unlike that of 5km running TT (e.g. Bailey et al. 2012; 
Tocco et al. 2015).  The mechanisms associated may also have a greater impact for swimming due 
to the associated nature of the sport.  Clinical reports suggest that even after the removal of 
adenosine it still infers a protective effect lasting up to 72 h (Loukogeorgakis et al. 2005) and 
appears dependent on gene expression and de novo synthesis of proteins involving endothelial, 
immune response and cellular energy metabolism (Koch et al. 2014).  Unique to the late phase is 
the role of reactive oxygen species (ROS) triggering delayed protection, nitric oxide (NO) being 
both a trigger and a mediator in the late IPC and prevention of endothelial dysfunction normally 
associated with exercise due to altered neutrophil function; FMD was preserved when IPC was 
applied 24 h prior to exercise (8.7% before and 8.4% after) (Loukogeorgakis et al. 2005).  
Improved endothelial function and prevention of decline in FMD improve aerobic contribution to 
performance (Dawson et al. 2013; Bailey et al. 2012).  The evidenced benefit of limb IPC for 
swimming performance makes it an attractive strategy to apply in elite sport, but the possibility of 
applying limb IPC 24 h would improve practicality and prevent additional requirements in an 
already busy schedule on the day of competition and therefore warrants further investigation in 
elite swimming performance. 
 
As specified, the importance of recovery and application of recovery strategies is also a key 
component that can improve athletic performance during ever increasing congested competition 
schedules.  Acute and chronic exercise induced physiological adaptations, mechanical and 
biochemical changes occur in response to exercise which cause fatigue, this includes both central 
and peripheral fatigue (Bishop et al. 2008).  Short term fatigue resulting from athletic performance 
has been negatively linked to subsequent performance (Montgomery et al. 2008), injury (Bishop 
et al. 2008) and even illness (Cunniffe et al. 2011).  Recovery has therefore become an integral 
part of training and competition to optimise performance. Accordingly, various methods are used 
in applied practice to indicate the presence of exercise induced muscle damage (EIMD) and fatigue 
to inform recovery required following competition before successive workouts or indicate 
readiness for the next training session (Ferguson et al. 2014; Bishop et al. 2008).  Specifically 
within team sport, elevated Creatine Kinase (CK) (Cunniffe et al. 2010; Russell et al. 2016), 
disruption in T and cortisol (C) hormonal milieu (Shearer et al. 2015) and impairments in 
neuromuscular function (NMF) have been measured to identify responses which occur post-match 
(West et al. 2014) and have shown to be disrupted for at least 48 h (West et al. 2014; Russell et al. 
2016).  Since multiple games are played in the week (<72 h separating games) recovery strategies 
are integral components in the weekly training regimen to prevent any negative effects on 
performance.  However, since the causes of fatigue are varied, depending on the nature of exercise, 
there are several approaches to restoring homeostasis of the muscle cell (Bishop et al. 2008).  
Numerous recovery strategies have been reported in the literature; results of a meta-analysis by 
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Nédélec et al. (2013) highlighted cold water and contrast therapy (88% teams), active recovery 
(81%), massage (78%), stretching (50%), compression garments (22%) and electrical stimulation 
(13%) were the recovery strategies used in team sport.  However, many of these strategies have 
limitations for application due to required equipment, space, time and cost, with literature also 
reporting contrasts in the effectiveness of each of these strategies.  Ice baths for instance decrease 
muscle temperature which may be negative for multiple efforts or games performed in one day of 
competition.   
 
Acknowledging the importance of recovery as one component to improve performance, additional 
recovery strategies are sought after.  Recently, vascular occlusion, the use of blood pressure cuffs 
applied to specific limbs, whilst in the supine position, to restrict blood flow, has become more 
prevalent as a recovery strategy (Beaven et al. 2012; Page et al. 2017).  However, there are many 
unanswered questions and limited investigations to date, with inconsistencies in the current 
literature.  Vascular occlusion follows a similar protocol for use as a recovery strategy as that 
discussed for limb IPC.  Other than timing of application, the athlete is rested in the supine position 
when cuffs are applied, inflated and deflated for cycles of occlusion (ischemia) and reperfusion.  
Variances exist between continual and intermittent occlusion within the recovery literature (see 
section 2.6) with further differences in duration of occlusion; successful studies have implemented 
two cycles of three min occlusion and three min reperfusion and three cycles of five min occlusion 
and five min reperfusion (Beaven et al. 2012; Page et al. 2017).  These two studies (out of five 
investigating occlusion for recovery; see section 2.6 for all studies) have found a benefit of vascular 
occlusion on recovery rate (Beaven et al. 2012; Page et al. 2017), however, the exact mechanisms 
of how this strategy improved performance are debated.  Reports suggest vascular occlusion raises 
the level of adenosine, causing an increase in blood flow and thus O2 and nutrient delivery due to 
the associated dilation of vasculature, believed to be exaggerated in the reperfusion phase once the 
cuff pressure is released (see section 2.6.2 for further detail).  Alternatively, attenuated 
inflammatory response (Konstantinov et al. 2004) and reduction of muscle oedema and 
intramuscular pressure decrease nocioreceptor stimulation, potentially reducing muscle soreness 
(Howatson & van Someren 2008).  Page et al. (2017) identified increased recovery of CK 
following vascular occlusion.  However, only one indicator of recovery and research completed in 
un-trained participants reduces practical application, therefore, replication of current research 
protocols in elite athletes with physiological markers is required to identify the efficacy of 
occlusion as a recovery strategy. 
 
While some research has been completed into the use of limb IPC and vascular occlusion for pre-
competition and recovery, there are still numerous unanswered questions in multiple areas of this 
research area, however specifically for the focus of this thesis, there are many unanswered 
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questions on practicality and application for elite athletes spanning a range of sports.  A broad 
question links to participants and methodological protocols; limited research has investigated the 
use of limb IPC or vascular occlusion in elite athletes, a large majority of literature is reported in 
healthy un-trained males, which has limited application in elite sport as it is difficult to transfer a 
possible positive effect to an elite population due to differences in physiological responses in 
comparison to un-trained participants (Marocolo et al. 2016).  For example, statistically significant 
differences have been observed in systolic blood pressure and heart rate both before and after 
exercise (p<0.001) between trained and un-trained males.  Trained athletes are able to increase 
their systolic blood pressure with relatively lower heart rates as compared to untrained individuals 
(Vandavasi & Sukumar 2016).  Furthermore, research has suggested a faster recovery of muscle 
function when compared to an untrained group (Newton et al. 2008) and therefore efficacy of 
recovery strategies may vary between trained and untrained individuals. 
 
Within elite sport it is essential all strategies are individualised, however previous research has 
implemented a standardised cuff pressure despite research acknowledging the same pressure may 
not restrict blood flow similarly in each individual, especially since the amount of tissue 
surrounding the blood vessels influences the pressure exerted on the vasculature and impacts the 
degree of blood flow restriction (Hargens et al. 1987).  Thicker skin and subcutaneous fat in the 
thighs may act as a barrier between the occlusion cuffs and circulatory pathways resulting in low 
or no change in the diameter of the targeted blood vessels and minimising overall effect of external 
pressure (Karabulut & Perez 2013).  It is likely the degree of intramuscular pressure depends on 
the architecture features of the muscle (Hunt et al. 2016) with hypertrophied muscles having an 
increased volume of tissue than fat and therefore less pressure is required to restrict the vasculature 
(Wernbom et al. 2006).  Initial investigations suggested pressures to restrict blood flow of the 
lower limbs should be determined by limb circumference for both sexes (Loenneke et al. 2012) 
with more recent research supporting this finding, however, research has identified brachial blood 
pressure may be an additional significant predictor (Loenneke et al. 2015).  Therefore, to ensure 
practical application and individualisation for elite athletes to improve performance, this is an area 
requiring further investigation to determine application in elite sport.  There are also three very 
specific areas where questions are unanswered relating to elite sport, potentially offering 
application on the day of competition due to protocols and associated mechanisms identified in 
Figure 2.4 Section 2.3.  Firstly, the use of vascular occlusion combined with exercise performed 
the morning prior to afternoon performance has not received any attention despite hormonal 
response observed previously (Cook et al. 2014) when performing a lower volume of resistance 
exercise than adopted in morning priming strategies (Russell et al. 2015), with the lower volume 
of exercise favourable for athletes to complete prior to competition.  Secondly, only one study has 
researched the effect of the delayed phase of IPC on performance, with potentially excellent 
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practical application as the timings would not be restricted by competition day timelines of strict 
marshalling regulations and warm up timings for example, in addition to the consistent supportive 
research of the use of limb IPC to improve swimming performance, it may be an attractive strategy 
for elite athletes and coaches.  Thirdly, vascular occlusion provides a practical strategy for recovery 
due to limited required equipment and space, suitable for use when travelling away, however, 
research is contrasting and minimal in elite athletes providing too many questions at present to 
implement within elite sport. 
 
The research questions and practical application for elite sport were designed in accordance to the 
models proposed by Jones et al. (2017) and Coutts (2016) in which strategies have been designed 
to undertake and integrate research into practice, suggesting the researcher to develop not inform 
practice, as development is more synonymous with a successful integrated research practice model 
(Jones et al. 2017).  The models are built upon Kahneman 2011 ‘Thinking, Fast and Slow’ and 
Pasteur’s Quadrant 2007, developing a continuum of research and practice, assessing ‘on-field’ 
and ‘off-field’ brains to develop practice (Jones et al. 2017). 
 
Therefore, the overall aims of this thesis were to assess the use of vascular occlusion and limb IPC 
for use pre-competition and recovery across elite athletes, both individual and team sports, 
implementing individualised cuff pressures for all strategies.  The specific objectives to be realised: 
i. Investigate the use of vascular occlusion during resistance exercise in the morning (5 h 
prior) as a priming strategy to improve afternoon strength/power performance including 
identifying hormone response and the difference in response between sexes (Chapter 4) 
ii. Investigate the use of limb IPC applied in the early (2 h) and late (24 h) phase on swimming 
performance (Chapter 5) 
iii. Investigate the use of vascular occlusion as a recovery strategy following sprint exercise 
in team sport (Chapter 6) 
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Chapter 2 – Review of Literature 
 
2.1 INTRODUCTION 
 
The purpose of this review was to evaluate and appraise current research that examined the use of 
vascular occlusion and limb IPC on exercise performance when used as pre-competition and 
recovery modalities; the following review is separated into sub-sections.  Section 2.2 provides an 
overview of the theoretical background for the use of pre-competition in elite sport, providing 
discussion around potential pre-competition strategies and associated physiological mechanisms, 
inclusive of hormone response.  This will be followed by recovery strategies used in elite sport 
and a rationale for how this can positively impact athletic performance. 
 
Section 2.3 provides a review of vascular occlusion and limb IPC, a definition and the clinical 
background to establish the origin of this strategy, providing context to the following sections.  
This is followed by section 2.4 and 2.5 which will discuss the impact of vascular occlusion and 
limb IPC on athletic performance, split into two sections of pre-competition and recovery, 
respectively.  Within each section, current literature available will be reviewed along with reported 
mechanisms impacting performance.  These sections aim to demonstrate that research to date has 
numerous questions regarding the application and protocol of limb IPC and vascular occlusion and 
where limitations lie regarding implementation in elite sport. The following criteria was used to 
determine research reviewed and the following criteria excluded articles from this section of the 
review: (i) articles that were review papers, (ii) articles that did not report outcomes directly 
relating to exercise performance, (iii) articles that examined sedentary participants or included 
participants under 18 or over 40 years (iv) articles that examined multiple or repeated (daily) 
application of limb IPC and vascular occlusion.  
 
Section 2.6 will discuss variables of blood flow restriction, including cuff pressure and thus will 
aim to provide rationale for the methodology for limb IPC and vascular occlusion in the 
experimental chapters. Section 2.7 will discuss methodological considerations of saliva as a 
medium to measure hormone response along with safety considerations of vascular occlusion, 
before providing conclusions in section 2.8. 
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2.2 PRE-COMPETITION AND RECOVERY STRATEGIES IN ELITE SPORT 
 
Coaches, performance scientists and athletes spend a significant amount of time understanding 
competition demands and ensuring training is appropriate and well planned to result in optimal 
performance at competition.  However, training is only one component impacting performance, 
alongside competition itself, pre-competition and recovery are two keys areas that can improve 
athletic performance. 
 
2.2.1 Pre-competition strategies 
Pre-competition strategies can acutely enhance performance with appropriately designed warm up, 
passive heat maintenance, post activation potentiation, prior exercise and hormonal priming and 
limb IPC all reported as strategies implemented within elite sport (Kilduff et al. 2013).   
 
The pre-event warm up is a well-established practice preceding athletic events (Pearce et al. 2012), 
acting as a means to prepare the body for impending training or competition (Sporer et al. 2012).  
Evidence to support the positive aspects of an active warm up on performance is extensive, with 
coaches and athletes supporting this view from a practical perspective; prior physical activity is 
considered a vital component of preparation for optimal performance (Houmard 1991).  A meta-
analysis investigating the effects of warm up on physical performance highlighted enhanced 
performance in 79% of the criterions examined, with the degree of improvement ranging from 1-
20% (Fradkin et al. 2010), the importance of completing warm up is therefore evident within 
competitive sport.  A recent report has also shown 16 of 21 outcome pairings highlighted a positive 
effect of a high-load dynamic warm up to enhance power and strength performance (McCrary et 
al. 2015).  Despite this, Fradkin et al. (2010) highlighted 20% of studies showed no improvement 
or a detrimental effect consequence of either an inappropriate warm up not suited to the 
performance to follow,  intensity and duration were insufficient or the time delay between warm 
up and performance prevented improved performance (e.g. West et al. 2013) .   
 
The theoretical intention behind the interest afforded to warm up is to reduce the potential risk of 
injury and enhance performance by increasing muscle temperature and/or core temperature 
(Bishop 2003).  Previous literature has documented the beneficial effects of an active warm up are 
the consequence of temperature dependent physiological processes; this is outside the scope of this 
review, for further detail refer to Bishop (2003).  Research has also observed that the physiological 
responses to warm up may not be solely related to temperature and in fact can be categorised into 
temperature and non-temperature related factors (Bishop 2003).  For example, existing evidence 
suggests that temperature alone is not deterministic of the volume of oxygen (VO2) response and 
subsequent performance (Burnley & Jones 2007).  Therefore, the concepts of ‘priming’ and ‘prior 
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exercise’ are appropriate in describing strategies available to coaches and performance scientists 
to implement prior to competition to improve performance through physiological mechanisms 
other than those related to temperature (Bishop 2003).  The proposed benefits of priming are to 
prepare the energy systems involved in O2 transport and utilisation, allowing the athlete to reach a 
higher level of aerobic metabolism more rapidly (Bishop et al. 2001; Bishop et al. 2003).  
Additional physiological (metabolic, biochemical, neuromuscular) benefits of priming exercise 
have been reported to improve performance, for example priming exercise seems to increase blood 
flow, oxygenation, oxidative enzyme activity and electromyography (EMG) activity and accelerate 
the overall VO2 response (Jones et al. 2003). Ingham et al. (2013) reported an increase of 
1.84mmol×L-1 in blood lactate and 1.43 s faster 800 m running performance following prior 
exercise.  It was reported the intervention increased the speed of O2 kinetics and spared the 
anaerobic metabolism (Intervention: 68% aerobic and 32% anaerobic contribution; Control: 62% 
aerobic and 38% anaerobic contribution).  Higher initial rates of ATP hydrolysis have also been 
associated with prior exercise and possible influences on performance (Bailey et al. 2011).   
 
An alternative priming strategy has been termed post activation potentiation, this is a method 
reported to improve muscle performance following a pre-loading stimulus due to an increase in 
muscle twitch force or H-reflex amplitude following prior contraction (Gullich & Sehmidtbleicher 
1996; Trimble & Harp 1998).  The mechanisms of muscle potentiation and fatigue co-exist and 
any resulting performance benefits are dependent on the balance between these two factors 
(Kilduff et al. 2013); the optimal recovery time to maximise the effect of post activation 
potentiation on PPO has been reported between 8 and 12 min for the lower body (Kilduff et al. 
2007; Kilduff et al. 2008; Crewther et al. 2011; Seitz et al. 2015).  Therefore, as with active warm 
up, relatively close proximity (10-20 min) of completion prior to competition is required, which 
may be limited by logistics and strict marshalling regulations at competition.   
 
Significant barriers and challenges are present within sport, preventing the completion of optimal 
pre-competition (priming) routines; this includes time delays, the environment and logistics of 
sporting competition (Sporer et al. 2012).  However, there is opportunity for coaches and athletes 
to apply several pre-competition strategies and optimise alternative physiological aspects other 
than temperature-related mechanisms to improve performance, for instance limb IPC may be 
applied to increase blood flow prior to performance, with reports suggesting application 15 min to 
8 h prior to performance.  One aim of this thesis is to look at alternative options to optimise athletic 
performance, that would be practical to implement within elite sport, subsequently the use of prior 
exercise, hormonal priming and limb IPC will be discussed for use as pre-competition strategies. 
The following section will highlight mechanisms involved in prior exercise, hormonal priming; 
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the mechanisms associated with limb IPC and sport performance will be outlined after clinical 
mechanisms of IPC have been discussed. 
 
2.2.2. Hormone response to exercise 
Aside from priming mechanisms discussed above, the effects of androgen T on strength and muscle 
adaptations to exercise have been well reported (Sinha-Hikim et al. 2004).  Testosterone is a steroid 
hormone produced from cholesterol via a series of conversions catalysed by specific enzymes 
(Vingren et al. 2012) and T is considered a key anabolic hormone with multiple physiological 
functions in the human body.  The primary production site of T is the Leydig cells, found in the 
testes, which explains approximately 10-fold higher circulating concentrations in men (Vingren et 
al. 2012).  Whereas T is produced in small quantities in the ovaries and the zona reticulans of the 
adrenal cortex in women (Maroulis & Triantafillidis 2006), conversion of androgens is another 
source of T in females (Vingren et al. 2012).  The signal for T production and release originates in 
the hypothalamus which is innervated by the central nervous system (CNS) and provides a direct 
link between the nervous and endocrine systems (Kim 2007).  Within the hypothalamus, 
gonadotrophin releasing hormone (GnRH) is produced and secreted, this stimulates the production 
and release of lutenising hormone (LH) and follicle-stimulating hormone (FSH) from the 
gonadotrophs (Kim 2007).  In the gonads, LH stimulates T production in the Leydig cells of men 
and theca cells of women; LH binds to a G-protein coupled membrane receptor which activates 
cyclic adenosine monophosphate-dependent protein kinases (protein kinase A) which stimulates 
the rate limiting step in T synthesis (Miller 1988).  In women, T is further processed to estradiol 
in the granulosa cells adjacent to the theca cells, FSH stimulates production of pregnenolone in the 
granulosa cells and steroid binding protein production in the liver (Vingren et al. 2012).  The signal 
cascade from FSH is similar to that induced by LH in the theca and Leydig cells; pregnenolone 
can leave the granulosa cells for the theca cells where it can be further processed to T (Vingren et 
al. 2012).  Initiation of the hypothalamic pituitary gonadal (HPG) axis, leading to T release, is 
caused either by direct nervous stimulation of the hypothalamus by the CNS or by reduced 
feedback inhibition on the hypothalamus by T (Vingren et al. 2012).  Testosterone induces negative 
feedback on the hypothalamus to reduce GnRH release and the gonadotrophs in the anterior 
pituitary to reduce the release of LH and FSH in response to GnRH; the signal for increased T 
response with exercise is controlled at the hypothalamus (Vingren et al. 2012). 
 
Testosterone is important for sports performance as it can promote increases in voluntary exercise 
(Beaven et al. 2008; Crewther et al. 2014); athlete T levels have been positively correlated to self-
selected workloads (Goto et al. 2007) whilst greater T responses to competition have been 
associated with higher motivation to win (Hellhammer et al. 1985), thus fluctuations in T could be 
a major factor determining competition performance.  For example, within elite populations, 
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Crewther et al. (2012) found salivary T concentrations to be highly correlated with both squatting 
(r =0.92) and sprint times (r =0.87) in elite strength trained athletes, but not so much in their less 
strong counterparts. 
 
Research suggests total T and free T are elevated following heavy resistance exercise in men.  
There appears to be a relative intensity and volume threshold that must be reached to induce a T 
response; it is well known that brief, intense physical exertion increases the circulating T levels 
(Cumming et al. 1987).  Acute exercise increases T linearly once a specific threshold intensity is 
reached, with peak concentrations usually occurring at the end of exercise.  From a physiological 
perspective, Lin et al. (2001) observed that lactate in-vitro dose-dependently increased the 
production of T by acting on rat Leydig cells; intensity and volume therefore need to be sufficient 
to induce this response.  Further research by Ratamess et al. (2005) showed that six sets, but not 
one set of 10 repetitions of squats significantly increased total T post exercise, suggested to be the 
result of a larger increase in lactate and high metabolic demand.  Beaven et al. (2008) also 
identified greatest increase in T (13.1 ± 19.9%) following three sets of five repetitions performed 
at 85% of 1RM and also following four sets of ten repetitions performed at 70% 1RM (increase 
11.3 ± 19.7%) whereas three sets of five repetitions performed at 40% 1RM caused a 3.5 ± 29.7% 
decrease in T.  These studies highlight the importance of both intensity and volume to stimulate 
an increase in T. 
 
Alongside T, C is also a biomarker of particular interest in sport (Cook et al. 2014).  Cortisol, the 
principal glucocorticoid in humans, or otherwise known as the major stress hormone, targets an 
array of both peripheral and central processes (Lupien et al. 2007); the regulation of stress-induced 
as well as basal C secretion is thus essential for the maintenance of homeostasis (McEwen 2000; 
Tsigos & Chrousos 2002).  Cortisol is released from the adrenal cortex in response to stress during 
exercise (Kon et al. 2012), and promotes catabolism via decreased protein synthesis and increased 
protein degradation (Kraemer & Ratamess 2005).  When triggered outside of circadian rhythms, 
C release is specific to stress (Herman et al. 2005).  The key target of the various direct and indirect 
pathways is the paraventricular nucleus (PVN) of the hypothalamus (Herman et al. 2005), upon 
perception of acute stress, cells within the PVN release corticotropin releasing hormone which 
travels through the infundibulum to the pituitary gland where it stimulates secretion of 
adrenocorticotropic hormone (ACTH) into the bloodstream (Dedovic et al. 2009).  ACTH binds 
to receptors in the adrenal cortex, that stimulate secretion of C into the blood stream.  The majority 
of cells in the human body have receptors for C, thus having a broad variety of effects including 
metabolic, cardiovascular and immune responses (Buckingham 2009; McEwen 2000).  
Glucocorticoids are released from the adrenal cortex in response to the stress of exercise, of which 
C accounts for approximately 95% (Kraemer & Ratamess 2005).  Due to the major role C plays in 
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tissue remodeling, acute and chronic changes in response to resistance exercise have been 
examined (Kraemer & Ratamess 2005). 
 
In sport, C is often used as a marker of both physiological and psychological stress (Teo et al. 
2011), prolonged elevation of C has been shown to exhibit an inhibitive effect on the 
neuromuscular system (Teo et al. 2011).  For example, Tafet et al. (2001) reported a negative 
correlation between physical performance and prolonged elevated salivary C levels.  However, the 
rapid hormone response to maximal exercise promotes the mobilisation of energy reserves during 
physical activity by stimulating gluconeogenesis, promoting lipolysis and increasing protein 
catabolism (Viru & Viru 2004).  Previous research has highlighted that the magnitude of the acute 
endocrine response is influenced by the intensity and volume of the resistance exercise with high 
volume, moderate to high intensity protocols eliciting greater C responses (Kraemer & Ratamess 
2005).  For example, Kim (2007) reported significant increases in C in females in response to three 
sets of ten repetitions at 80% 1RM.  Thus, the C response to resistance exercise appears to be 
dependent on the stress and metabolic requirements of the exercise (Goto et al. 2005).  
 
The impact of exercise on hormone response in females is not so clear, with an increase in free T 
following resistance exercise found in some studies  (Nindl et al. 2001; Copeland et al. 2002; 
Häkkinen & Pakarinen 1995; Vingren et al. 2009) but not all studies (Linnamo et al. 2005; Kraemer 
et al. 1993; Marx et al. 2001), along with inconsistent evidence of C response to exercise.  For 
example, Linnamo et al. (2005) demonstrated no changes in total T following five sets of ten 
repetitions for three exercises using three different loading conditions.  Whereas in men, the same 
maximal loading condition lead to a significant increase in total T (Linnamo et al. 2005).  Kraemer 
et al. (1991) measured serum T levels before, during, and after resistance exercise and found that 
circulating T is significantly increased in males and was not changed in females throughout the 
duration of the exercise.  This is supported by Weiss et al. (1983) investigating sex differences in 
androgen response to heavy resistance exercise.  The T levels of 20 men and 20 women were 
measured following weightlifting; T increased significantly in men by 21.6% but the increase was 
not significant in women (16.7%), with men having 43% higher resting levels than women.  The 
biological mechanisms for a potential exercise-induced increase in T might be different in females 
as they do not have Leydig cells and Kvorning et al. (2007) have shown that the Leydig cells are 
likely involved in acute resistance exercise-induced increase in T in men.  In comparison Edwards 
& Neal (2009) identified an increase in T from pre-to post competition in female athletes from 
intercollegiate sport, reporting oral contraceptive users and non-users, whether analysed by 
absolute change in T level or by percent change from before-competition value, increased in 
response to competition. This effect is in accordance with reports for college-age women rugby 
players (Bateup et al. 2002).  However, it has also been acknowledged that a simulated team 
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handball match did not increase saliva T (Filaire & Lac 2000), suggesting (by comparison to the 
results reported above) that a simulated competition lacking meaning to participants may be 
relatively ineffective in elevating T level in comparison to a competition fixture.  Furthermore, 
Cook & Beaven (2013)  suggested elite female athletes have higher baseline T levels than non-
elite females and secondly individual T concentrations demonstrated strong relationships with self-
selected workloads during training, similar to results reported in male participants.  Therefore, this 
provides evidence elite females may exhibit similar T response to exercise.  The variation in 
previous research may be explained by previous research not considering the effect of competition, 
athlete level and menstrual cycle or oral contraceptives (e.g. Dabbs & de La Rue 1991; Sellers et 
al. 2007). 
 
The nature of inter-hormonal dynamics in females and response to exercise requires more research.  
Pronounced levels of estradiol levels occur over the course of the menstrual cycle with low levels 
in the early follicular phase, which peak shortly before or during ovulation and slowly decrease 
throughout the luteal phase (Kirschbaum et al. 1999).  In women, T serves as a precursor for 
estradiol, the primary (pre-ovulation) peak and secondary (luteal) peak of T are followed by similar 
peaks of estradiol (Celec et al. 2009) (Figure 2.1).  However, research has suggested when adding 
day of menstrual cycle into a regression model to test if stability changed as a function of menstrual 
cycle phase, the effect of menstrual cycle on stability was non-significant for T and C, for instance 
C was found to be highly stable in both men (r =0.93) and women (r =0.73) (Liening et al. 2010).  
Basal C levels before stimulation or immediately after awakening in the morning did not show 
cyclic variation when previously measured in the follicular versus luteal phase, in agreement with 
previous reports (Fujimoto et al. 1986; Kanaley et al. 1992).  Research has shown men, and women 
in the luteal phase had the largest salivary free C responses, which were clearly enhanced when 
compared to women in the follicular phase in response to a psychosocial test (Kirschbaum et al. 
1999).  In contrast to the biologically active free hormone fraction, total blood C levels masked 
these differences with similar levels between the groups, this may suggest female adrenal cortex 
may be more sensitive to ACTH (Roelfsema et al. 1993; Horrocks et al. 1990) with no apparent 
change of net C secretion in follicular compared to luteal phases (Kirschbaum et al. 1999).  The 
capacity of the female adrenal cortex to synthesise and secrete C in response to maximal 
stimulation is similar to that of men.  However, when in the luteal phase, women may display 
higher circulating salivary free C levels after ACTH stimulation (Kirschbaum et al. 1999).  
Following morning and evening measurement of salivary hormone concentrations across one 
menstrual cycle (luteinising hormone marked mid-cycle), it was concluded that the menstrual 
cycles were statistically significant but smaller than daily cycles or individual differences (Dabbs 
& La Rue 1991). 
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The use of oral contraceptives should also be considered when examining women’s baseline T, C, 
and response to training and competition.  Oral contraceptives can decrease the blood or salivary 
levels of T and other androgens in healthy women (Coenen et al. 1996; Graham et al. 2007; 
Wiegratz et al. 2003; Zimmerman et al. 2014).  Oral contraceptives are low doses of exogenously-
administered synthetic hormones for the naturally occurring levels of estrogen and progesterone 
that would otherwise vary systematically as part of a normal menstrual cycle (Edwards & Neal 
2009).  Reports highlight oral contraceptive users have significantly lower saliva T values than 
non-users which may result from decreased ovarian secretion of T owing to oral contraceptive 
inhibition of hypophyseal secretion of FSH and LH.  Moreover, oral contraceptive-related 
decreases in free T levels are much greater (61%) than those observed for total T (31%) and likely 
due to oral contraceptive-related increase in steroid binding proteins (e.g. sex-hormone binding 
globulin) (Coenen et al. 1996; Zimmerman et al. 2014), thereby reducing the bioactive free steroid, 
along with suppression of ovarian and adrenal androgen synthesis (Zimmerman et al. 2014).   
Schultheiss et al. (2003) determined the impact of menstrual cycle phase and oral contraceptive 
use on steroid hormone levels in saliva; T levels were significantly lower in women using oral 
contraceptives, matching other research that found the same effect (Edwards & Neal 2009; Anders 
& Watson 2006; Wirth & Schultheiss 2007), however, Schultheiss et al. (2003) found that T levels 
did not significantly differ across the menstrual cycle for both normally-cycling women and 
women using oral contraceptives.  It is worth noting, oral contraceptive use did not account for 
any significant differences in levels of C or progesterone.  
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Figure 2.1 Dynamic changes of salivary estradiol, progesterone and testosterone during one 
menstrual cycle in young healthy women (Adapted from Celec et al. 2009) 
 
 
 
Days 
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However, research has suggested that women using oral contraceptives were found to repeatedly 
show blunted free C responses to psychosocial or physical stress (Kirschbaum et al. 1996).  It is 
unknown whether lower free C responses reflect a hypo-reactive HPA axis or if oral contraceptive 
users secrete similar amounts of C, but due to increased production of corticosteroid-binding 
globulin induced by oral contraceptive medication, the biologically active free C fraction is largely 
reduced (Kirschbaum et al. 1999).   Whereas contrasting research has reported oral contraceptive 
use was associated with lower levels of T, but did not affect C levels (Liening et al. 2010); for 
instance, when adding oral contraceptive use into a regression model to test if stability changed as 
a function of oral contraceptive use, the effect of oral contraceptives on stability was non-
significant for both T and progesterone (Liening et al. 2010).  In contrast, oral contraceptive use 
was found to significantly affect C (p=0.01), however, women using oral contraceptives had a 
higher stability coefficient (r =0.81, p<0.01) than normally-cycling women (r =0.75, p<0.01) 
(Liening et al. 2010).  
 
Although oral contraceptive users are responsive to sports competitions (Edwards & Casto 2013), 
some research has demonstrated oral contraceptive users display lower absolute T levels in 
response to training and competition (Crewther et al. 2015).  However, Edwards & Neal (2009) 
demonstrated although oral contraceptive users had significantly lower saliva T levels than non-
users before and after competition, both users and non-users showed virtually the same increase in 
saliva T over the course of a competition suggesting reporting the change in T response may be 
beneficial for females within future research.  Furthermore it has been evidenced that individual 
differences in levels of salivary C (Liening et al. 2010) and T tend to be relatively stable (Edwards 
& Kurlander 2010). 
 
2.2.3 Circadian rhythmicity and morning exercise 
Both T and C basal levels exhibit circadian rhythms, which are elevated in the morning with a 
nadir in the late afternoon (Kanaley et al. 2001; Kraemer et al. 2001).  Accordingly, circadian 
rhythmicity of specific physiological responses such as endocrine release have been proposed to 
modulate characteristics deemed key to sports performance (Teo et al. 2011).   Circadian rhythms 
are endogenous biorhythms that persist on cyclic periods of approximately 24h and have been 
shown to influence a wide array of physiological systems (Hadley & Levine, 2006).  In humans, 
the primary circadian pacemaker is the suprachiasmatic nucleus (SCN) which is located within the 
hypothalamus (Teo et al. 2011).  The SCN receives direct input regarding the solar cycle from the 
retina (Hastings & Herzog 2004).  With this information, the SCN coordinates daily biological 
rhythms (i.e. hormone secretion, temperature fluctuations, neural activation) in line with the solar 
time and sleep wake cycle (Buijs et al. 2003; Waterhouse et al. 2005).  Many physiological 
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functions associated with athletic performance have been shown to follow a specific circadian 
rhythm (Winget et al. 1985).   
 
The basal concentrations of T and C are regulated by the hypothalamus, as previously discussed, 
by pulsatile secretion that defines both ultradian and circadian rhythmicity (Beaven et al. 2010).  
There are many underlying factors contributing to circadian rhythms in physical performance.  
These factors can stem from both internal (physiological) and external (environmental) changes 
that occur throughout the day (Teo et al. 2011).  Reilly & Waterhouse (2009) identified 3 major 
determinants in the contribution towards a circadian rhythm in sporting performance.  The first 
determinant takes into consideration external (environmental) influences that are usually 
uncontrollable.  The second determinant involves internal (physiological) influences and lastly 
lifestyle (psycho-biological) influences affecting timing preferential in activities and sleeping 
patterns.  Regarding the internal physiological influences, Buśko & Opaszowski (2005) have 
shown rapid elevation in T, unlikely to be explained by the ‘typical’ hormonal cascade of HPG 
axis activation, which involves the release of secretagogines from the arcuate nucleus and anterior 
pituitary gland (Beaven et al. 2010).  The pulsatile release and rapid changes of endogenous 
steroids as a result of an exercise stimulus, overlay the circadian rhythm and characterise an 
ultradian rhythm that has the effect of exposing tissues to large fluctuations of hormones (Young 
et al. 2004; Veldhuis et al. 2008).  Acknowledging the circadian rhythmicity of T and C, there is 
opportunity to influence competition performance as resistance exercise has shown to increase T 
and pre-workout T levels have correlated with the snatch (r =0.70) and clean and jerk (r =0.62) 
1RM lifts in males.  The benefits of resting T concentrations and exercise performance during tests 
of power and strength have been established (Cardinale & Stone 2006); T contributes to 
neuromuscular performance and has been shown to produce rapid changes in intracellular calcium 
(Ca2+) in muscle cells (Estrada et al. 2003) which can regulate membrane potential and muscle 
contractility (Crewther & Cook 2010).  Considering the potential role of T in mediating athletic 
performance, it could be advantageous to attempt to offset the circadian decline in T as athletes 
maybe requested to perform in both the morning and afternoon (Cook et al. 2014). 
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Table 2.1 The influence of early morning physical activity on afternoon performance 
(Author & Date) AM exercise Time between AM & PM 
measures (h) 
PM performance Outcome 
(Cook et al. 2014) 1.Running 5x40m sprints 
2.Weights 3RM bench 
press & squat 
3.Passive rest 
6 3RM bench & squat, 40m 
sprint, CMJ 
Weights improved PM 
performance & reduced 
decline in T AM to PM 
(Ekstrand et al. 2012) 1.Back squat to failure and 
4 reps per set power clean 
2.Passive rest 
4-6 Backward overhead shot and 
VJ 
Increased throws but not jump 
performance 
(McGowan et al. 2016) 1.1200m swim 
2.1200m swim & land 
resistance exercise 
3.Passive rest 
6 100m swimming TT 1.6% and 1.7% improvement 
swim performance from AM 
exercise 
(Russell et al. 2015) 1.Bench press 5x10 at 
75%1RM 
2.Cycling 6x6s sprint 
3.Running 6x40m sprints 
4.Passive rest 
5 CMJ, reaction time, repeated 
sprint ability (6x40m) 
PM sprint improved & 
reduced decline in T AM to 
PM after AM weights & 
running. PM jump height 
increased after cycling & 
running.  
AM – morning; PM – afternoon; CMJ – countermovement jump; VJ – vertical jump; RM – repetition maximum; T - testosterone 
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Of practical importance, early morning physical activity may influence subsequent activities 
performed later in the day (Ekstrand et al. 2012).  Considering competition is frequently held in 
the late afternoon when T has declined, athletes may be susceptible to changes in their physical 
performance as a function of time, as morning training may influence afternoon performance 
(Cook et al. 2014) (Table 2.1).  Previous research by Ekstrand et al. (2012) demonstrated that a 
morning resistance session improved throwing performance in well trained shot putters when 
measured in the afternoon.  This has been supported by McGowan et al. (2016), finding morning 
exercise improved afternoon running and swimming performance, respectively.  However, 
hormone concentrations were not measured within this previous research, whereas additional 
research completed by Cook et al. (2014) reported morning strength training was associated with 
improvements in CMJ PPO, 40 m sprint times, 3RM bench and squat performance performed 6 h 
later in rugby union players in alignment with research in this area.  However, a strength of this 
research highlighted morning strength training offset the circadian decline in T.  Further research 
by Russell et al. (2015) measured the hormone response to the effect of morning exercise on the 
circadian decline in T, whilst also acknowledging the practical considerations associated with pre-
competition practices and the limited application of the methods of morning exercise examined 
previously.  Therefore, four interventions were assessed; control, weights, cycling and running 
(Table 2.1).  After 5 h rest, 3 CMJ and repeated sprint ability were assessed.  Afternoon sprint 
performance improved after weights and running, with greater T concentrations in the afternoon 
following weights (+17 ± 18%, p=0.002).  Despite acknowledging practical application, five sets 
of ten repetitions is still a high volume for some athletes and sports such as weightlifting, where T 
may impact performance, therefore alternative strategies are well sought after, evidencing the 
practical opportunity to implement vascular occlusion. 
 
2.2.4 Fatigue and recovery 
Sport performance and training can result in short term fatigue due to induced physiological 
adaptations, mechanical and biochemical changes (Bishop et al. 2008) which can negatively affect 
subsequent performance or result in injury (Bishop et al. 2008) or illness (Cunniffe et al. 2011).  
Fatigue has previously been defined as sensations of tiredness and associated decrements in 
muscular performance and function (Kay et al. 2001; Green 1997; Millet et al. 2002; Pinniger et 
al. 2000).  As fatigue is considered an inevitable and negative consequence of physical activity 
(Kay et al. 2001; Pinniger et al. 2000) there has been much research into its effect on exercise 
performance (Millet et al. 2003; Millet et al. 2000; Gibson et al. 2001; Lepers et al. 2000; Kay et 
al. 2000).  It has been hypothesized that fatigue has two origins; (i) in the central fatigue hypothesis, 
the muscles are believed capable of greater output but the CNS acts as a protective mechanism to 
prevent excessive damage to the muscles (Taylor et al. 2000) which denotes that the CNS fails to 
drive the motor neurons adequately (Gandevia 2001).  (ii) Peripheral fatigue, a state whereby the 
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muscles homeostasis has been perturbed, either metabolically through tissue damage, induced 
alterations in muscle homeostasis (e.g. depletion of creatine phosphate or accumulation of 
inorganic phosphate) or alterations in excitability due to potassium (K+) efflux from the cell (Allen 
et al. 2008), to the point that the muscle is biochemically or mechanically incapable of responding 
as effectively as it does when rested (Macintosh & Rassier 2002).  Physiological stress induced by 
intense exercise symptomatically manifests post exercise as a decrease in NMF, increased muscle 
soreness, stiffness and swelling (Bishop et al. 2008).  Athletes completing exercise whilst 
experiencing these symptoms will likely perform below their potential (Howatson & van Someren 
2008).  Along with these perturbations, physical activity can affect the musculature, resulting in 
EIMD.  EIMD is a phenomenon that occurs as a result of unaccustomed, eccentric exercise 
inducing disruption of the sarcomeres (Brown & Hill 1991; Fridén et al. 1983), disruption of the 
cytoskeletal elements that are involved in force transmission (Koh & Escobedo 2004), damage to 
the muscle cell membrane (Lovering & De Deyne 2004; McNeil & Khakee 1992), impaired 
excitation-contraction coupling (Warren et al. 1993), loss of Ca2+ homeostasis and a subsequent 
loss of force production (McCully & Faulkner 1985).  Exercise induced alterations in muscle 
homeostasis include hydrogen ion (H+) accumulation, K+, depletion of high energy phosphates 
(ATP and creatine phosphate) and glycogen (Suzuki et al. 2002; Steele & Duke 2003).  Alongside 
these symptoms, an increase in intramuscular proteins in the blood is present; this is the result of 
increased intracellular Ca2+ derived from extracellular sources leading to myofibrillar damage in 
skeletal muscle (Duncan 1987; Gissel & Clausen 2001).  The influx of Ca2+ into the cytosol 
initiates a cascade of events that further damage the cell by causing alteration to the cytoskeleton, 
sarcoplasmic reticulum, mitochondria and myofilaments (Gissel & Clausen 2001; Byrd 1992).  
The Ca2+ mediated responses appear to be manifested by the activation of proteolytic and lipolytic 
pathways that lead to degradation of the cell membrane and sarcolemma, cell infiltration and 
activation, production of reactive oxygen species (ROS) (Jones et al. 1986) and ultimately 
regeneration of fibres after several days (Fridén et al. 1983).  The loss of membrane integrity allows 
for leakage of intramuscular proteins such as CK, which can be seen in the blood for many days 
post exercise (Warren et al. 1999).  The presence of the muscle proteins and enzymes in the blood 
is a commonly reported indicator of muscle damage (Ehlers et al. 2002; Howatson & van Someren 
2008).  The response of CK to exercise has received research attention, as strenuous exercise that 
damages skeletal muscle cell structure results in an increase in blood CK activity. 
 
An understanding of the physiological, neuromuscular and perceptual challenges in sport is 
required.  Accordingly, various methods are used in applied practice to indicate the presence of 
EIMD and the efficacy of recovery interventions (Ferguson et al. 2014; Bishop et al. 2008).  
Although valid as independent measures, there is rationale for measuring a set of markers 
especially as EIMD is a phenomenon encompassing various physiological processes (Damas et al. 
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2016).  The use of biomarkers providing combination of biological and performance tests offers a 
more thorough understanding of the physiological responses to exercise, therefore, CK and 
hormone response are frequently monitored to provide indirect evidence of muscle damage (Bessa 
et al. 2016).  Specifically within team sports, alongside CK, and T and C hormonal milieu, NMF 
and perception of muscle soreness are indirect markers used to assess EIMD, fatigue and recovery 
with disruptions previously observed post-match lasting at least 48 h (Cunniffe et al. 2010; Shearer 
et al. 2015; West et al. 2014; Russell et al. 2015; Twist et al. 2012).   
 
Creatine Kinase is an enzyme that catalyses the transfer of phosphate from phosphocreatine (PCr) 
to adenosine diphosphate (ADP) (Koch et al. 2014).  As discussed, EIMD can result in the leakage 
of CK out of the cell and into the blood stream as well as other biochemical markers including 
lactate dehydrogenase, leukocyte levels, Tumor necrosis factor-alpha, iL-6 and CRP as reported 
by Bessa et al. (2016).  Creatine Kinase provides a more practical marker in the field to measure 
as venous blood samples are not required, offering a safer, quicker and less invasive option.  
Previous research reviewing biomarkers of exercise intensity and recovery highlighted CK levels 
increased (p<0.01) from 12 to 24 h after exercise and returned to pre-exercise values within 48 h 
(Bessa et al. 2016).  This is supported by numerous studies showing increases in CK following 
team sport matches (Jones et al. 2014; Russell et al. 2015; Russell et al. 2016; Shearer et al. 2015; 
Twist et al. 2012).  For example, Thorpe & Sunderland (2012) identified 84% increase in CK from 
pre-to post-match with similar results reported by McLellan et al. (2010) (peak CK values 24 h 
post-match) and Russell et al. (2015) confirming these results.  Limitations should be 
acknowledged regarding CK measurement presented in the literature (e.g. variance across 
individuals due to ethnicity, gender or age; Bessa et al. 2016), however, CK measured in plasma 
has been reported to be a reliable indirect marker of EIMD (Koch et al. 2014).   
 
Hormonal disruption is also commonly used to assess physiological response and readiness to 
train; T and C have been identified as reliable markers of the endocrine response to competitive 
sports performance (Clarkson et al. 1992; Cunniffe et al. 2009; McLellan et al. 2010).  Testosterone 
is the primary anabolic marker for protein signalling (Suzuki 2004) and muscle glycogen synthesis 
(Salvador et al. 2003).  Cortisol is considered an important stress hormone and acts antagonistically 
with T to mediate catabolic activity, increasing protein degradation and decreasing protein 
synthesis in muscle cells (Hoffman et al. 2002).  It is possible the various hormonal and muscle 
enzyme measures may assist in assessing the immediate response and time course of recovery after 
competition (McLellan et al. 2010).  The use of salivary T and C assay measures provides a 
relatively simple, non-invasive procedure that provides a valid and reliable indication of plasma-
unbound C (Cadore et al. 2008; Vining et al. 1983) and plasma-free T (Wang et al. 1981).  In 
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response to a single soccer match, an anticipatory rise in C has been reported with increases during 
the match; equivocal findings for T have been observed (Thorpe & Sunderland 2012). 
 
Decreases in free T up to 48 h may occur after acute exercise, it has been suggested that 
catecholamine may be responsible for the prolonged inhibitory effect of stress on T biosynthesis 
(Tanaka et al. 1986).  However, decreases may be attributable to increased utilisation of T during 
exercise to preserve protein tissue or via a decreased rate of production because of inhibitory 
mechanisms (Kraemer et al. 1991; Kraemer et al. 2004; Kraemer et al. 2007).  Other potential 
mediators explaining observed decreases in T with exercise involves the role of stress hormones 
such as C.  It is thought that elevations in C with exercise may interfere with T production, either 
acutely during exercise or chronically as a result of training (Kraemer et al. 2004; Kraemer et al. 
2007).  Changes in hormone T/C ratio have been suggested as a possible indictor of physiological 
strain (Fry & Kraemer 1997).  Alterations in T and C are thought to represent a disturbance in 
overall anabolic/catabolic balance of the athlete (Hoogeveen & Zonderland 1996) and are known 
to affect the recovery state and duration of recovery after exercise (Fry et al. 1991).  A change in 
this balance is dependent on intensity and duration of exercise (Hoogeveen & Zonderland 1996); 
a decrease in free T/C ratio of 30% or more in plasma has been shown to indicate temporary 
incomplete recovery from intensive training in elite speed skaters (Banfi et al. 1993).  
 
Functional tests involving completion of maximal jumps  which evaluate PPO and fatigue remain 
the primary tools to assess recovery in the field (Bessa et al. 2016).  PPO is used as a measure to 
assess NMF, frequently assessed by a CMJ performed on a force platform, as previously 
established as a criterion method to determine peak mechanical power (Owen et al. 2014).  
Research suggests the CMJ to be one of the most used tests for monitoring NMF in individual and 
team sports (Claudino et al. 2016) with numerous researchers finding CMJ performance to be an 
objective marker of fatigue (Balsalobre-Fernańdez et al. 2014; Jiménez-Reyes & González-Badillo 
2011; Cormie et al. 2009; Coutts et al. 2007); a recent meta-analysis (Claudino et al. 2016) reported 
the use of average CMJ height to monitor neuromuscular status.  Several studies, while reporting 
an initial decline immediately after the stimulus, observed a short-term recovery in NMF following 
a second decrease in performance between 24 and 48 h post, with the mechanisms behind this 
pattern potentially linked to the time frames associated with the onset of recovery from metabolic 
disturbance and muscle damage, respectively (Kuitunen et al. 2004).  A likely explanation for the 
initial decrease might be a reduced functioning of the contractile mechanisms of the muscle fibre 
(Skurvydas et al. 2007) in the presence of metabolites produced during exercise (H+, ADP,  
Phosphate [Pi]). 
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A practical, non-invasive method to assess fatigue and recovery is the use of subjective measures 
including perception of recovery and muscle soreness.  Due to the practicality, research is 
validating and assessing reliability of these measures.  For instance, Impellizzeri & Maffiuletti 
(2007) have shown perceived lower body muscle soreness scale (7-point scale) to be a valid and 
reliable measure of lower limb soreness whilst Laurent et al. (2011) observed participants 
accurately assessed perceived levels of recovery using the perceived recovery scale (11-point 
scale) indicated by correspondence with negative and positive changes in total sprint time relative 
to a prior session.  Further research is required; however, the results indicate a subjective approach 
may be an effective means for assessing recovery. 
 
To date, multiple studies have investigated NMF, hormonal, biochemical and perceptual post-
match fatigue.  Twist et al. (2012) monitored the perceptual, NMF and biochemical responses to a 
rugby league match.  The results identified perceived muscle soreness and fatigue both increased 
relative to baseline (pre-match) on both day one and day two post-match (24 and 48 h).  CK was 
also elevated day one and day two whereas flight time of CMJ was reduced in all players 
immediately post-match and on day one but was recovered by day two suggesting recovery 
between measured variables i.e. tissue damage from CK but impaired central drive affecting CMJ 
was affected by disruption of Ca2+ homeostasis and impaired excitation-contraction coupling 
(Twist et al. 2012).  Results are similar when identifying response to a single maximal speed 
training session; Johnston et al. (2015) reported blood lactate increased immediately post session 
with CMJ PPO decreasing at the same time point.  Muscle soreness increased immediately, 2h and 
24 h post training session along with CK also increasing and remaining elevated at the same time 
points, whereas T and C both decreased at 2 h post but returned to baseline by 24 h after the session 
terminated.  The combination of markers to assess fatigue and recovery are being increasingly 
applied in practice due the variance in physiological responses to exercise and are monitored in 
response to competition and training to ensure sufficient recovery to optimise subsequent 
performance.  These markers also help determine the efficacy of recovery interventions by 
allowing acknowledgement of the area of performance and physiology that is impacted whether 
this is NMF or clearance of biochemical or hormonal markers.   
 
Recovery strategy efficacy may also be determined by monitoring stress-induced hormone 
reactivity, providing information on individual recovery and readiness to train or compete.  
Changes in hormone T/C ratio have been suggested as a possible indictor of physiological strain 
(Fry & Kraemer 1997).  Adlercreutz et al. (1986) proposed the use of free T/C ratio as a diagnostic 
or preventative test to detect overtraining as it gives an indication of the anabolic/catabolic balance 
in response to training and competition, which are known to affect the recovery state and duration 
of recovery after exercise (Fry et al. 1991).  Crewther & Cook (2012) investigated post-match 
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interventions and subsequent hormonal responses to a physical stress test and game performance 
to measure stress-induced hormone reactivity.  Positive feedback to a video of match performance 
was associated with significantly (p<0.01) greater free T (36 to 42%) responses to a physical stress 
test when compared to negative feedback provided (16 to -3% free T).  Positive feedback was also 
associated with higher (28 to 51%) pre-game T and superior game performance.  This is supported 
by Gonzalez-Bono et al. (1999) reporting T levels affected the contribution individuals made to 
team competition performance.  Literature indicated T regulates adaptive physiology and physical 
performance (Crewther et al. 2011).  This induces rapid bioavailability and effects on the CNS, 
such that human behaviour (motivation) towards physical performance may be modified through 
acute perturbations (Crewther et al. 2011).  Extending the above literature, research has highlighted 
a larger T response and lower C response to a mid-week stress test was found before winning (vs 
losing) (Crewther et al. 2017).  Therefore, responses to a mid-week stress test dicate what happens 
in performance after, how recovered players are from previous matches and following 
performance.  Therefore, T could provide an important mediator of athlete recovery, moreover T 
response to a physical stressor may be indicative of recovery and performance following an 
association between T response to a mid-week exercise stressor (three sets of power cleans, three 
sets of back squat and three sets of bench press at 40, 60 and 70% 1RM) and subsequent winning 
or losing (Crewther et al. 2017).  Thus, monitoring of T responsiveness to a physical ‘stress test’ 
could provide additional information on competitive readiness, future resilience and potentially a 
marker of recovery intervention success.  
  
Keeping in mind EIMD, hormonal disruption and potentially reduced NMF, the post-competition 
recovery period is an integral component of the management of players/athletes (West et al. 2014).  
Insufficient recovery, with ensuing fatigue, could potentially lead to poor or inconsistent 
performance (Barnett 2006) magnified during the competitive season due to accumulative effects 
from both competition and training (Maso 2004).  It is evident in the sport setting there is need for 
suitable methods to enhance the rate of recovery after fatiguing exercise (Pinar et al. 2012).  
Recovery of muscle function is primarily a matter of reversing the major cause of fatigue or 
damage (Bishop et al. 2008).  Since the causes of fatigue may be many and varied, there are 
numerous approaches to restoring homeostasis in the muscle cell (Bishop et al. 2008).  For the 
purpose of this review, as reported by Bishop et al. (2008), recovery is the initial period between 
successive training sessions or competition with the potential to improve subsequent performance.  
Recovery has become a key facet of weekly preparation and training regimen (Kellmann 2010) to 
ensure continued optimal performance in successive training and matches (Taylor et al. 2014).  
Consequently, recovery strategies are defined as the implementation of a technique or combination 
of techniques to accelerate the time to achieve full recovery and potentially reduced the risk of 
injury (Dupont et al. 2010).  These strategies include, but are not limited to cold water immersion, 
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contrast water therapy, active recovery, neuromuscular electrical stimulation, compression 
garments and massage.  For reviews of these strategies refer to Nédélec et al. (2013) and Bishop 
et al. (2008) as this is outside the scope of this review.   
 
Several mechanisms are discussed within the literature regarding the underlying purpose of using 
recovery strategies; strategies aim to reduce acute inflammation from muscle damage and enhance 
its rate of removal are reported to be a priority in soccer (Nédélec et al. 2013).  These strategies 
are believed to improve the rate of recovery through the manipulation of blood flow, for example, 
cold water immersion is thought to reduce blood flow to the legs, inducing a redirection of blood 
flow from the periphery and thereby improve venous return and cardiac efficiency (Vaile et al. 
2011), which is assumed to improve O2 and nutrient delivery, and therefore ATP, PCr and 
glycogen resynthesis (Byrne et al. 2004).  One efficient mechanism of recovery enhancement at 
muscle level may be the augmented removal of exercise metabolites by improving 
microcirculation (Pinar et al. 2012).  However, previous recovery strategies are inconsistent in 
success of increasing rate of recovery and also are not practical for situations such as away games 
where equipment, time and space are required.  Practical recovery strategies are sought after and/or 
additional strategies due to inconsistencies in the literature to date.  Consequently, an emerging 
strategy termed IPC or vascular occlusion will be discussed as an alternative option. 
 
2.3 CLINICAL BACKGROUND AND DEFINITIONS   
 
Ischemia refers to the restriction in blood supply to a tissue, causing a shortage of O2 required for 
metabolism (Kalogeris et al 2012).  Prolonged ischemia may lead to cellular dysfunction, apoptosis 
and cell death, which might be amplified by reperfusion (the return of blood supply to tissue after 
ischemia), resulting in IRI after restoration of blood flow (Jean-St-Michel et al. 2011). 
 
Vascular occlusion originated in the medical literature, in which this strategy referred to intervals 
of sub-lethal ischemia-reperfusion applied to the heart to provide protection against lethal IRI that 
occur during myocardial infarction, subsequently reducing tissue damage (Hausenloy & Yellon 
2008).  Within a clinical setting it is a strategy utilised to exploit the body’s endogenous protective 
capabilities against the injury incurred by IRI (Hausenloy & Yellon 2008).  In its original concept, 
it described intra-myocardial protection, which could be relayed from the myocardium served by 
one coronary artery to another (Hausenloy & Yellon 2008).  The brief episodes of ischemia were 
shown to slow the rate of ATP depletion during subsequent ischemic episodes and therefore it was 
thought multiple brief ischemic episodes (strategy termed IPC) might protect the heart from a 
subsequent sustained ischemic insult (Murry et al. 1990).  Specifically, IPC refers to the 
phenomenon whereby 3-4 brief periods of ischemia, followed by tissue reperfusion, confers 
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subsequent protection against the magnitude of tissue injury following ischemia (Thijssen et al. 
2016).  IPC was first described in a study by Murry et al. (1986), in which the hearts of 
anaesthetised dogs were preconditioned with 4 cycles of 5 min occlusions of the circumflex artery, 
each separated by 5 min of reperfusion (Sharma et al. 2015).  This was followed by a sustained 40 
min occlusion and 4 days of reperfusion.  The extent of myocardial infarction in the preconditioned 
hearts was found to be dramatically reduced to a mere 25% of that seen in the control hearts which 
did not receive preconditioning (Murry et al. 1986). 
 
However, the clinical utility of IPC was limited by the invasive approach that needed to achieve 
ischemia in the target organ before a predictable injury (Jean-St-Michel et al. 2011).  An 
alternative, non-invasive strategy applied the cardio-protection remote from the heart, an approach 
referred to as remote ischemic preconditioning (RIPC); this idea was first conceived by Przyklenk 
et al. (1993) and referred to this phenomenon as ‘preconditioning at a distance’.  This was followed 
by studies showing that preconditioning of the heart could be achieved by applying brief episodes 
of ischemia and reperfusion to a remote organ such as the kidney or other abdominal visceral 
organs (Gho et al. 1996).  Birnbaum et al. (1997) made the critical observation that RIPC could 
also be applied to the limbs.  In this investigation, brief cycles of blood flow restriction combined 
with brief cycles of blood flow restriction with electrical stimulation to the gastrocnemius muscle 
were applied to induce demand ischemia (Birnbaum et al. 1997).  When applied prior to sustained 
coronary artery occlusion and reperfusion, this intervention reduced infarct size by more than 65%.  
Kharbanda et al. (2001) were the first to demonstrate that the application of an RIPC stimulus 
without the need for electrical stimulation reduced the extent of myocardial infarction in-vivo in 
pigs.  This gave rise to a non-invasive method of protecting the heart against lethal IRI that could 
be applied in a clinical setting.  Oxman et al. (1997) demonstrated application of a tourniquet to 
the hind-limb to induce ischemia, had the ability to reduce reperfusion arrhythmias in a rat heart 
following a sustained ischemia insult.  Through medical development, a non-invasive strategy is 
now practiced in patients, involving the application of the cardio protection to an organ or tissue 
remote from the heart (Przyklenk et al. 1993). 
 
The concept of remote organ protection has been extended beyond that of protecting the heart to 
providing inter-organ protection against IRI including skeletal muscle (Hausenloy & Yellon 2008).  
This has been achieved by applying inflated blood pressure cuffs to the upper or lower limbs 
(Hausenloy & Yellon 2008).  Kharbanda et al. (2002) and Loukogeorgakis et al. (2005) pioneered 
the use of this approach in human volunteers and in patients.  In the original study, transient 
ischemia and reperfusion of the arm was induced by inflating a blood pressure cuff placed on the 
upper arm to 200mmHg for 5 min and deflating the cuff for 5 min; a cycle which was repeated 3 
times (Kharbanda et al. 2002).  This RIPC stimulus was able to attenuate the endothelial 
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dysfunction in the contralateral arm arising from a 20-min episode of sustained cuff inflation.  The 
same experimental model has been used to reproduce the concept of delayed RIPC, in which the 
pre-conditioning upper limb ischemia confers an improvement in endothelial function in the 
contralateral arm 24-48 h later (Loukogeorgakis et al. 2005). 
 
2.3.1 Clinical mechanisms 
Mechanisms of IPC have been well established; IPC appears to begin with ligand binding G-
protein coupled receptors on the surface of the cardiomyocytes (Sharma et al. 2015).  These ligands 
include adenosine, bradykinin, opioids, angiotensin and endocannabinoids (Sharma et al. 2015).  
The binding of the cardiomyocyte surface receptors to the respective ligands initiates signalling 
pathways, which eventually lead to changes in the myocardium, rendering it resistant to IRI 
(Hausenloy & Yellon 2008; Sharma et al. 2012), specifically, reports suggest adenosine can 
increase O2 delivery by dilation of the resistance vessels and decreased inatrophy, which decreases 
myocardial O2 demand (Eisen et al. 2004).  Expression of signalling molecules leads to activation 
of mediators that transmit the protective signal in the cytosol (Thijssen et al. 2016).  Ultimately, 
the signalling pathways converge at the mitochondria, the most important effector of protection 
induced by IPC (Thijssen et al. 2016), with the opening of the mitochondrial permeability 
transition pore being a crucial step in this process (Davidson et al. 2006).  Eisen et al. (2004) also 
described receptor independent triggers, identifying them as nitric oxide (NO), free radicals and 
Ca2+.  The effect of these receptors may be further explained by mediators of IPC; the protective 
effect of IPC is thought to be due to intracellular mediators of which 2 have been identified; ATP 
sensitive potassium channels (KATP) and protein kinase C (PKC) (Eisen et al. 2004).  Inner 
mitochondrial membrane KATP contribute to the protective effects of IPC against prolonged 
ischemia (Ardehali & O’Rourke 2005).  Further research supports this, in which the myocardial 
sarcolemmal and the mitochondria KATP have been proposed to be critical activators or mediators 
in the cardioprotective mechanism of IPC (Yellon & Downey 2003).  The current theory suggests 
that the ligand-receptor binding at the cell surface activates signal transduction pathways, which 
terminate at the mitochondria and result in the opening of the mitochondrial KATP channels 
(Hausenloy & Yellon 2008).  This leads to the generation of mitochondrial ROS that facilitate 
cardioprotection by either activating pro-survival kinases (Yellon & Downey 2003) or inhibiting 
the opening of mitochondrial permeability transition pore.  In contrast, Gürke et al. (2000) assessed 
the possible involvement of KATP channels and adenosine receptors in IPC of skeletal muscle in a 
rat model.  It was identified that either IPC or the KATP channel opener cromakalim significantly 
improved post-ischemic muscle function.  The protective effect of cromakalim was not seen when 
the KATP channel blocker glibenclamide was added, however this did not block IPC induced 
protection.  Therefore, the results show significant improvements in post-ischemic skeletal muscle 
function after IPC or cromakalim pre-treatment, but do not support a role of KATP channels or 
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adenosine receptors in IPC of skeletal muscle.  However, alternative reports have suggested 
modulation of KATP channels reduced ATP depletion, preserved intracellular pH and enhanced 
recovery of ATP and phosphocreatinine levels during reperfusion (Takaoka et al. 1999).  These 
observations are supported (e.g. Pang et al. 1997) and suggest KATP channels serve as an end 
effector in adenosine pathways (Tapuria et al. 2008).   
 
Alternative mechanisms and impacts of IPC on physiological responses have been investigated, 
for example Murray et al. (1990) identified preconditioning reduced starting levels of ATP by 
29%, but an episode of IPC to the heart resulted in a decrease in adenine nucleotide pool at 0 min 
of ischemia in comparison to the control (20.4 ± 0.4 vs 29.2 ± 0.3).  This identified that IPC caused 
a slowing in the initial rate of adenine nucleotide degradation during sustained ischemia, with 
preconditioning resulting in depletion of nearly 50% of myocardial glycogen reserves.  The 
biochemical analyses from the study revealed energy metabolism during ischemia was slowed by 
preconditioning; resulting in reduced accumulation of metabolic products and preservation of ATP 
stores (Murray et al., 1990).  A reduced metabolic demand could slow the rate of high-energy 
phosphate utilisation, consequently preserving ATP stores and reducing the rate of anaerobic 
glycolysis (Murray et al., 1990).  An accumulation of glucose-1-phosphate, glucose-6-phosphate 
and lactate were shown to be reduced by preconditioning, indicating a reduction in rate of 
anaerobic glycolysis and high energy phosphate depletion and a limitation of catabolite 
accumulation (Murray et al., 1990).  The study reported this to be the most likely explanation for 
slower metabolic activity; suggesting if glycolytic rate were limited by glycogen depletion it would 
have been expected that ATP depletion would have occurred more rapidly in the IPC trial (Murray 
et al., 1990). It was therefore proposed that IPC reduces myocardial energy demand during 
ischemia (Murry et al., 1990). 
 
Within clinical literature, there are reports of an early and delayed phase of IPC (Figure 2.2); the 
delayed or late phase has been known as the ‘second window’ (Fryer et al. 2002).  Baxter et al. 
(1997) first characterised the time-course of the late phase of IPC and demonstrated that it appears 
24, 48, and 72 hours following brief periods of preconditioning ischemia.  IPC studies have shown 
that adenosine mediates both the early and the late phases of preconditioning via different end-
organ receptors (Fryer et al. 2002). In the heart adenosine acts via the A1 receptor; adenosine 
receptors mediate anti-adrenergic effects indirectly by reducing cyclic adenosine monophosphate 
(cAMP) levels.  The A1 receptor-mediated effects involve activation of PKC, tyrosine kinases 
(Dana et al. 2000), heat shock protein, and mitogen-activated protein kinase, whereas kinases 
modulate end effector mitochondrial KATP channels (Tapuria et al. 2008).  Activation of these 
receptors and their effects are due to endothelium dependent and independent mechanisms, 
indirectly through release of NO and through direct relaxation of vascular smooth muscles.  NO 
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modulates microvascular perfusion through its vasodilatory effect (Jaeschke et al. 1996) and 
through its anti-inflammatory actions, including inhibition of stellate cell activation (Rockey & 
Chung 1995), neutrophil adhesion (Lefer & Lefer 1996), and platelet aggregation (Tapuria et al. 
2008).  The early phase of preconditioning, mediated by endogenous NO, is through generation of 
cAMP, as shown by Lochner et al. (2002) in the myocardium and subsequently inhibition of cAMP 
levels as well as reduction in energy demands. The late phase is protein synthesis dependent and 
is through activation of protein kinase C and transcription of inducible NO (Nandagopal et al. 
2001).  Therefore, this biphasic adaptation has been attributed to distinct cellular mechanisms 
(Franz et al. 2017); early effects are thought to be related to an altered ionic channel permeability 
or post-translational modification of proteins, while late effects could be induced by an altered 
gene expression or immune response (Murphy et al. 2010; Konstantinov et al. 2004). 
However, the underlying mechanisms of RIPC are not clear, the pathway through which the 
protective signal is transmitted from a remote organ to organs targeted by RIPC is still being 
investigated (Sharma et al. 2014).  The literature has proposed several theories and mechanisms 
that may be involved;  reports suggest the peripheral stimulus can be chemical, mechanical or 
electrical and involves activation of peripheral sensory nerves (Heusch et al. 2015), with the signal 
transfer to the heart and other organs associated with neuronal and humoral communications 
(Heusch et al. 2015) (Figure 2.3).  Further studies have investigated whether endogenous 
substances such as adenosine, opiods (e.g. Patel et al. 2002) and endocannabinoids (e.g. 
Hajrasouliha et al. 2008) are released from the remote organ during IPC and are carried to the heart 
in the blood stream where they have been proposed to activate intracellular pathways of cardio-
protection (Hausenloy & Yellon 2008).  Two alternative mechanisms have also been proposed; (i) 
the influence of the neural pathway and RIPC generating an endogenous substance e.g. adenosine, 
which activates a local afferent neural pathway stimulating an efferent neural pathway; the effects 
of adenosine include vasodilation’s, inhibition of leukocyte adhesion, neutrophil and platelet 
function (Bouma et al. 1997) and free radical production (Tapuria et al. 2008) and (ii) a systemic 
response which may suppress inflammation and apoptosis (Pope et al. 2013).  
 
The hypothesis for a neural pathway was further developed with the proposition that endogenous 
substances such as adenosine and bradykinin released by the remote preconditioned organ, 
stimulated afferent nerve fibres (Hausenloy & Yellon 2008).  Regarding a systemic response, 
studies have investigated the effect of RIPC on the myocardial gene transcription profile 
(Konstantinov et al. 2005) and the inflammatory response (Peralta et al. 2001) and have discovered 
that the inflammatory response is suppressed and a favourable profile of gene transcription appears 
to be achieved that is both anti-inflammatory and anti-apoptotic (Hausenloy & Yellon 2008). 
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This concept, based on assumption that a tissue with some history of ischemic conditions 
eventually becomes more resistant to ischemia and its potential deleterious effects (Kocman et al. 
2015; Lott et al. 1996; Ovize et al. 2013) attracted many researchers in sports medicine and 
exercise science. The demonstration of the favourable effects of IPC and RIPC on endothelial 
function, skeletal muscle and the heart raised the possibility that in addition to the benefits 
identified in a clinical setting, IPC could also be applicable within sport.  Consequently, a 
reasonable number of experimental researchers have attempted to demonstrate beneficial effects 
of IPC on athletic performance as discussed in the following sections. 
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Figure 2.2 Mechanisms of the early and delayed (late) phase of ischemic preconditioning (adapted from Koch et al. 2014) 
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Figure 2.3 Potential mechanistic pathways underlying remote ischemic preconditioning 
(extracted from Hausenloy & Yellon 2008) 
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2.3.2 Introduction to IPC and vascular occlusion in sport performance 
The discovery of IPC as a potential tool for improving skeletal muscle performance was first 
investigated by Libonati et al. (1998); they associated IPC with higher force generation.  It is 
important at this stage to note the term IPC and comparison to RIPC and limb IPC. IPC referred 
in the clinical literature to an invasive method of pre-conditioning the heart, the definition of RIPC 
is related to an intervention that does not directly affect the same part/system of the body where it 
is applied (Przyklenk et al. 1993).  In this respect, some studies suggested a humoral hypothesis 
postulating that an ischemic event leads to the production of substances that could reach another 
tissue (Marocolo et al. 2016).  Previous research has argued that RIPC would not likely be relevant 
in the majority of sports, if applied to the legs for example, and subsequent sports performed 
involved the lower extremities; the application would not be ‘remote’ and therefore, it is the 
concept of IPC applied to the limb that may have potential to improve exercise performance via 
both local effects (i.e. to the limb) and remote effects (via cardiovascular or nervous system); this 
has been referred to as limb IPC to distinguish from the concept of using RIPC to target the remote 
organ alone.  Therefore, for the purpose of this thesis, limb IPC will be terminology used to 
describe the application of this strategy to the limbs, within a sports performance environment, 
where cycles of ischemia and reperfusion are used as a pre-conditioning strategy and vascular 
occlusion will describe the application of cuffs and blood flow restriction during exercise or for 
use as a recovery strategy. 
 
Within the context of sports performance, limb IPC or vascular occlusion is achieved via 
application of an external pressure over the proximal portion of the upper or lower extremities 
(Pope et al. 2013), achieved using a tourniquet, pressurised cuff or elastic band.  Generally, the 
limb IPC protocol involves four cycles of five min occlusion, followed by five min reperfusion 
period (Thijssen et al. 2016).  As this method is relatively easy to conduct and non-invasive, limb 
IPC may have various advantages in athletic settings (Horiuchi 2017).  The aim of external 
pressures is to maintain partial arterial inflow to the muscle while occluding venous return (Pope 
et al. 2013) resulting in the pooling of venous blood around the exercising muscle when occlusion 
is combined with exercise (Fahs et al. 2012) or create cycles of ischemia and reperfusion when 
applied during passive rest. 
 
Figure 2.4 summarises the suggested mechanisms for the use of vascular occlusion combined with 
exercise, limb IPC or for use as a recovery strategy.  The proposed theory behind the use of vascular 
occlusion combined with exercise (previously used as a training modality), suggests improved 
athletic performance due to a reduction in intramuscular O2 delivery (Tanimoto et al. 2005) and 
decreased venous clearance of metabolites (Inagaki et al. 2011).  This can lead to exaggerated 
levels of metabolic acidosis, which consequently may increase hormone response or increased 
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fibre type recruitment (Yasuda et al. 2011), which may improve muscle contraction efficiency 
through increased muscle force and contractility (Lawson & Downey 1993) along with an 
increased efficiency of excitation contraction coupling (Pang et al. 1995).   
 
The mechanisms relating to limb IPC or vascular occlusion during passive rest, have been 
speculated to include improvements in the vasculature, optimising blood flow to working tissues, 
improvements in oxygenation during exhaustive exercise (De Groot et al. 2010) and improvement 
in mitochondrial metabolism (Andreas et al. 2011).  The majority of the literature attributes 
improved performance to the release of adenosine, which provides a protective effect (Goto et al. 
1995) as well as causing vasodilation, which subsequently increases blood supply during exercise 
(De Groot et al. 2010).  This can improve performance due to increased metabolic waste removal 
(Vaile et al. 2011) and repletion of ATP (Connolly et al. 2003).  In vivo studies have shown that 
limb IPC or vascular occlusion can lead to opening of mitochondrial KATP and uncoupling of 
oxidative phosphorylation (Fryer et al. 2000).  It has been speculated that this allows for a faster 
uptake of aceyl-CoA and thus maintains lactate accumulation at a metabolically acceptable level 
(Jean-St-Michel et al. 2011).  As included in Figure 2.4 the late phase has been associated with 
ROS, FMD and NO and consequently increased O2 delivery and extraction along with attenuation 
of endothelial function to improve aerobic contribution to performance. 
 
To date, limited research has investigated the mechanisms associated with use of vascular 
occlusion as a recovery modality, however from speculation, it has been suggested that 
performance is improved consequence of increased blood flow associated with elevated adenosine 
levels (Liu et al. 1994) and activation of KATP channels (De Groot et al. 2010) which increase 
vasodilation and increase removal of H+.  It has also been hypothesized that ischemia may reduce 
the inflammatory response, decreasing intramuscular pressure and subsequently decreasing pain 
and muscle soreness associated with EIMD (Figure 2.4). 
 
2.3.3 Summary 
Despite an increasing number of studies examining the effects of limb IPC and vascular occlusion 
on exercise performance, preliminary conclusions regarding the beneficial effects are difficult to 
establish due to inconsistent methods used among studies including protocols, exercise modes, 
exercise durations, timings and populations.  The next sections will highlight current literature 
which has investigated the use of limb IPC and vascular occlusion for use as a pre-competition or 
recovery strategy and the suggested mechanisms influencing performance. 
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Figure 2.4 The mechanisms associated with each experimental chapter and application of vascular occlusion or limb IPC as pre-competition and recovery 
strategies
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2.4 PRE-COMPETITON: THE USE OF VASCULAR OCCLUSION AND LIMB IPC  
 
On the day of competition there is an opportunity to enhance performance using pre-competition 
strategies.  As previously discussed, these strategies include appropriate warm up protocols, 
passive heat maintenance, post activation potentiation, priming and more recently vascular 
occlusion and limb IPC (Kilduff et al. 2013).  Within the constraints of athletic performance, the 
benefits of limb IPC have been observed in time to exhaustion (e.g. De Groot et al. 2010; Crisafulli 
et al. 2011), anaerobic performance tests (e.g. Bailey et al. 2012; Jean-St-Michel et al. 2011; Lisbôa 
et al. 2017) and muscle activation (e.g. Yasuda et al. 2014; Teixeira et al. 2017).  Although there 
is some disparity in findings between the effects on athletic performance, it can be postulated that 
vascular occlusion and limb IPC may provide an ergogenic aid for competition preparation.  
  
2.4.1 Vascular occlusion with resistance exercise  
Vascular occlusion in combination with exercise has been demonstrated to result in numerous 
positive training adaptations and acute physiological responses.  Within the literature, the effects 
of vascular occlusion with various exercise modes (e.g. cycling, walking, resistance exercise) have 
been examined, however for the purpose of this review the focus will remain on vascular occlusion 
with resistance exercise. 
 
The ability to increase muscle strength and hypertrophy when combined with vascular occlusion 
is different from the traditional paradigm, which suggests lifting higher intensities to increase such 
characteristics (Pope et al. 2013).  For example, The American College of Sports Medicine 
recommends lifting weights of at least 70 % 1RM to achieve muscular hypertrophy, through 
increased mechanical work, which increases amino acid transport into cells and enhances the 
synthesis of contractile proteins (Schoenfeld 2010). However, many studies have shown muscle 
hypertrophy to occur with training as low as 20 % 1RM when combined with vascular occlusion 
(Abe et al. 2005; Abe et al. 2005; Fujita et al. 2008; Luebbers et al. 2014).  Therefore low-load 
resistance exercise (20-50% of 1RM), combined with vascular occlusion, has been proposed as an 
alternative or addition to heavy resistance exercise.  Of particular benefit, Yasuda et al. (2011) 
reported that vascular occlusion training does not require a long recovery time between training 
sessions (Abe et al. 2005; Yasuda et al. 2009) owing to the very low mechanical stress and minimal 
muscle damage (Abe et al. 2005; Fujita et al. 2008) therefore allowing for repeated training 
sessions within a short time frame or preparation for competition performance. 
 
There has been conflicting evidence regarding the benefits and outcomes of this strategy, reports 
have shown no effects of vascular occlusion on hypertrophy or tension properties (Kubo et al. 
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2006; Barcelos et al. 2015), along with no additional benefit compared to traditional resistance 
exercise (e.g. Kim et al. 2012).  However, different applications for the use of training with 
vascular occlusion within an athletes training program are emerging.  For example, during a busy, 
high volume schedule it can allow for continued resistance exercise training that achieves the same 
response as high intensity resistance exercise traditionally required, that cannot ordinarily be 
complete.   
 
Lowery et al. (2014) completed a protocol consisting of individuals using vascular occlusion either 
for the first 4 weeks or second 4 weeks of an 8-week resistance exercise program.  Both groups, 
regardless of order, increased muscle thickness significantly from baseline to week 4 (6.9 % and 
8.6 %, p<0.01) and from weeks 4 to week 8 (4.1 % and 4.0 %, p<0.01) respectively.  This identified 
that similar hypertrophy gains were possible from low intensity resistance exercise with vascular 
occlusion compared to high intensity resistance exercise without vascular occlusion.  This can 
allow for lighter loads to be utilised in the return from injury, but still achieve the same benefit for 
athletic performance. 
 
An alternative strategy has examined combining high intensity resistance exercise and low 
intensity resistance exercise with vascular occlusion into one training program.  Luebbers et al. 
(2014) investigated the effect of a 7-week vascular occlusion protocol on measures of muscular 
strength.  Sixty-two American Football Players were divided into four groups, one of which 
completed supplemental lifting with vascular occlusion.  Within this group greater 1RM squat 
performance (p<0.000) was achieved compared to the traditional program with supplemental lifts 
without vascular occlusion (p=0.025) and the traditional high intensity resistance exercise program 
(p=0.009).  This study was a modification of that implemented by Yamanaka et al. (2012) in which 
a 4-week period was investigated.   Exercise at 20 % 1RM with vascular occlusion resulted in an 
increase of 7.0 % and 8.0 % in squat and bench press performance, respectively in comparison to 
3.2 % and 4.9 % in the control condition.  These studies provide evidence that when high resistance 
exercise cannot be completed, or the load is high within a training schedule, but training needs to 
be sustained, 20 % 1RM can be used to either maintain or improve muscular strength and 
hypertrophy when in combination with a traditional resistance exercise program. 
 
Further studies included in the literature search have shown a direct improvement in performance 
using vascular occlusion, in the following study 70% 1RM with occlusion was implemented in 
comparison to 20-30% 1RM in previous studies, which may provide reasoning for the 
improvement in performance identified.  Cook et al. (2014) investigated the use of vascular 
occlusion during 3 weeks of training.  Vascular occlusion resulted in significantly greater 
improvements in bench press (p=0.0044; 1.4 ± 0.8 %), squat (p=1.03x10-16; 2.0 ± 0.6 %), maximal 
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sprint times (p=0.0162; 0.4 ± 0.3 %) and CMJ (p=0.0003; 1.8 ± 0.7 %).  In addition to previous 
research in this area, T and C concentrations were reported in response to training with vascular 
occlusion.  Large to very large increases in T were observed in response to vascular occlusion 
training sessions (Effect Size [ES]: 1.50 to 2.19).  An elevation in T has been shown to benefit 
performance, increasing adaptation from training, but also as a pre-competition strategy (Kilduff 
et al. 2013), therefore this may identify a further practical use for this strategy. 
 
Although traditionally used as a training modality, responses to a single bout of low intensity 
resistance exercise with vascular occlusion have been reported (Table 2.2).  When exploring 
records in more detail, the results are variable with studies showing lower EMG amplitude and 
repetitions complete (Karabulut et al. 2010; Loenneke et al. 2012), identifying no or an unknown 
effect (Takada et al. 2012) and records also showing a positive effect (Cayot et al. 2014).  Fatela 
et al. (2016) potentially provide evidence for disparity in previous results.  It was identified 
muscular activation, as well as neuromuscular fatigue varied as a function of relative occlusion 
intensity; 20% 1RM at 40, 60 and 80% AOP.  Torque only decreased in 80% AOP condition, 
except for the vastus medialis in the 40% condition, median frequency decreased in both muscles 
post exercise in all conditions.  Median frequency decrements were of greater magnitude post 
exercise at higher levels of occlusion. Post reports, examining the interaction between occlusion 
and neuromuscular response, have shown this form of exercise implicates greater muscular 
activation to maintain the same total work output (Moritani et al. 1992; Shinohara et al. 1998; 
Takarada et al. 2000; Takarada et al. 2002; Yasuda et al. 2008).  However, several methodological 
inconsistencies have generated conflicting findings, for instance, the large majority of research 
applied an arbitrary restrictive pressure for all participants. 
 
In contrast, Neto et al. (2014) identified compromised muscle strength immediately after exercise 
with occlusion but when performed at 80% 1RM.  However, no biochemical markers were 
measured and also the level of vascular occlusion was not controlled.  Further studies have started 
to investigate the effect of higher intensity exercise with occlusion immediately prior to 
performance.  Teixeira et al. (2017) applied vascular occlusion during the rest period between sets, 
whilst exercising and compared this to knee-extension exercise performed at 70% 1RM without 
any vascular occlusion.  The results infer vascular occlusion applied during the rest intervals 
increased lactate to a greater extent, possibly due to reduced restoration of ATP, however, EMG 
of the vastus laterallis indicate a decreased activation in all conditions.  It was suggested that 
although previous studies have identified an increase in muscle activation when combined with 
low-load resistance exercise, when the load is already relatively high (i.e. 70% 1RM) vascular 
occlusion does not further increase activation and may induce acute fatigue of both the contractile 
apparatus and CNS (Teixeira et al. 2017).  These results have been supported by Dankel et al. 
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(2017) again identifying that the stimulus of high-load training is sufficient to meet or exceed the 
stimulus which is provided by vascular occlusion when combined with low-load resistance 
exercise.  A study by Takarada et al. (2000) assessed EMG during high and low-load resistance 
exercise, demonstrating vascular occlusion was able to augment EMG during elbow flexion 
exercise at 40% but not at 80% 1RM, however, this study only assessed EMG during one set and 
the effectiveness of vascular occlusion has been reported to be reliant on the ability to pool 
metabolites within the muscle (Dankel et al. 2017) 
 
Research suggests benefits of muscle activation when using vascular occlusion with low-load 
resistance exercise, however there is disparity when combined with high-low resistance exercise.  
To note, previous studies implementing vascular occlusion are inconsistent in the protocol applied, 
with intermittent occlusion completed during exercise and released during rest (e.g. Teixeira et al. 
2017) compared to occlusion for the duration of exercise and rest (e.g. Neto et al. 2014).  
Alternative to the benefits of muscle activation on performance, previous research has identified a 
beneficial effect on hormone levels in response to vascular occlusion combined with exercise.  
Similar to high intensity protocols, low intensity occlusion has shown to increase serum hormone 
levels and blood lactate in men (Tanimoto et al. 2005; Takarada et al. 2000) and women (Kim et 
al. 2014) identifying growth hormone and C increased in response to resistance exercise with and 
without vascular occlusion suggesting a similar increase in anabolic and catabolic hormone 
response.  Research completed by Cook et al. (2014) implemented high-load (70% 1RM) with 
vascular occlusion for a training program in males, but of interest, salivary T response was 
monitored immediately post sessions.  An occlusion-dependent elevation in salivary T 
immediately after exercise was reported, potentially the result of an increased metabolic stress.  
This offers application as a pre-competition strategy to influence the circadian decline of T as 
discussed in section 2.2.2 and 2.2.3 to impact afternoon competition if performed in the morning 
prior to performance. 
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Table 2.2: Characteristics of the studies examining the acute response of resistance exercise combined with vascular occlusion 2010-2017 
 
 
Author Participants  Exercises Limbs occluded 
& Cuff pressure 
(mmHg) 
Intensity Protocol (sets, 
reps, rest) 
Performance benefit 
(Cayot et al. 2014) 7 healthy, active 
males 
MIVC Legs – 130% 
resting SBP 
20, 40, 60 & 
80% MVC 
5s contraction, 30s 
recovery 
Applying VO 5min prior to 
exercise enhances metabolic 
stress, no difference in NM 
activation 
(Dankel et al. 
2017) 
10 male & 
female, 
resistance trained 
Elbow 
flexion 
Arms – 70% 
AOP 
70% 1RM 2 sets to failure, 
3min rest between 
With VO less reps completed, 
no difference in muscle 
activation 
(Fatela et al. 2016) 14 males, healthy 
& active 
Knee 
extension 
Legs – 40, 60, 
80% AOP 
20% 1RM 30-15-15-15, 30 s 
rest between bouts 
Muscle activation and NM 
fatigue vary relative to 
restrictive level 
(Husmann et al. 
2017) 
17 resistance 
trained males 
Knee 
extension 
Legs - 60% AOP 30% 1RM 30-15-15-15, 30 s 
rest between bouts 
Decrease MVT, increase 
muscle fatigue immediately, 
but diminished after 2min 
(Karabulut et al. 
2011) 
14 healthy men Leg 
extensions 
Legs – SBPx1.44 20% 1RM 5x20 reps, 30s rest 
between bouts 
Greater decrease in MVC 
following exercise with VO 
(Lauver et al. 
2017) 
24 healthy 
participants 
Knee 
extension 
Legs – 130% 
SBP 
MVC 6x10 reps, 2 min 
rest between 
NM and metabolic responses 
different with VO 
(Loenneke et al. 
2012) 
20 healthy, 
active male & 
females 
Leg 
extension 
Legs – not 
reported 
30% 1RM 2x sets to failure Failure occurred sooner with 
VO with similar metabolic 
stress 
(Loenneke et al. 
2013) 
16 healthy active 
males & females 
Knee 
extension 
Leg – 60% AOP 30% 1RM 30-15-15 reps, 30s 
rest  
VO + exercise does not result 
in prolonged decrements in 
torque 
(Neto et al. 2014) 12 Jiu-Jitsu 
fighters 
Squat Legs - 110 80% 1RM To failure HI + VO compromise muscle 
strength after exercise 
(Takada et al. 
2012) 
12 male trained 
participants 
Plantar 
flexion  
Legs – not 
reported 
20% 1RM 
or 65%1RM 
30reps per min for 
2min 
No difference in fast twitch 
recruitment 
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(Teixeira et al. 
2017) 
12 healthy males Knee 
extension 
Legs – 80% AOP 70% 1RM 3 x 8 reps VO during rest periods 
increased lactate, no 
difference muscle activation 
(Yasuda et al. 
2010) 
16 healthy, 
active 
Elbow 
flexion 
Arms – 100 or 
160 
LI – 20% 
1RM 
HI – 70% 
1RM 
LI - 30-15-15-15, 
30s rest between 
sets 
HI – 3 sets to 
failure, 3min rest 
between  
Changes in pH involved in 
stimulating muscle activation 
group III & IV afferents 
(Yasuda et al. 
2014) 
9 healthy trained 
men,  
Tricep 
extension 
Arms – 170-260 
based on RPE 
10, 20, 30, 
40, 50% 
1RM 
30-15-15-15, 30s 
rest between sets 
Enhanced muscle activation 
with VO 
 
MIVC – maximal isometric voluntary contraction; MVC; maximal voluntary contraction; AOP – arterial occlusion pressure; HI - high intensity, LI - low 
intensity, VO – vascular occlusion, 1RM - 1 repetition maximum; GH – growth hormone; NM – neuromuscular; MVT – maximal voluntary torque 
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2.4.2 Identified mechanisms for the use of vascular occlusion and resistance exercise 
Consequence of the additive effects of mechanical and metabolic stress (Pearson & Hussain 2015), 
it has been hypothesized that resistance exercise with vascular occlusion signals a number of 
mechanisms for induction of muscle activation and growth.  Reviews by Kacin et al. (2015), Pope 
et al. (2013) and Heitkamp (2015) summarised the potential physiological responses of resistance 
exercise with vascular occlusion: (i) hypoxia-induced additional or preferential recruitment of fast-
twitch muscle fibers, (ii) greater duration of metabolic acidosis via the trapping and accumulation 
of intramuscular protons (H+ ions) and stimulation of metaboreceptors, possibly eliciting an 
exaggerated acute systemic hormonal response, (iii) external pressure-induced differences in 
contractile mechanics and sarcolemmal deformation, resulting in enhanced growth factor 
expression and intracellular signaling, (iv) metabolic adaptations to the fast glycolytic system that 
stem from compromised O2 delivery, (vi) production of ROS that promotes tissue growth, (vii) 
gradient-induced reactive hyperemia after removal of the external pressure, which induces 
intracellular swelling and stretches cytoskeletal structures that may promote tissue growth, and 
(vii) activation of myogenic stem cells with subsequent myonuclear fusion with mature muscle 
fibers (Kacin et al. 2015) . 
 
Expanding on the summarised mechanisms, a primary mechanism identified is the preferential 
recruitment of fast twitch fibres due to the effect of the hypoxic-induced environment.  Heavy load 
typically used in resistance exercise programs are thought to be a requirement to ensure that most 
motor units are recruited and thus exposed to the stimulus of strength training (Wernbom et al. 
2009).  During resistance exercise, motor units and hence muscle fibres are recruited according to 
the size principle (Dideriksen & Farina 2013), to increase muscle mass and strength, it is important 
to activate type II muscle fibres during training (Häkkinen & Keskinen 1989).  Changes in blood 
flow to skeletal muscle can alter the level of supply of substrates, the removal of metabolites, and 
fatigue, which significantly affects the recruitment and activation of muscle fibres needed to 
perform under specific conditions (Karabulut & Perez 2013).  Reducing blood flow to the active 
skeletal muscle during exercise may affect the pattern and the number of skeletal muscle fibres 
recruited and therefore the level of neuromuscular activation and adaptation (Karabulut & Perez 
2013).   
 
Research has demonstrated that recruitment of fast-twitch muscle fibres is also possible at low 
intensities with vascular occlusion, likely due to inadequate O2 supply and high metabolite 
accumulation (Moritani et al. 1992; Meyer 2006).  Both reduced O2 and metabolite accumulation 
can increase type II fibre recruitment through the stimulation of group III and IV afferents, causing 
inhibition of alpha motorneuron, increasing fibre recruitment to maintain muscular force and 
protect against conduction failure (Yasuda et al. 2010; Loenneke et al. 2011).  It is the progressive 
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increase in the recruitment of type II motor units that elevates the stress on these units and 
consequently produces adaptation in the form of hypertrophy (Kawada 2005). As a result, overall 
exercise volume may play a significant role in the muscular adaptations (Fahs et al. 2012).  
Theoretically, vascular occlusion exercise to volitional fatigue would produce a greater metabolic 
accumulation and lead to greater adaptations than exercise terminated prior to fatigue.  
 
Similarly, Kacin & Strazar (2011) evaluated vastus medialis and rectus femoris EMG activity 
during dynamic knee extensions performed to repetition failure under 2 different conditions i) 
control 15% of maximal voluntary contraction without vascular occlusion, ii) 15% of maximal 
voluntary contraction with vascular occlusion at 230mmHg.  The authors found similar increases 
in EMG amplitude during both testing conditions.  These results might indicate a greater sensory 
feedback or perception of exertion during vascular occlusion that inhibits motor drive and 
subsequent levels of muscle activity (Loenneke et al. 2011).  Whereas Fujita et al. (2007) found 
that resistance exercise with vascular occlusion compared to a work matched protocol without 
vascular occlusion demonstrated increased S6K1 phosphorylation following occlusion, which 
primarily occurs in type II muscle fibres (Koopman et al. 2006), indirectly linking vascular 
occlusion to increased recruitment of fast twitch fibres.  Hypoxia induced muscular activation is 
supported by a study conducted by Katayama et al. (2010), where it was determined that hypoxic 
conditions were responsible for changes in muscle fibre activation from type I to type II as well as 
increase motor unit recruitment.  Since slow twitch muscle fibres rely heavily on oxidative 
phosphorylation, they may have been unable to contribute to isometric force production due to 
reduced blood flow to skeletal muscles during the post exercise maximal voluntary contraction 
trials with vascular occlusion. 
 
However, some investigations have failed to demonstrate increased muscle activation during 
resistance exercise with vascular occlusion.   Research suggests that low intensity vascular 
occlusion with resistance exercise does not facilitate muscle activation of the same magnitude as 
higher intensity resistance exercise without vascular occlusion (Suga et al. 2009; Cook et al. 2013).  
Reports suggest it is unlikely that low intensity vascular occlusion with resistance exercise will 
stimulate all of the high-threshold motor units as experienced during high intensity resistance 
exercise, resulting in lower chronic neuromuscular responses following low intensity exercise with 
vascular occlusion (Scott et al. 2014).  This should be considered when implementing this strategy 
to athletes; it may not benefit sports where rapid force production is required (Scott et al. 2015). 
 
Alternatively, vascular occlusion has been reported to increase intramuscular pressure, thus 
affecting blood circulation and resulting in even higher lactate build up.  The increased metabolic 
stress caused by accumulation of metabolites is thought to be the result of reduced venous outflow.  
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By combining exercise with vascular occlusion, it has been identified that the ischemic (Takano et 
al. 2005) intramuscular environment induces a greater rate of ATP hydrolysis, exaggerated PCr 
depletion (Suga et al. 2009), decreased pH (Suga et al. 2009; Suga et al. 2010) and an increased 
lactate response (Takano et al. 2005; Fujita et al. 2007; Reeves et al. 2006) to cause greater 
response and adaptation. Metabolic stress has been defined as the decrease in ATP, depletion of 
PCr, increased inorganic Pi, increased ADP/ATP ratio, increased adenosine monophosphate 
(AMP) production, and decreased intramuscular pH and accumulation of lactate.  The importance 
of metabolic stress for hypertrophy has been highlighted by Goto et al. (2003) comparing the 
effects of 2 volume/intensity matched resistance exercise protocols, the only difference being one 
protocol included 30 s rest between sets.  Blood lactate concentrations were significantly higher 
following the without-rest protocol and following 12 weeks of training muscle cross sectional area 
increased significantly compared to no difference in the rest condition, thus indicating a direct link 
between metabolic stress and muscle hypertrophy. Furthermore, high intramuscular proton 
concentrations can inhibit Ca2+ release from the sarcoplasmic reticulum, disrupting excitation-
contraction coupling of myofilaments, thereby reducing tension development as manifested in 
peripheral muscular fatigue (Favero et al. 1993).  
 
Adaptive responses to resistance training with hypoxia (Scott et al. 2014), propose that a localised 
hypoxic stimulus may play an important role; downstream of the hypoxic stimulus, it is likely that 
a greater accumulation of metabolites, due to both increased production in the more hypoxic state 
and limited removal due to vascular occlusion, acts as a primary moderator of the anabolic 
response to this form of exercise (Schoenfeld 2013).  This accumulation may cause increased 
muscle fibre recruitment (Takarada et al. 2000; Yasuda et al. 2009), along with muscle cell 
swelling and altered anabolic/catabolic signalling (Fry et al. 2010; Fujita et al. 2007; Laurentino 
et al. 2012) and elevated endocrine responses (Takarada et al. 2000). 
 
However, a recent review by Loenneke et al. (2011) indicated a minimal T response to vascular 
occlusion with resistance exercise as supported by previous research (e.g. Abe et al. 2006; Fujita 
et al. 2007; Reeves et al. 2006).  These results may be attributable to the exercises selected; larger 
muscle groups have been associated with an increase in T.  Furthermore, the low volume or 
intensity of the exercise protocols used may provide explanation for the difference in results.  This 
has been demonstrated with research completed by Cook et al. (2014), in which large to very large 
increases in T were observed in response to vascular occlusion training sessions due to exercise 
being complete at 70 % 1RM rather than low intensity (20-30 % 1RM) as used in previous studies. 
Further explanation for this disparity in results is apparent when comparing vascular occlusion 
protocols utilised.  In the studies identifying no elevation in T, continuous occlusion rather than 
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intermittent occlusion and also the studies utilised blood rather than salivary sampling, which could 
influence steroid hormone concentrations (Credeur et al. 2010).   
 
2.4.3 Limb IPC and athletic performance 
Within the literature, 17 out of 24 studies identified improvement in exercise performance, 
including; 5 km TT, total exercise time and 100 m swim TT (Table 2.4).   
 
Due to the direct impact of time to exhaustion on exercise performance, research has recently 
investigated the use of limb IPC to extend time to exhaustion.  Eight studies (Barbosa et al. 2015; 
Clevidence et al. 2012; Crisafulli et al. 2011; De Groot et al. 2010; Hittinger et al. 2015; Kido et 
al. 2015; Sabino-Carvalho et al. 2016; Tanaka et al. 2016) have investigated the use of limb IPC 
on time to exhaustion (Table 2.3).  Six of the studies identified improvement in performance, for 
instance De Groot et al. (2010) examined and identified a beneficial effect of limb IPC on O2 
consumption (3% improvement) and workload (maximal power output 372 ± 59 W) during a 
maximal cycling test to exhaustion (Table 2.3).  However, in contrast, research complete by 
Clevidence et al. (2012) implemented the same limb IPC protocol (Table 2.3) but documented no 
improvement in performance.  Differences in the exercise test to exhaustion provide somewhat of 
an explanation for the contrast in results.  The reported workload during the initial submaximal 
component of the incremental test varied significantly with De Groot et al. (2010) initiating 
exercise at 50 W for four min compared to 121 ± 13.5 W for five min with the elevation remaining 
higher throughout the test complete by Clevidence et al. (2012).  Thus, a higher workload was 
completed during the initial stages of the test to exhaustion and may explain the inconsistencies in 
results.  
 
Tanaka et al. (2016) examined the effects of limb IPC on local muscle endurance during fatiguing 
isometric exercise.  Endurance time to task failure was significantly longer following limb IPC 
than in the control, although quadriceps EMG activity was not significantly different between 
conditions, deoxygenation dynamics in the quadriceps vastus lateralis muscle was significantly 
faster in limb IPC than in the control.  This suggests enhanced muscular endurance during fatiguing 
isometric exercise as a result of accelerated muscle deoxygenation dynamics and enhanced 
mitochondrial metabolism.  This is supported by Paradis-Deschenes et al. (2016) identifying three 
cycles of limb IPC immediately increased muscle perfusion and O2 uptake, conducive to higher 
repeated force capacity in strength-trained athletes. 
 
Physiologically Kido et al. (2015) and Hittinger et al. (2015) assessed the systemic and local O2 
dynamics in response to limb IPC.  Disparity in results may be explained between the variation in 
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study design and participants examined.  In addition to variation in performance test, the cuff 
pressure applied and total duration of ischemia were not comparable (e.g. Cuff pressure: 
>300mmHg versus 10-20mmHg > systolic blood pressure, respectively).  Furthermore, Kido et al. 
(2015) reported an improvement in performance in 15 healthy male participants, whereas Hittinger 
et al. (2015) did not find limb IPC improved subsequent performance, however this was with 15 
highly trained male cyclists and triathletes suggesting the training history of the participant may 
impact the efficacy of limb IPC on athletic performance.  However, none of the performance tests 
from the previously discussed studies were specific to the peak and mean power and duration 
required for athletic performance in competition, therefore further research in this area may 
provide increased insight and practical application to the use of limb IPC within sport. 
 
Exercise such as repeated six s or 30 s sprints is frequently performed in sports performance.  This 
is associated with an increase venous lactate, reduction of arterial pH and a cause of fatigue 
(Hargreaves et al. 1998).  Limb IPC may improve this type of maximal performance as a result of 
the opening of KATP channels in the mitochondria by the release of adenosine (Lalonde & Curnier 
2014) consequently improving the metabolic pathway.  However, there has been disparity within 
the results of limb IPC and repeated sprint performance, including a detrimental (Gibson et al. 
2013; Paixão et al. 2014), no effect (Gibson et al. 2013; Lalonde & Curnier 2014) or positive effect 
(Patterson et al. 2015) 
 
For instance, Gibson et al. (2013) identified no beneficial effect of limb IPC on repeated sprints 
(3x30 m) and a potential small negative effect in female participants.  It is postulated the protocol 
implemented (Table 2.3) was insufficient to have an accumulation of metabolites to initiate a 
biochemical cascade associated with limb IPC (Downey et al. 2007).  Furthermore, Gibson et al. 
(2013) suggested the detriment in female participants could be due to methodological issues of 
thigh circumference and associated level of limb IPC or participants’ perception of discomfort and 
individual pain tolerance.  In addition, Paixão et al. (2014) identified a reduced maximal power in 
the first wingate test following limb IPC.  However, the limb IPC protocol varied with a pressure 
cuff of 250 mmHg being utilised with no individualisation and may be attributable to the decreased 
performance.  Furthermore, both studies only allowed 12-15 min rest between limb IPC and the 
onset of the performance test.  Records that identified a benefit of performance concluded the limb 
IPC protocol 30 to 90 min before the onset of performance, a shorter rest between limb IPC and 
performance may have a detrimental effect on performance resulting from lowered PCr, ATP and 
buffer capacity immediately after limb IPC and therefore the outcome on athletic performance may 
be different following an extended rest period. 
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This may be confirmed by research completed by Patterson et al. (2015), although not in trained 
participants, an improved peak and mean power output (2-4 %) during the early stages (sprint 1-
3) of repeated sprint cycling (12x6 s) was reported following the use of limb IPC, completed 45 
min before the start of the exercise test. The variation in methodologies regarding time, distance 
and recovery of repeated sprint exercise protocols (Table 2.3) in addition to differences in the limb 
IPC protocol do not allow conclusions or recommendations to be drawn on the effect of limb IPC 
on repeated sprint exercise performance.  Therefore, further research is required on the use of limb 
IPC before repeated sprints in highly trained athletes ensuring a prolonged rest period is included 
between limb IPC and the onset of performance.   
 
Within sports competition, it is common to perform single, maximal efforts such as in athletics 
and swimming.  Contradicting results have been identified within this area of performance; Bailey 
et al. (2012) reported improved 5 km running TT performance, whereas Tocco et al. (2015) failed 
to identify an improvement in 5 km running TT performance after limb IPC (Table 2.3).  There 
were differences in cuff pressure applied, the number of cycles of ischemia and also the time 
between conclusion of limb IPC and performance test was notably different; five min versus 45 
min respectively.  This potentially explains the disparity in findings as reported lower levels of 
PCr, ATP and reduced buffer capacity after limb IPC may impair performance reliant of anaerobic 
metabolism (Salvador et al. 2016) and highlights the importance of appropriate timing for the 
implementation of limb IPC in relation to the time of athletic performance, consistent with research 
investigating repeated sprint performance. 
 
To date, three studies (Jean-St-Michel et al. 2011; Lisbôa et al. 2017; Marocolo et al. 2015) (Table 
2.3) have identified a positive effect of implementing limb IPC at a single time point prior to 
swimming performance.  For example, Jean-St-Michel et al. (2011) reported that five min of 
ischemia followed by five min of reperfusion, repeated for four cycles, implemented 45 min prior 
to 100 m swimming TT improved personal best swimming times by 1.1%.  However, no 
physiological measures are available to determine the underlying mechanism responsible for the 
improvement in performance.  In addition to the maximal competition effort, a submaximal 
performance test was completed; however, no beneficial effect of limb IPC was identified.  This 
is potentially explained by the differences in pathways of energy utilisation during submaximal 
and maximal exertion (Jean-St-Michel et al. 2011).  During submaximal exercise, mainly the 
aerobic oxidative pathways produce energy, whereas during maximal performance energy is 
produced not only by the breakdown of PCr but also by the anaerobic glycolytic pathway (Wells 
et al. 2009) in addition to the aerobic oxidative system.  Furthermore maximal exercise represents 
a physiologic form of ischemic injury and therefore maybe modified by limb IPC implemented 
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pre-competition (Jean-St-Michel et al. 2011).  Therefore, this suggests the benefit of limb IPC is 
influenced by the intensity of exercise performed.   
 
Most recently, Lisbôa et al. (2017) applied limb IPC one h, two h and eight h preceding a 50 m TT 
performance, with performance improvements of 1.0% and 1.2% in two h and eight h conditions, 
respectively.  The previous research relating to limb IPC and swimming performance has 
investigated the effects of the early phase of limb IPC on performance as application has been 
<12h prior to performance.  However, for short duration events (i.e. 10-90 s), a recent meta-
analysis showed that a longer duration between limb IPC and exercise resulted in a higher effect 
size; suggesting that limb IPC may be dependent on the timing of the preconditioning strategy 
relative to the start of subsequent performance (Salvador et al. 2016).  However, only one study 
(Seeger et al. 2017) relating to sports performance has differentiated between the observed early 
and late phase of limb IPC reported within the clinical literature (see section 2.3.1), exposing 12 
healthy participants to limb IPC either immediately or 24 h prior to a self-paced 5 km running TT; 
no differences in finish time after either limb IPC were found in comparison to the control, but 
suggested that at an individual level, the effects of limb IPC 24 h prior to TT were closely related 
to the effects of limb IPC.  However, the study further stated that participants started at a higher 
pace during the 24 h limb IPC, although ending with a slower pace; this may suggest application 
for anaerobic exercise to improve performance. 
 
2.4.4 Identified mechanisms for the use of IPC as a pre-competition strategy 
There are many physiological determinants that can affect performance, especially across different 
sporting activities.  The use of limb IPC has been explored across varying durations and intensities 
of exercise as previously outlined, thus highlighting the potential of different mechanisms that 
could be improving performance.   
 
Within different sporting endeavours there are three distinct yet closely integrated processes that 
operate together to meet the energy requirements of muscle (Gastin 2001).  The splitting of the 
stored phosphagens, ATP and PCr and the nonaerobic breakdown of carbohydrates comprise the 
anaerobic energy system (Gastin 2001).  This pathway is capable of regenerating ATP at high 
rates, resulting in large muscle power output (Gastin 2001) for explosive, single effort activities as 
explored in the above studies describing anaerobic race specific and muscular activation.  The 
capacity of the anaerobic system is limited by the amount of energy that can be released in a single 
exercise bout (Gastin 2001). In contrast, the aerobic system is capable of producing large amounts 
of ATP, yet is rate limited by oxidative phosphorylation and the respiratory and cardiovascular 
systems to deliver O2 to the muscle (Gastin 2001).  These systems are able to cope with high, often 
sustained and diverse energy demands placed on them during sporting activities (Gastin 2001), 
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including time to exhaustion.  However, there are several factors that can affect fatigue and 
therefore performance in sport. 
 
Exercise performance in highly trained athletes has been reported to be limited by tissue 
hypoxemia and acidosis due to a decrease in arterial pH and substantial rise in venous lactate 
(Wells et al. 2009), which may therefore represent a type of ischemia-reperfusion stress modifiable 
by limb IPC (Jean-St-Michel et al. 2011). Exercise-induced arterial hypoxemia may be a 
significant contributor to the development of fatigue in skeletal, respiratory and cardiac muscles 
(Noakes 2000) responsible for the physiological limitation in maximal exercise (Jean-St-Michel et 
al. 2011).  Literature has presented limb IPC as a potential strategy to be incorporated before 
exercise to generate resistance in tissues to the adverse metabolic effects of high intensity exercise 
(Jean-St-Michel et al. 2011).  In the instance where studies were not associated with positive 
outcomes, it is possible that this was due to variation in the protocol utilised regarding cuff 
pressure, width and duration; as reported in the previous section all of these variables can have a 
large impact on the effectiveness and outcome of limb IPC. 
 
Several mechanisms have been proposed to explain the effect of limb IPC on athletic performance.  
Research has reported the positive effects of limb IPC appear to depend on specific metabolites’ 
(adenosine, bradykinin or opioids) reaching a critical level (Downey et al. 2007).  It has been 
speculated, consistent with clinical literature, that adenosine released during occlusion provides a 
cardiac protection and stimulates adenosine A1-receptors, which have a protective effect even after 
adenosine has been removed (Liu et al. 1991).  Furthermore, adenosine is a vasodilator that 
contributes to the vasodilation response during exercise (Joyner & Proctor 1999); therefore 
adenosine may help to optimise blood supply during exercise (De Groot et al. 2010), increasing 
O2 delivery, removal of metabolic waste (Vaile et al. 2011) and repletion of ATP (Connolly et al. 
2003).  Research suggests if limb IPC and/or the exercise challenge is not severe enough to cause 
an accumulation of metabolites (adenosine, bradykinin, opioids) required to reach a critical 
threshold, this may explain the absence of the beneficial effects of limb IPC on athletic 
performance (Liu et al. 1991). 
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Table 2.3 Characteristics of the studies identifying the effect of limb ischemic preconditioning on exercise performance 
 
Study (date) Participants Sport 
specific 
Series of 
occlusion 
Pressure Area 
occluded 
Time to 
test 
Performance test Findings 
(Bailey et al. 
2012) 
13 healthy  Running 4x5:5min,  220mmHg Thigh 90min Incremental 5km 
running TT 
34s (2.3% reduction) 
improvement in 5km 
 
(Barbosa et 
al. 2015) 
13 healthy  Handgrip 3x5:5min,  200mmHg Thigh  Constant load 
rhythmic hand grip 
& MVC 
 
Increase time to task 
failure by 11.2% 
(Clevidence 
et al. 2012) 
12 cyclists Cycling 3x5:5min,  220mmHg Thigh 5min Incremental to 90% 
max PO until 
exhaustion 
No improvement in 
submax or time to 
exhaustion 
 
(Cocking et 
al. 2017) 
12 cyclists Cycling 4x5:5min 
8x5:5 min 
220mmHg Thigh & 
arms 
30min 375KJ cycling TT 4x5:5min resulted in 
17s faster TT 
(Crisafulli et 
al. 2011) 
17 healthy  Cycling 3x5:5min 
 
50mmHg > 
SBP 
Thigh 5min Incremental to 
exhaustion. Total 
exercise time, 
maximal PO 
 
Improvements total 
exercise time, 4% 
increase PO 
(Cruz et al. 
2015) 
15 cyclists Cycling 4x5:5min 220mmHg Thigh 33min 60s sprint cycle Improved performance 
2.1% 
(De Groot et 
al. 2010) 
15 cyclists Cycling 3x5:5min,  220mmHg Thigh 5min Incremental to 
exhaustion 
Improved maximal 
oxygen consumption 
3% and PO by 1.6%. 
 
(Gibson et 
al. 2013) 
25 team 
sport 
athletes 
Running 3x5:5min,  220mmHg Thigh 11.1min 3 max sprints over 
30m, 1min rest,  
No effect on sprint 
speed, small negative 
effect on female athletes 
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(Hittinger et 
al. 2015) 
15 male 
cyclists & 
triathletes 
Cycling 4x5:5min 10-20mmHg > 
SBP 
Thighs 45min 10min submax at 
55% altitude 
specific Wpeak & test 
to exhaustion 
No change in 
performance 
(Jean-St-
Michel et al. 
2011) 
16 
swimmers 
Swimming 4x5:5min 15mmHg > 
SBP 
Arms 45min 100m max TT Improvement 0.7s, no 
improvement submax 
(Kido et al. 
2015) 
15 healthy Cycling 3x5:5min, >300mmHg Thigh 12min Incremental step test 
to exhaustion 
Increase time to 
exhaustion 
 
(Kjeld et al. 
2014) 
31 divers & 
rowers 
Diving & 
rowing 
4x5:5min 40mmHg > 
SBP 
Arm 30min 1km row and 
distance swam 
underwater 
Decreased 1km rowing 
time and increased 
distance swam 
(Kraus et al. 
2015) 
Total 43 
healthy 
Cycling 4x5:5min Not reported Arm 10min 4x30s wingate test Bilateral but not 
unilateral IPC improved 
performance 
(Lalonde & 
Curnier 
2014) 
15 healthy  Cycling 4x5:5min 50mmHg>SBP Arm 10, 
65min 
6x6sec sprint – 
2min active rest  
No improvement 
(Lisbôa et al. 
2017) 
11 male 
swimmers 
Swimming 4x5:5min 220 thighs, 
180 arms 
Thigh & 
arm 
1, 2 or 8h 50m swim TT 2h – 1.0% and 8h – 
1.2% improvement in 
performance 
(Marocolo et 
al. 2015) 
15 
swimmers 
Swimming 4x5:5min 220mmHg Arm Not 
reported 
100m swim TT Improved performance 
in IPC and SHAM 
compared to CON 
(Marocolo et 
al. 2016) 
13 males Resistance 
exercise 
4x5:5min 200mmHg Thigh Not 
reported 
3RM sets leg 
extension at 12RM 
load 
Improved performance 
with IPC and placebo 
(Paixão et al. 
2014) 
15 amateur 
cyclists 
Cycling 4x5:5min 230mmHg Thigh 12min 3 Wingate tests, 
10min rest  
Detrimental to max PO 
in 1st Wingate.  
 
(Paradis-
Deschenes et 
al. 2016) 
10 strength-
trained 
Resistance 
exercise 
3x5:5min 200mmHg Thigh 20min 5x5 sets knee 
extension 
dynamometer 
Increase peak force and 
muscle O2 uptake 
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(Patterson et 
al. 2015) 
14 healthy  Cycling 4x5:5min  220mmHg Thigh 45min 12x6s sprints, 30s 
passive recovery  
2-4% increase in mean 
and peak power output  
 
(Sabino-
Carvalho et 
al. 2016) 
18 runners Running 4x5:5min 220mmHg Thigh Not 
reported 
Discontinuous 
incremental test to 
exhaustion 
Increase time to 
exhaustion with IPC 
and SHAM compared to 
CON 
(Seeger et al. 
2017) 
 
12 healthy Running 4x5:5min 220mmHg Thigh 1 or 24h 5km running TT No improvement in 
5km running test 
(Tanaka et 
al. 2016) 
12 males Resistance 
exercise 
3x5:5min >300mmHg Thigh 5min Knee extension at 
20% MVC to failure 
Enhanced endurance 
and accelerated muscle 
deoxygenation 
(Tocco et al. 
2015) 
 
11 runners Running 3x5:5min  50 > SBP Thigh 5min 5km running TT No improvement in 
5km running test 
MVC - maximal voluntary contraction, Wpeak - peak exercise capacity, IPC - ischemic preconditioning, SBP - systolic blood pressure, TT - time trial, 1RM - 1 
repetition maximum, CON - control 
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Alternatively, to the potential humoral mechanism of adenosine, limb IPC may lead to a local 
release of adenosine that activates a neural pathway, which subsequently leads to systemic 
adenosine-receptor activation, implicating a role for adenosine in the neural pathway of limb IPC 
protection (Liem et al. 2002).  The majority of the experimental evidence suggests that limb IPC 
generates adenosine in the remote tissue, which then activates afferent sensory nerves (Sharma et 
al. 2015). 
 
Another mechanism explaining limb IPC and athletic performance is the effect of adenosine on 
the vasculature.  Adenosine is a vasodilator that contributes to the vasodilation response during 
exercise (Joyner & Proctor 1999).   Limb IPC has been shown to increase O2 and blood flow via a 
vasodilation mediated effect by elevated adenosine levels (Liu et al. 1991).  Delivery of O2 to the 
peripheral tissues by blood is a potential limiting factor during exercise (De Groot et al. 2010); as 
a result, the vasodilation of blood vessels may overcome this and improve delivery of O2 and 
clearance of metabolites.  However, although the changes in adenosine and KATP channels may 
enhance maximal exercise-induced blood flow, this does not necessarily improve O2 consumption 
as O2 extraction can be decreased due to a less efficient flow distribution (Calbet et al. 2006).  In 
contrast, the effects of limb IPC on vasodilators, adenosine and bradykinin, may also contribute to 
the effects of limb IPC via protection against cellular damage (Riksen et al. 2004) this may assist 
athletic performance especially when multiple efforts are required within a day or week of 
competition. 
 
Previous literature suggested the benefit of limb IPC for athletic performance on vascular function, 
improving muscle blood flow via increases in intramuscular KATP channels in the vascular smooth 
muscles locally and increased local production of NO due to limb IPC (Horiuchi et al. 2015) as 
well as from the local release of adenosine (Maczewski et al. 2004) all of which can contribute to 
vasodilation in muscles (Duncker et al. 1993; Joyner & Proctor 1999).  The vasodilation response 
after exposure of rat muscles to limb IPC can be blocked using KATP channel blockers (Weselcouch 
et al. 1993) which suggests activation of KATP channels contributes to the effect of limb IPC on the 
vasculature (De Groot et al. 2010). 
 
Along with improving muscle blood flow and therefore increasing delivery of O2 to the working 
muscles, limb IPC initiates functional sympatholysis in humans during exercise (Keller et al. 
2004), an important integrative response during exercise to optimally meet the increased metabolic 
requirements through redistributing blood from inactive areas to active skeletal muscles during 
exercise (Horiuchi et al. 2015).  At the onset of exercise, activation of the sympathetic nervous 
system results in a systemic vasoconstriction.  However, accumulation of metabolites in exercising 
skeletal muscle locally blunts the sympathetically driven vasoconstriction in the active muscles 
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allowing for a marked increase in blood flow to the active muscles (Remensnyder et al. 1962).  
Horiuchi et al. (2015) showed enhanced functional sympatholysis at rest and at 25% of maximal 
voluntary contraction suggesting improved distribution of the regional skeletal muscle blood flow 
to the most active fibres.  This may speed and increase O2 extraction by means of matching O2 
demand with O2 delivery or elongating mean capillary transit time as recently suggested by Kido 
et al. (2015).  Additionally, limb IPC may induce up-regulation of the NO pathway (Kharbanda et 
al. 2001; Loukogeorgakis et al. 2005).  As NO antagonises sympathetically mediated 
vasoconstriction through KATP channel activity (Murphy & Brayden 1995; Thomas & Victor 
1998), up-regulation of the NO pathway may contribute to the improved functional sympatholysis 
after limb IPC (Horiuchi et al. 2015b), supporting increased blood flow and O2 delivery to active 
muscles and contributing to exercise performance.   
 
A reflex pathway may be activated by metabolic changes in the skeletal muscles during limb IPC, 
which may have a beneficial systemic and/or local effect during subsequent exercise or the 
metabolic changes in the skeletal muscles induced during limb IPC may positively influence neural 
pathways to improve performance, through its effect on blood flow locally or systematically 
(Sharma et al. 2015).  For instance, group III and IV afferent sensory neurons respond to 
mechanical and metabolic alterations in the skeletal muscles during exercise and initiate a reflex 
that is transmitted to the cardiovascular regulation centers in the brain stem, which in turn increase 
sympathetic efferent activity and reduces parasympathetic activity during exercise (Murphy et al. 
2011).  This causes an increase in the heart rate and cardiac output as well as vasoconstriction in 
non-skeletal muscle vascular beds to divert blood flow to the actively exercising skeletal muscles 
(Sharma et al. 2015).  Limb IPC may cause metabolic changes in the skeletal muscle, activating 
this neural pathway and thus increasing blood flow and initiating functional sympatholysis.  Limb 
IPC may also lower the sensitivity of the body to fatigue signals, allowing participants to exercise 
longer enhancing time to exhaustion. Evidence suggests complete skeletal muscle recruitment does 
not occur during exercise and that regulation of the exercise performance resides in the CNS, which 
allows the presence of a skeletal muscle recruitment reserve (Noakes 2011). As a result, a 
desensitising of the afferent groups III and IV potentially allows an increase in neural drive and 
force output (Gibson et al.  2013).  This is reinforced by further literature that proposes limb IPC 
can cause a greater force generation through augmented neural drive or a reduced perception of 
fatigue. Limb IPC has been hypothesized to increase work rate in trained cyclists with enhanced 
muscle recruitment via activation of a proposed muscle recruitment reserve (Crisafulli et al. 2011). 
 
There has been interest in the effect of limb IPC on endothelial function and flow mediated dilation 
(FMD). Endothelial function is believed to contribute to blood flow regulation (Salvador et al. 
2016), increasing tissue oxygenation at rest (Lalonde & Curnier 2014) to improve vascular 
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function and perfusion (Enko et al. 2011; Kraemer et al. 2011) as well as to prevent the decline in 
vascular function after high intensity exercise (Bailey et al. 2012).  Limb IPC mediated increases 
in muscle blood flow during exercise are likely secondary to the ability of limb IPC to protect 
against exercise induced and ischemia induced endothelial (Loukogeorgakis et al. 2005; 
Kharbanda et al. 2002; Bailey et al. 2012) and microvascular dysfunction (Wang et al. 2004). 
 
High intensity exercise has been associated with a significant reduction in artery endothelium-
dependent function immediately after cycling (Dawson et al. 2013), however this may be 
counteracted by the use of limb IPC.  For example, results of FMD have shown a change from 
5.1% post control to 3.7% following 5km TT, however following vascular occlusion, FMD was 
similar post vascular occlusion and post 5km TT; 5.4 and 5.7% respectively (Bailey et al. 2012).  
These results highlight that strenuous running is associated with a decrease in endothelial function 
by ~1.4%.  With the use of vascular occlusion this can prevent the exercise-induced decrease in 
FMD and may provide a strategy to improve endothelial function and therefore improve aerobic 
exercise performance. 
 
Application of limb IPC to the legs prevents endothelial dysfunction in the upper body, 
highlighting the systemic effects against IRI beyond the ischemic area (Bailey et al. 2012).  These 
combined effects might improve exercise performance by maintaining the supply of O2 and energy 
substrates to the skeletal muscles during intense exercise, when the exercising muscle groups might 
be subject to hypoxia, thereby sustaining contractile activity (Sharma et al. 2015).   Previous 
research has shown that exercise training can improve endothelial function with chronic resistance 
training protecting against vascular dysfunction in trained athletes, with the addition of limb IPC 
it can assist with vasodilators (e.g. NO), adenosine and bradykinin that may contribute to the 
effects of limb IPC via protection against cellular damage (Riksen et al. 2004).  Recurring periods 
of exercise-induced endothelial dysfunction may represent a beneficial stimulus that contributes 
to longer term improvement of the endothelial function, commonly referred to as hormesis (Padilla 
et al. 2011), however, limb IPC may provide a strategy to improve endothelial function acutely 
which may be beneficial prior to athletic performance at competition to increase or maintain O2 
and energy substrate supply during intense exercise. 
 
Flow mediated dilation is also related to NO bioavailability and the benefits of limb IPC are related 
to increased NO synthase (Kido et al. 2015).  It is well known that NO is produced from vascular 
endothelial cells following an increase in shear stress (Kooijman et al. 2008; Green et al. 2014), 
which is induced by the rapid increase in blood flow, such as that occurs at the onset of exercise 
or with reperfusion of limb IPC (Kido et al. 2015).  Limb IPC is able to improve NO availability 
(Kimura et al. 2007), in addition to potential vasodilation, NO may impact on the ability to 
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consume O2 during exercise as NO has been shown to attenuate mitochondrial O2 consumption 
through maintenance of O2 extraction reserve (Cooper & Brown 2008).  Therefore, it was 
aforementioned that limb IPC could increase blood flow and consequently O2 delivery but there 
was skepticism whether increased O2 delivery would be utilised by the active skeletal muscle.  NO 
may play a role in the use of limb IPC by increasing O2 extraction to contribute to improved 
exercise performance. 
 
Research completed by Kido et al. (2015) has identified that limb IPC accelerates the muscular O2 
response during systemic whole body exercise, specifically muscle O2 extraction has been analysed 
through the use of near-infrared spectrometry (NIRS), this reflects the regional balance between 
O2 utilsation and O2 availability (DeLorey et al. 2003).  Prior exercise induced acceleration of the 
muscle O2 response is associated with mitochondrial enzymatic activation in skeletal muscle 
(Gandra et al. 2012), this is acutely enhanced by a single bout of exercise (Leek et al. 2001; 
Fernström et al. 2004) and it may be related to the accelerated O2 metabolism resulting from limb 
IPC which enhances exercise performance due to skeletal muscle mitochondrial activation, as 
indicated by accelerated O2 extraction (Kido et al. 2015).   
 
Barbosa et al. (2014) observed deoxygenated hemoglobin and myoglobin concentrations in the 
forearm were higher at exhaustion point indicating higher O2 extraction after limb IPC.  The greater 
deoxygenated hemoglobin and myoglobin indicates that O2 uptake was proportionally larger than 
O2 delivery (i.e. greater O2 extraction).  Similarly, Kjeld et al. (2014) found lower O2 saturation in 
the frontal cortex, forearm and thigh at the end of a breath hold after limb IPC of one forearm.  
However, it cannot be concluded that the greater peak O2 extraction was merely a consequence of 
longer time to task failure (Barbosa et al. 2014).  When compared at equal time points during 
submaximal exercise, it appears limb IPC does not alter the magnitude of deoxygenation, rather it 
alters the kinetics, speeding up deoxygenation at the onset of moderate cycling exercise (Kido et 
al. 2015) which would reduce the O2 deficit (Incognito et al. 2015) and allow increased aerobic 
energy provision.  Such increased aerobic energy provision may reduce the rate of utilisation of 
the finite anaerobic energy stores, delaying exhaustion (Demarle et al. 2001; Jones et al. 2008; 
Turnes et al. 2014). 
 
Alternatively, both the cardiovascular and the respiratory systems have been examined and shown 
to increase during activity following limb IPC, without any improvement in VO2max but a greater 
level of physical effort (e.g. Crisafulli et al. 2011).  It is speculated that ATP-sparing may occur 
through a tightening of excitation-contraction coupling, a reduction in futile ion pumping, or 
through a lower reliance on anaerobic energy production (Pang et al. 1995).  If ATP-sparing 
occurred, it may be expected that muscle efficiency was increased, leading to a larger work per O2 
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consumed (De Groot et al. 2010).  Crisafulli et al. (2011) reported that the cascade of metabolic 
effect induced by the limb IPC strategy could produce a more efficient muscle contraction, thereby 
promoting an ATP-sparing effect, which in turn, could lead to a larger workload/O2 consumption 
and reduce the energy requirements per unit of work done (Crisafulli et al. 2011).  It was speculated 
that limb IPC permits the recruitment of additional higher order motor units via enhanced central 
motor efferent command, allowing subjects to exercise slightly beyond their individual critical 
threshold of fatigue for the task (Crisafulli et al. 2011). In practical terms, these effects could be 
increasing/maintaining the rate of force development during exercise, which would be very 
important in the context of sprint swimming exercises (Lisbôa et al. 2017). 
In vivo studies have shown that limb IPC leads to opening of mitochondrial KATP channels and 
uncoupling of oxidative phosphorylation (Fryer et al. 2000).  As a result, it was proposed that limb 
IPC allows for faster uptake of acetyl-CoA by mitochondria thus maintaining lactate accumulation 
at a metabolically acceptable level due to greater contribution of aerobically generated ATP for 
exercise rather than involvement from the anaerobic capacity (Jean-St-Michel et al. 2011).  
However, some studies have reported lower PCr, ATP and total adenosine nucelotides in addition 
to reduced buffer capacity immediately after limb IPC (Salvador et al. 2016); this may impair 
performance reliant on anaerobic metabolism and highlights the importance of appropriate timing 
for implementation of limb IPC. 
 
The proposed mechanisms discussed predominately occur as a result of the early phase of limb 
IPC, however, as reported in the clinical literature, there are two phases that result from limb IPC; 
an early phase is activated immediately and is no longer evident after 4h (Sack et al. 1993; 
Burckhartt et al. 1994), a second phase presents 24 h after the application of the limb IPC stimulus 
and sustained for at least 48 h (Loukogeorgakis et al. 2005), in some cases the protective effect 
may still be seen after 72 h (Eisen et al. 2004), this has been termed delayed or late preconditioning.  
Once the early and late effects of limb IPC on the cardiovascular system were demonstrated in 
clinical experimental settings (Hagar et al. 1991; Yamashita et al. 1998), it would be interesting to 
determine the ideal window of time after which limb IPC could result in exercise benefits 
(Marocolo et al. 2016).   
 
Relating to athletic performance, both phases have been shown to be mediated by endogenous 
substances activating KATP channels (Loukogeorgakis et al. 2005; Randhawa et al. 2015).  The 
early phase affects ion channel permeability and the post translational modification of proteins, 
with release of autocoids such as adenosine, NO and bradykinin (Koch et al. 2014).  Whereas, the 
later phase appears dependent on gene expression and de novo synthesis of proteins involving 
endothelial health, hemostasis, immune response and cellular energy metabolism (Koch et al. 
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2014).  A large part of the genetic response involves mitochondrial proteins, leading to more 
efficient energy homeostasis (Perez-Pinzon 2004).  Unique to late phase of limb IPC is the role of 
ROS, triggering delayed protection (Kaeffer et al. 1997; Bolli et al. 1997; Sun et al. 1996).  NO 
generated in ischemic tissue during ischemia has been proposed as both a trigger and a mediator 
in late preconditioning (Bolli et al. 1998; Bolli 2000).  The formation of peroxynitrite anion from 
NO and free O2 radicals is considered an important upstream event during the triggering of delayed 
limb IPC (Bolli 2000). 
 
There appears to be different timing of mechanisms resulting from limb IPC and therefore may 
explain variation in results seen to date on performance as timing for specific exercise (e.g. time 
to exhaustion, single effort anaerobic and repeated sprint) may be influenced by the early and late 
phase of protection.  Therefore, an appropriate protocol needs to be established to effectively utilise 
these two distinct phases and the resultant physiological responses to improve performance. 
 
2.4.5 Summary 
 
It is plausible that the reduced O2 delivery and elevated metabolic accumulation as a result of 
decreased venous outflow initiates several mechanisms that contribute to the response seen when 
combining vascular occlusion with exercise including the hormonal response following high load 
exercise with vascular occlusion whereas limb IPC increases the release of adenosine having a 
subsequent effect on vasodilation, blood flow and O2 delivery and extraction.  The previous results 
have highlighted the different applications of vascular occlusion and limb IPC with athletes and 
support its use as a pre-competition strategy.  There is a large variance in protocols regarding 
percentage of 1RM, volume of sets and repetitions and continuous versus intermittent occlusion 
when combing vascular occlusion with resistance exercise, therefore, it is hard to draw conclusions 
on the most suitable or effective protocol to implement. There are further disparities in the protocol 
applied for limb IPC, with several mechanisms attenuating improvement in performance with 
factors such as cuff pressure and time between limb IPC and athletic performance that are 
influencing the results and outcomes of limb IPC and exercise performance.  Due to the non-
invasive nature and easy application of vascular occlusion or limb IPC, it may be advantageous to 
use within sport (De Groot et al. 2010), for example limb IPC could be used as an intervention 
before athletes commence their warm up routine (Gibson et al. 2013).  However, little is known 
about the optimal limb IPC protocol and timing to improve exercise performance at present (De 
Groot et al. 2010). 
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2.5 USE OF VASCULAR OCCLUSION FOR RECOVERY  
 
The effect of vascular occlusion as a recovery modality has only recently received attention and 
potential application in athletic performance.  Initial research by Beaven et al. (2012) reported 
varied results on the effect on performance; beneficial effects were identified on power output and 
sprint performance immediately and 24 h post. The three min cycles of occlusion and reperfusion 
were selected to fulfil the duration threshold criterion that has been reported previously (Van 
Winkle et al. 1991).  This threshold has been suggested to reflect the period of ischemia required 
to accumulate sufficient localised adenosine concentrations where the adenosine receptors are 
sufficiently populated to elicit a preconditioning effect (Beaven et al. 2012). Importantly, a total 
ischemic stimulus of 4–6 min has been shown to be most effective at eliciting a protective effect 
in human myocardium, regardless of the number of cycles of ischemia and reperfusion (Ghosh et 
al. 2000). Although the occlusion intervention used was effective in improving specific aspects of 
subsequent exercise performance, negative effects at different time points and different 
performance measures were also identified resulting in inconclusive results (Beaven et al. 2012). 
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Table 2.4 The use of vascular occlusion as a recovery modality 
 
Study (date) Participants Intervention Control 
condition 
Performance test Time points Findings 
(Beaven et 
al. 2012) 
14 healthy male 
& females 
220mmHg for 
2x3:3min 
15mmHg post 
exercise for 
2x3:3min 
3x squat jump, 3x 
CMJ, 6 reps leg 
press, 6x40m 
sprints 
0 and 24 h Beneficial & negative 
effects performance tests 
immediately & 24h later 
(Borne et al. 
2016) 
33 sprint cyclists 
and middle-
distance runners 
90-110mmHg 
for 24min 
Supine rest 
24min 
30s Wingate test 0 h No beneficial effect of 
occlusion 
(Garcia et al. 
2017) 
8 male rugby 
union players 
220mmHg for 
3x5min, 2min 
reperfusion 
Supine rest 
21min 
Agility test, CMJ, 
30s continuous 
jump test 
1 h No acute improvement in 
recovery 
(Northey et 
al. 2016) 
12 strength 
trained males 
220mmHg for 
2x3:3min & 
supine rest 
33min 
Supine position 
45min 
Concentric peak 
isokinetic torque, 
jump height from 
SJ & CMJ 
0 h, 1 h, 24 h No improvement in 
recovery 
(Page et al. 
2017) 
16 healthy males 220mmHg for 
3x5:5min 
20mmHg for 
3x5:5min 
CMJ, MIVC 24, 48 and 72 h Accelerated recovery 
 
 CMJ - countermovement jump; SJ - squat jump; MIVC - maximal isometric voluntary contraction. 
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2.5.1 Use of vascular occlusion as a recovery strategy 
To date, five studies have investigated the use of vascular occlusion as a potential recovery strategy 
(Table 2.4) with two studies reporting a beneficial effect (Beaven et al. 2012; Page et al. 2017), 
and three studies reporting no effect (Northey et al. 2016; Borne et al. 2016; Garcia et al. 2017).  
The initial study by Beaven et al. (2012) examined the effect of vascular occlusion on recovery, 
14 participants performed a series of exercises inducing muscle damage and performance measures 
prior to being exposed to a control or vascular occlusion condition (Table 2.4).  The results 
indicated vascular occlusion had a beneficial effect on mean squat jump height immediately after, 
although there were detrimental effects on mean eccentric peak velocity and peak acceleration in 
the CMJ and mean eccentric PPO in the squat jump immediately post intervention.  The results 
after 24 h show a beneficial effect in the CMJ after vascular occlusion, specifically on mean 
concentric and eccentric peak velocity.  The inconclusive results initiated further work in this area, 
and more specifically, in well trained participants. 
 
However, there is disparity within the research that may be explained by methodological 
differences in the implementation of vascular occlusion, variance in participant activity levels and 
variability in the stimulus for EIMD.  Neither Borne et al. (2016), Northey et al (2016) or Garcia 
et al. (2017) found vascular occlusion improved rate of recovery in trained participants. Although 
differences in participant activity levels existed, the methodologies also varied, for instance, Borne 
et al. (2016) applied 24 min of continual pressure using elastic wraps versus the intermittent 
application of pressure for 12 min in other studies (Beaven et al. 2012; Northey et al. 2016).  It is 
possible that the training status of the individuals may explain the differences between studies.  For 
example, the participants in the study by Page et al. (2017) were recreationally active and therefore 
maximal isometric voluntary contraction was reduced by 18.5% following EIMD in the control 
group.  In contrast, the participants in the study by Northey et al. (2016) had a history of strength 
training which resulted in a smaller loss of force production (4%), which was likely due to the 
repeated bout effect (Howatson et al. 2007), suggesting that vascular occlusion was less likely to 
play a role in the trained group. Moreover, standardised cuff pressures have been used (Table 2.4) 
irrespective of participant characteristics despite recommendations regarding individualisation of 
cuff pressures relative to thigh girth and resting blood measurements (Loenneke et al. 2015).  
Similarly, inconsistencies in the timing of recovery markers (1-72h post occlusion) have occurred 
between studies.   
 
2.5.2 Proposed mechanisms for the use of vascular occlusion as a recovery modality 
Recovery after strenuous exercise often relies on alleviating the effects of impaired muscle 
function and soreness (Cochrane et al. 2013).  The most frequently proposed mechanism through 
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which strategies may contribute to recovery after high-intensity exercise is by increasing or 
maintaining local and/or systemic blood flow (Barnett 2006; Bishop et al. 2008).  Effective 
recovery strategies enhance blood flow to the recovering muscles, which is assumed to improve 
O2 and nutrient delivery, and therefore ATP, PCr and glycogen resynthesis (Byrne et al. 2004), 
while at the same time transporting lactate and metabolic by-products away from the active 
muscles to removal sites and non-exercised muscles (Cheung et al. 2003).  According to some 
studies, an increase in local and/or systemic blood flow can be achieved through several parameters 
such as activation of the skeletal muscle pump and release of endothelium-derived relaxing factors 
which increase venous return and arterial inflow (Davies et al. 2009; Delis et al. 2000).  Garcia et 
al. (2017) speculated the vascular occlusion would induce improvement due to increased blood 
flow (i.e., reperfusion) and muscular O2 utilisation for a faster recovery of muscular function. 
However, blood flow and O2 consumption were not assessed in that study and their mechanistic 
statements were speculative.  
 
The proposed beneficial effects of vascular occlusion on exercise performance and recovery have 
been attributed to post occlusion increases in blood flow associated with elevated adenosine levels 
(Liu et al. 1994) and activation of KATP channels (De Groot et al. 2010), which potentially result 
in elevated blood flow.  Within the clinical literature, as previously discussed in section 2.3, 
vascular occlusion has been used to protect cardiac and skeletal tissue against IRI (Zhao & Vinten-
Johansen 2006), this is the damage that occurs when blood supply returns to the tissue after a 
period of prolonged ischemia, causing metabolic and contractile damage (Wang et al. 2011).  The 
metabolic and contractile damage observed following IRI, is similar to that seen in EIMD, namely 
increased intracellular Ca2+ concentrations (Warren et al. 1995) and an increase in appearance of 
muscle proteins in the blood and cytokine markers such as CK, lactate dehydrogenase and 
interleukin-6 (Wang et al. 2011; Chan et al. 2004).  Vascular occlusion has shown to attenuate IRI 
and thus may potentially be used to speed up the recovery process following EIMD, via increased 
blood flow due to its effects on activating KATP channels (De Groot et al. 2010), elevating 
adenosine levels (Liu et al. 1994) and/or reducing the inflammatory response (Konstantinov et al. 
2004), yet the exact mechanisms are currently unknown. Whilst vascular occlusion may attenuate 
the functional and metabolic damage associated with EIMD, few studies have examined the 
efficacy of this intervention on recovery (Page et al. 2017). 
 
Page et al. (2017) investigated physiological response; the data demonstrated occlusion attenuated 
the increase in CK as evidenced by reduction at 24 and 48 h following exercise.  The reduction in 
CK following the application of vascular occlusion suggested cell membrane integrity was 
maintained to a greater extent than the control group, suggesting a reduction in the inflammatory 
response to EIMD. A reduction in inflammatory response leads to a reduction in muscle oedema 
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and intramuscular pressure, which reduces the stimulation of nociceptors, potentially reducing 
pain, stiffness and muscle soreness sensations (Howatson & van Someren 2008), which 
corresponds to the positive reduction on muscle soreness following EIMD in the research by Page 
et al. (2017).   
 
Speculatively, the mechanism(s) by which occlusion might lead to reduced soreness/pain may be 
due to a downregulation of circulating leukocytes (Konstantinov et al. 2004) and/or increased NO 
which is up-regulated in response to vascular occlusion (Rassaf et al. 2014), and appears to be an 
important intracellular and intercellular regulator of muscle inflammation and muscle remodeling 
(Tidball 2005).  It should be noted however that a reduced inflammatory response may not always 
be sought. Whilst this may be beneficial for short term recovery, the inflammatory response is 
important for adaptations to exercise and thus practitioners should take care as to when they apply 
different recovery techniques (Page et al. 2017). 
 
Although mechanisms were not the primary focus of the investigation by Beaven et al. (2012), it 
was reported that ischemia can improve muscle function (Lawson & Downey 1993) as well as 
exercise performance and maximal O2 uptake in humans (De Groot et al. 2010).  It is possible that 
hypoxia has an effect on muscle spindle reactivity and the alterations of sensorimotor control may 
contribute to the observed effects on eccentric measures (Hoshikawa et al. 2010).  In contrast, the 
majority of the beneficial effects of occlusion were observed after 24h in the study completed by 
Beaven et al. (2012), the authors suggested that the increased blood flow due to reperfusion and 
improved muscular O2 utilisation may have led to a more rapid return of muscle function.  
However, as stated the physiological mechanisms were not examined in the study and therefore 
this is not conclusive.  
 
2.5.3 Summary 
Increasing literature is investigating the use of vascular occlusion implemented as a recovery 
strategy to improve athletic performance following EIMD. However, within the five studies 
completed, there are many disparities between the protocol implemented, varying from the cuff 
pressure used, duration of occlusion and reperfusion, along with participant activity level, training 
history and timing of and performance tests enforced.  All of these factors combined prevent any 
conclusions to be drawn regarding the use of vascular occlusion for recovery and therefore requires 
further investigation. 
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2.6 VARIABLES OF LIMB IPC AND VASCULAR OCCLUSION  
 
The inconsistencies in the current literature on the experimental results of limb IPC and vascular 
occlusion may be a result of the use of different equipment and/or variation in the protocol and 
procedures previously utilised.  A standard protocol for limb IPC has involved a number of cycles 
of inflation of a cuff on the arm or leg followed by cuff deflation for a short period of time (Sharma 
et al. 2014).  Examples of previous protocols include 3-4 cycles of cuff inflation and deflation, five 
min cycles, using a cuff inflation of 220mmHg (Bailey et al. 2012; Clevidence et al. 2012; De 
Groot et al. 2010; Gibson et al. 2013) or continuous occlusion combined with low intensity 
exercise.  A range of cuff pressures and cuff widths have currently been reported within the 
literature (Table 2.5).   
 
2.6.1 Cuff Pressure 
It is common in limb IPC and vascular occlusion protocols for the cuff to be inflated to the same 
absolute occlusion pressure (mmHg) (Jean-St-Michel et al. 2011; Beaven et al. 2012; Cook et al. 
2014).  However, a standard occlusion pressure may not reduce blood flow to the same degree in 
different individuals (Hunt et al. 2016). As such, the level of O2 delivery as well as accumulation 
and clearance rate of local metabolic by-products are likely to be different between individuals 
(Takarada et al. 2000; Yasuda et al. 2008; Karabulut et al. 2011).  Furthermore, complete arterial 
occlusion causes greater ratings of perceived exertion  compared to partial occlusion and limits the 
tolerable duration of exercise (Yasuda et al. 2009), reducing the effectiveness of vascular occlusion 
when combined with exercise (Sumide et al. 2009; Kacin & Strazar 2011). 
 
Within the systematic review completed by Fahs et al. (2012), it was reported that the majority of 
studies have utilised a cuff pressure of between 140-240mmHg for the lower body and 100-
160mmHg for the upper body.  However, restrictive cuff pressures in this range may not be 
appropriate for all individuals.  The pressure applied should be high enough to occlude venous 
return from the muscle but low enough to maintain arterial inflow into the muscle (Loenneke et al. 
2014). The optimal pressure for beneficial effects on skeletal muscle are currently disputed; 
however, preliminary data has suggested that there may be a point where greater pressure may not 
augment the response (e.g. metabolic accumulation) but may actually result in decrements (e.g. 
decrease muscle activation and fatigue) (Loenneke et al. 2014), the latter more important when 
applying vascular occlusion with exercise. 
Therefore, applying the same pressure to every individual could inadvertently lead to the complete 
occlusion of blood flow for some participants (Jessee et al. 2016).  Figure 2.5 from Jessee et al. 
(2016) highlights the effect of applying an absolute pressure of 160 mmHg,  resulting in arterial 
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occlusion at rest for many participants in the upper body [also true in lower body (Loenneke et al. 
2013)].  This same pressure may not necessarily restrict the same amount of blood flow in all 
individuals or under conditions in which a different vascular occlusion device is used, since the 
amount of tissue surrounding the blood vessels influences the pressure exerted on the vasculature 
and therefore, the degree of occlusion (Hargens et al. 1987).   Consequently, the stimulus and 
response may differ depending on the degree of occlusion in each individual.  To control for this, 
efforts to make restriction relative are made by applying a pressure 50mmHg greater than systolic 
blood pressure or 20 mmHg less than brachial systolic blood pressure (Horiuchi 2017; Pope et al. 
2013).  Although this makes it relative, the resulting pressure may vary as a percentage of arterial 
occlusion due to differences in cuff width/type (Jessee et al. 2016) and furthermore no guidance 
whether pressure should be above or below and to what degree greater than systolic blood pressure.  
Thus, pressure should also be made relative to the individual and cuff being used during the actual 
occlusion session. 
It is often speculated in the literature that thigh circumference or composition of the limb may 
restrict flow differently between individuals which might account for some of the variability in the 
response to vascular occlusion combined with exercise (Karabulut et al. 2011).  Karabulut & Perez 
(2013) proposed that variation in the regional body composition between genders could change 
the degree of pressure caused by the tightness of the cuff used during occlusion and the subsequent 
effect on neuromuscular activation.  Thicker skin and subcutaneous fat in the thighs may act as a 
barrier between the occlusion cuffs and circulatory pathways resulting in low or no change in the 
diameter of the targeted blood vessels minimising overall effect of external pressure.  Karabulut 
& Perez (2013) completed a study to investigate the effects of this; participants were required to 
have their upper leg length, thigh circumference and skin and subcutaneous fat thickness 
determined.  Following this an elastic cuff was placed proximal to the inguinal area of the right 
thigh and was manually tightened to the final pressure which was determined by multiplying arm 
systolic blood pressure by 1.44.  Participants lifted the same weight (set between 41 and 68Nm) 
during dynamic exercise for both testing sessions. The study reported that skin and subcutaneous 
fat thickness was the most important independent variable creating variations in the amount of 
pressure being applied by the tightness of the occlusion cuff.  The changes in EMG response due 
to tightness of cuff and the effect of skin, and subcutaneous fat thickness on tightness of cuff 
provide important details on the occlusion protocol and leg composition on NMF during exercise 
with vascular occlusion (Karabulut & Perez 2013).  It is likely the degree of intramuscular pressure 
depends on the architecture features of the muscle (Hunt et al. 2016). Hypertrophied muscles have 
a greater thickness and volume, and subsequently blood flow occlusion may occur at relatively 
lower pressures (Wernbom et al. 2006).  Despite this, fat as opposed to muscle cross-sectional area 
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has explained most of the variance in the cuff pressure required to completely occlude arterial flow 
(Loenneke & Abe 2012).  
 
However, hierarchical regression models have been used to determine what factors (i.e., gender, 
leg size, blood pressure, and limb composition) should be accounted for when prescribing the cuff 
pressure for this training technique (Loenneke et al. 2012).  An interesting finding was that the leg 
circumference (field method) models predicted the cuff pressure needed to restrict arterial blood 
flow equally or better than the limb composition (lab method) models. This provided evidence that 
measuring limb circumference rather than limb composition would be adequate for determining 
restrictive cuff pressure (Loenneke et al. 2012). 
 
Consequently, Loenneke et al. (2013) further investigated occlusion pressures that were relative to 
limb circumference.  Thigh circumference was measured 33% distal to the inguinal crease due to 
providing an accurate representation of the site at which the cuffs would be applied.  Thigh 
circumference was plotted with arterial occlusion pressure (AOP) for each individual.  For the 
occlusion protocol, an inflation pressure of 60% of participants predicted AOP was used to ensure 
that the inflated cuff pressure would not cause arterial occlusion.  The following measurements 
and occlusion pressure was determined; <45-50cm = 120mmHg; 51-55cm = 150mmHg; 56-59cm 
= 180mmHg and ≥60cm = 210mmHg.  However, all of these results have only been tested within 
the lower body and therefore may not translate to occlusion for the upper body and published 
research has not yet examined the efficacy of these recommendations for enhancing adaptive 
responses to training (Scott et al. 2015). 
To account for inter-individual differences, some investigators have implemented occlusion as a 
percentage of estimated AOP (Scott et al. 2015).  The pressure can be made relative to an 
individual’s AOP, which is the minimum pressure required to completely occlude blood flow.  By 
setting the pressure at a percentage of the pressure required to completely occlude blood flow with 
a specific cuff, it should allow a stimulus that accounts for differences in cuff type and limb size 
(Jessee et al. 2016).  Within the literature the use of a hand-held bidirectional Doppler probe placed 
on the posterior tibial artery for detection of complete arterial occlusion has been reported, to 
subsequently calculate percentage of pressure required to cause partial arterial occlusion (e.g. 
Laurentino et al. 2008).   
Within this protocol, a nylon cuff (17.5 x 90 cm) was placed at the top of the thigh and inflated to 
the lowest point at which an auscultatory pulse was no longer detected. This value was defined as 
the AOP (Teixeira et al. 2017). When arterial flow was no longer detected, cuff pressure was 
decreased by 100mmHg until arterial flow was present.  This process has also been reported for 
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wide (13.5cm) and narrow (5cm) cuffs (Loenneke et al. 2012); the results highlighted that 
restrictive cuff pressure should be based on width of the cuff; the wider cuffs cut off arterial flow 
at a lower pressure compared to the narrow cuffs.  Reports suggest that an arbitrary pressure of 
100mmHg with a 13.5cm cuff was similar to a pressure of 210mmHg with a 5 cm cuff (Loenneke 
et al. 2013).  By measuring the AOP with the cuff actually used during the occlusion protocol, then 
applying the stimulus as a percentage of that value, this ensures that the methodology is replicable, 
and allows investigators to compare various combinations of load and relative restriction pressures 
(Loenneke et al. 2013). 
 
Due to the increasingly common use of Doppler ultrasound to determine occlusion pressure 
Bezerra de Morais et al. (2017) examined the reproducibility of Doppler ultrasound for the 
measurement of occlusion pressure in upper limbs and determined the predictive variables. 
Thirteen male volunteers attended three times to the laboratory. On the first day, arm 
circumference, systolic and diastolic blood pressure, and brachial artery occlusion pressure were 
assessed. On second and third days, only occlusion pressure was assessed.  A coefficient of 
variation (CV) of 5.6% and an intra-class correlation coefficient (ICC) of 0.795 for the Doppler 
was found. In the analysis of occlusion pressure predictive variables, the Spearman coefficients 
were 0.813 systolic blood pressure, 0.786 diastolic blood pressure and 0·388 arm circumference. 
Therefore, these results support that Doppler has good reproducibility for occlusion pressure and 
that systolic and diastolic blood pressure should be considered to determine occlusion pressure in 
upper limbs.  
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Figure 2.5 The percentage of arterial occlusion applied when using vascular occlusion with 
absolute and relative pressures (bSBP – brachial systolic blood pressure). Data from Loenneke et 
al. (2015), extracted from Jessee et al. (2016). 
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Previous debate exists whether systolic blood pressure should even be considered since studies 
report a moderate (r =0.56, Younger et al. 2004) if not absent [r =0.05, Crenshaw et al. 1988; 
Loenneke et al. 2012) relationship between systolic blood pressure and limb occlusion pressure. 
This suggests that basing cuff pressure on systolic blood pressure alone may not lead to optimal 
occlusion and further variables should be investigated (Hunt et al. 2016).  Loenneke et al. (2015) 
provided evidence regarding the use of systolic blood pressure as a predictor but extended the 
research, investigating the impact of cuff pressure on upper and lower limbs, identifying optimum 
individual cuff pressure.  Within this study 171 participants were investigated; male and female 
un-trained participants (reported absence of cardiovascular or metabolic disease as criteria).  
Following baseline measures (blood pressure, arm and thigh circumference, muscle and fat 
thickness) AOP was determined using a Doppler ultrasound.  For the upper body two different 
models of hierarchal linear regression were used to determine which variables predicted the 
pressure at which arterial occlusion occurred.  Models included arm circumference or composition 
and systolic and diastolic blood pressure.  Similar was repeated for the lower body; thigh 
circumference, systolic and diastolic were added into the model.   
 
Results from this study identified that arm circumference or tissue composition may need to be 
accounted for when using vascular occlusion (Loenneke et al., 2015).  However, absolute arm size 
may be more important than composition.  Similarly, thigh circumference was reported as the 
biggest predictor of arterial occlusion in the lower body, highlighting that pressure in the lower 
body should be individualised on the basis of thigh size (larger thigh requires greater pressure).  
The results highlighted that for both males and female’s thigh girth and arterial blood pressure are 
important determinants for vascular occlusion.  Limitations of the study that should be considered, 
all measurements were taken at rest in the supine position and therefore research is required to 
identify if the same results are identified during exercise when in the upright position.  
Furthermore, little evidence has determined what percentage of arterial occlusion is required to 
achieve complete venous occlusion, which is the primary aim of vascular occlusion 
implementation for training, pre-competition or recovery strategies. 
 
This research supported previous findings in which thigh circumference was the biggest predictor 
of arterial occlusion in the lower body (Loenneke et al. 2012). This reinforces the idea that 
pressures in the lower body should to some degree be individualised on the basis of thigh size, 
meaning bigger thighs require greater pressures and smaller thighs require less pressure (Loenneke 
et al. 2015).  When the regression models were separated by sex, circumference was still explaining 
the most variance in arterial occlusion.  When applying occlusion to the upper body, results suggest 
brachial systolic blood pressure and arm circumference should be accounted for when setting the 
pressure. The fact that brachial systolic blood pressure explains a significant amount of the 
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variance with arterial occlusion is logical given that they are essentially measures of the same thing 
(Loenneke et al. 2015).  As a result equations were reported by Loenneke et al. (2015) to determine 
upper (2.1) and lower (2.2) body occlusion pressure based on blood pressure and arm or thigh 
circumference, respectively.  This method of determining individual cuff pressure in the absence 
of a Doppler ultrasound is practical to use in the field. 
 
Respective equations (Loenneke et al., 2015): 
 
(2.1) Arterial occlusion (mmHg) = 0.514(SBP) + 0.339(DBP) + 1.461(arm circumference) 
+ 17.236 
 
(2.2) Arterial occlusion (mmHg) = 5.893(thigh circumference) + 0.734(DBP) + 0.912(SBP) 
– 220.046 
Where SBP = systolic blood pressure; DBP=diastolic blood pressure 
 
Laurentino et al. (2008) determined the pressure required for complete vascular restriction at the 
upper thigh during rest, and subsequently employed an occlusion pressure of 80 % AOP during 
low-load resistance training.  However further results have demonstrated that an individualised 
cuff pressure of 50 % estimated AOP appears to maximise EMG amplitude and increase acute 
decrements in torque during and following low-load knee extension exercise (Loenneke et al. 
2015). This is supported by research suggesting increased restrictive pressures (60 % estimated 
AOP) did not result in further augmentation of these responses (Scott et al. 2015) and Mattocks et 
al. (2017) indicated higher RPE ratings and discomfort and lower volume completed at 90% 
compared to 50% AOP and below. 
 
Further research by Fatela et al. (2016) examined fourteen men exercising at 20 % 1RM combined 
with 40, 60 and 80 % AOP. Restrictive pressures were calculated based on direct blood-flow 
measurements taken at rest on each participant in accordance with previous Doppler measures.  
Results demonstrated muscular activation, as well as NMF, varies as a function of relative 
occlusion.  This extends previous statements and demonstrating the individual determination of 
vascular restriction levels is crucial before engaging in occlusion exercise.  In addition to the 
emphasis on individualisation of cuff pressure this study also demonstrated that muscle fatigue is 
dependent on the relative level of vascular restriction which is novel within the literature and 
highlights the protocol still requires further investigation.  The rapid decrease in peak velocity at 
pressures above 70% align previous findings, in which pressures above 60% would theoretically 
affect both the arterial and the venous circulation (Mouser et al. 2017). Due to the decrease in 
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transmitted pressure toward the centre of the limb, it would be expected that pressures greater than 
60% of arterial occlusion are required before the arteries become compressed. Once compressed, 
blood velocity decreases rapidly, likely due to the decreased amount of time that the artery remains 
open during systole (Mouser et al. 2017). 
 
Scott et al. (2015) questioned if equivalent restrictive pressures are used for both the arms and the 
legs, reporting it is likely that either arterial inflow in the arms will be limited or that insufficient 
venous occlusion for venous pooling will occur in the legs.   Based on previous research where 
limb circumference explained most of the variance in the cuff pressure required to occlude arterial 
flow and may influence the fatigue response during occlusion, a different cuff pressure would be 
required to elicit optimal occlusion of upper and lower limbs (Hunt et al. 2016).   Research 
completed by Sharma et al. (2014) tested a range of cuff inflation pressures (140, 160 and 
180mmHg) to induce limb ischemia in upper and lower limbs; results identified that ischemia can 
be induced in the upper limb at a much lower cuff inflation pressure compared with 200mmHg 
that is generally used for limb IPC, provided cuff inflation pressure is ~30mmHg greater than 
resting systolic blood pressure.  It was also proposed that to induce occlusion in the lower limb, a 
cuff pressure of ~55mmHg greater than resting systolic blood pressure is required to induce 
ischemia; 140mmHg did not occlude and 160mmHg cuff pressure only occluded in one volunteer.  
In the upper limb, cuff inflation of 160 and 180mmHg caused a decrease in pH of capillary arterial 
blood, whereas there was no change in pH at any cuff pressure in the lower limb.  The results 
highlighted different physiological responses and tolerability of limb IPC based on the limb and 
blood pressure cuff inflation used (Sharma et al. 2014).  Furthermore, Hunt et al. (2016) determined 
the level of blood flow restriction at different external cuff pressures applied to upper and lower 
limbs. With wide cuff (13 cm) application, the external pressure required to illicit 60 % occlusion 
in the popliteal was 111 ± 12 mmHg and was greater than in the brachial at 101 ± 12 mmHg.  Mean 
arterial pressure and adipose thickness were the largest independent determinants of lower and 
upper body partial occlusion (60 % AOP) pressures, respectively.  Despite entering further 
variables into an upper (diastolic blood pressure and body mass index) and lower (diastolic blood 
pressure and adipose thickness) limb regression model, the majority of variance remains 
unexplained.  
 
Increased attention has been provided to the influence of cuff pressure within the last year (2016-
2017), especially regarding occlusion pressure applied during exercise.  Methods of 
individualising cuff pressure have been acknowledged and initial research into factors affecting 
pressure and percentage occlusion required are appearing within the literature, for instance cuff 
pressure above 60% AOP does not seem to offer any additional advantage.  However, variance 
amongst Doppler regarding protocols exist; in some instances, research has completed 
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determination of AOP whilst supine, whereas others during standing.  Furthermore, there is a 
disparity between load (20 or 30% 1RM) and upper and lower body.  Due to inconsistency in the 
research, there is still no definitive protocol to apply.  In the instance Doppler is unavailable within 
the field in elite sport, the method described by Loenneke et al. (2015) which differentiates between 
upper and lower body may provide a good alternative.  The efficacy and application in elite sport 
is yet to be determined.  Limbs with a larger circumference require higher occlusive pressures to 
reach the same level of arterial occlusion. Furthermore, limb circumference was, if not more 
effective than laboratory-based measures of limb composition in predicting the pressure required 
to restrict arterial blood flow (Loenneke et al. 2012).  The majority of research into vascular 
occlusion pressure when being combined with exercise, is moving towards individualised cuff 
pressure, however, no attempt has been established to individualise when limb IPC is applied at 
passive rest, other than use of systolic blood pressure, considerations should also be made 
regarding the impact of perception, pain and discomfort if high pressures are applied in individuals 
with smaller thigh circumference. 
 
2.6.2 Cuff Width 
Vascular occlusion in the research literature is typically accomplished via inflation of a pneumatic 
cuff placed at the proximal portion of the limb; this is further modified by differing inflation 
pressures as discussed and cuff widths (Mouser et al. 2017).  Many studies utilising occlusion have 
applied a single arbitrary pressure to all participants and not accounted for cuff width (Table 2.5). 
 
Currently, wide and narrow, non-elastic and elastic cuffs are used in the research (Rossow et al. 
2012).  The size of the cuff, especially the width, has been variable within the literature despite it 
being an important variable to consider as wider cuffs have been shown to be more effective in 
restricting blood flow at lower inflation pressures compared to narrower restrictive cuffs 
(Loenneke et al. 2012).  Many studies have used KAATSU master elastic restrictive cuffs, which 
are typically 3 cm wide for upper body and 5 cm for lower body.  Other studies have used a variety 
of cuffs ranging in width from 3 cm to 18.5 cm dependent on material and manufacturing make 
used.  However, many of the studies within the literature do not report the width of the cuff used 
(Fahs et al. 2012), this is problematic as one determinant of the amount of occlusion is dependent 
upon the size of the cuff used (Loenneke et al. 2015).  As cuff width increases, the pressure 
requirements to achieve a given percentage of restricted blood flow decreases (Loenneke et al. 
2012). For example, applying 200mmHg across 5 cm with a KAATSU master cuff will likely 
produce a different stimulus than 200mmHg applied over 13.5 cm with a different cuff.   
 
It has been noted that if using wider restrictive cuffs for vascular occlusion in combination with 
elevated systolic cuff pressures, the exercise bout may become uncomfortable and the exercise 
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volume may be limited (Fahs et al. 2012).  For example, high levels of pain in the quadriceps have 
been reported during acute occlusion during knee extensor exercise using a cuff 13.5cm wide 
inflated to 200mmHg during exercise (Wernbom et al. 2006).  When directly comparing the effect 
of cuff width, it has been identified that the perceptual response to occlusion knee extension 
exercise with wider (13.5 cm) cuffs causes greater ratings of pain and perceived exertion during 
exercise and limits the exercise volume compared to narrow (5 cm) cuffs inflated to the same 
pressure (Rossow et al. 2012).  In addition to increased perception, the wide cuffs caused a greater 
elevation in heart rate, brachial and central blood pressure (Rossow et al. 2012) therefore this 
should be a consideration during study design.  There also needs to be distinguished protocols 
between lower limb and upper limbs.  For the upper body, relatively narrow cuffs (3-3.5 cm) appear 
to be preferable.  Additionally, narrow cuffs may be beneficial as wider cuffs can restrict the full 
range of motion during exercise (Loenneke et al. 2015). 
 
Physiologically, Fahs et al. (2012) indicated a wider (18.5 cm) cuff, set to pressures of 150 and 
200mmHg, elevated intramuscular inorganic Pi, however, when a narrow cuff (5 cm) was applied, 
although with slightly higher restrictive pressures (230 vs. 180mmHg), emanated more 
intramuscular inorganic Pi during exercise.  This suggests to increase fatigue and motor unit 
recruitment with low loads during lower body vascular occlusion exercise, slightly higher 
restrictive cuff pressure may be optimal with narrow cuffs while lower restrictive cuff pressures 
may be sufficient with wider cuffs (Fahs et al. 2012). 
 
Two recent studies have investigated the effect of cuff width on required inflation pressure in the 
upper body.  Jessee et al. (2016) examined differences in upper arm AOP between three different 
cuff widths and how individual characteristics influenced this.  Differences in AOP were observed 
between cuff widths (p<0.001). The 5-cm-wide cuff required the greatest inflation pressure (145 
± 19mmHg), followed by the 10 cm (123 ± 13mmHg), and 12-cm-wide cuff (120 ± 12mmHg).  A 
model encompassing arm circumference, arm length, arterial and brachial blood pressure and sex 
explained the most variance in AOP cuff pressure.  However, arm circumference explained the 
most unique variance for each cuff.  It was concluded that the AOP is dependent upon cuff width, 
highlighting the need for authors to report cuff width and consider the impact it has on restriction 
with a key point highlighted that an inverse relationship exists between cuff width and AOP in the 
upper body (Jessee et al. 2016). 
 
Consistent, Mouser et al. (2017) identified an inverse relationship between systolic pressure and 
cuff width for both men (5 cm: 160 ± 16mmHg; 10 cm: 125 ± 8; 12 cm: 122 ± 9, p<0.001) and 
women (5 cm: 139 ± 18mmHg; 10 cm: 114 ± 11; 12 cm: 110 ± 10, p<0.001). For the diastolic 
pressure measurement, there was also an inverse relationship with cuff width for both men (5 cm: 
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104 ± 13mmHg; 10 cm: 73 ± 8; 12 cm: 68 ± 9, p<0.001) and women (5 cm: 89 ± 15mmHg; 10 
cm: 67 ± 10; 12 cm: 63 ± 11, p<0.001).  Following an examination of relative pressures and their 
relationship to the measured diastolic blood pressure with each cuff, it was reported lower 
restriction pressures only affect the venous system indicating cuff pressures that are below the 
diastolic pressure will affect venous return without compressing the arteries (Mouser et al. 2017).   
 
However, the majority of this research, especially recently, has been within the upper body and 
therefore there is a lack of research specifically for the effect and recommendations of cuff width 
on occlusion pressure in the lower limbs.  Currently, no optimal cuff width/pressure combination 
has been established for vascular occlusion and limb IPC; therefore, no standard exists regarding 
the application of occlusion. As such, potential issues arise in finding an optimal restriction 
pressure due to the numerous different cuff widths and pressures used (Table 2.5).  Despite this, it 
is important to consider the effect of the cuff width on pressure applied and percentage AOP.  In 
addition to cuff pressure and width, the following sections will outline other influencing factors. 
 
2.6.3 Cuff Material 
Within the literature there has been a gradual move towards application of relative as opposed to 
absolute restrictive pressures and acknowledgement of the impact of cuff pressure.  However, 
within the literature, not all methodological concerns have been addressed (Buckner et al. 2017). 
Specifically, depending on the device, cuffs are made from different materials. For example, a 
variety of devices have been used to restrict blood flow during exercise, including elastic knee 
wraps, elastic belts with a pneumatic bag inside, nylon pneumatic cuffs, or a traditional nylon 
blood pressure cuff (Loenneke et al. 2012). 
 
While elastic automated cuff systems have been developed, it may be more practical to employ 
inflatable cuffs or simple elastic wraps, particularly when large groups are performing vascular 
occlusion (Scott et al. 2015).  The use of elastic knee wraps in particular has been recently 
popularised in research and real-world contexts as a practical method for implementing vascular 
occlusion without the need for expensive specialised equipment (Loenneke & Pujol 2009).  
Loenneke et al. (2014) examined differences in cuff type (nylon vs. elastic) in the lower body, 
finding that there were no differences in the repetitions to fatigue or perceptual response between 
different type of cuffs, suggesting that the occlusion stimulus was relatively similar.  This is 
supported by Dankel et al. (2017) reporting no difference between EMG amplitude or post-exercise 
strength measures when a 3 cm elastic cuff (160mmHg) was compared to 5 cm nylon cuff (40% 
individuals AOP), the only difference identified was lower levels of discomfort with the nylon 
cuff.  Whereas, Buckner et al. (2017) reported resting AOP was different between nylon (139 ± 
14mmHg) and elastic (246 ± 71mmHg, p<0.001) cuffs, however, when exercising at 40 % of each 
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cuff’s respective AOP (nylon: 57 ± 7 vs. elastic: 106 ± 38mmHg, p<0.001), there were no 
differences in repetitions to failure, torque, muscle thickness, or muscle activation between the 
cuffs.  Therefore, it was concluded exercising with cuffs of different material but similar width 
resulted in the same acute muscular response when the cuffs were inflated to a pressure relative to 
each individual cuff.  Furthermore, of importance to highlight, differences in resting AOP were 
observed despite similar-sized cuffs.  This demonstrates the importance of measuring AOP before 
applying the vascular occlusion stimulus, for example, if an arbitrary pressure of 200 mmHg were 
applied with each cuff, the majority of individuals in the study using the nylon cuff would be fully 
occluded, whereas, the elastic cuff condition would be receiving, on average, a stimulus of 
approximately 80 % AOP.  These differences in AOP are contrary to the findings of Loenneke et 
al. (2014) who observed no differences in AOP between cuff types (nylon vs. elastic) in the lower 
body. As such, anatomical differences between the upper and lower body may explain some of this 
discrepancy (Buckner et al. 2017). 
 
2.6.4 Continuous vs intermittent occlusion 
Occlusion with resistance exercise has previously been completed with either continuous or 
intermittent blood flow restriction during the exercise training (Fahs et al. 2012).  During 
intermittent vascular occlusion with exercise, muscle fatigue can quickly be reduced during rest 
periods between exercise sets, similar to free flow exercise. During resistance exercise some blood 
flow restriction occurs due to the muscle contraction. Therefore, external blood flow restriction 
applied only during the exercise period may not provide an additional stimulus (i.e. induce muscle 
fatigue) to cause muscular adaptations. In fact, during low-load resistance exercise, continuous 
blood flow restriction has been shown to be more effective in causing muscle fatigue (Cook et al. 
2007) and metabolic stress (Suga et al. 2012) compared to intermittent blood flow restriction. 
 
An alternative to continuous occlusion training is to deflate the cuff during rest periods, otherwise 
known as intermittent occlusion. Similarly, intermittent occlusion has been shown to increase 
muscle strength  (Evans et al. 2010) and size (Kacin & Strazar 2011) over no vascular occlusion. 
Although both continuous and intermittent vascular occlusion training appear to increase skeletal 
muscle size and strength at low loads, the efficacy of intermittent and continuous occlusion training 
have received limited attention (Fitschen et al. 2014).  
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Table 2.5: Summary of restrictive cuff pressures, cuff widths and times between vascular 
occlusion/limb ischemic preconditioning and performance (2015-2017 & excluding reviews) 
Author 
 
Time between occlusion 
& performance (min) 
Restrictive cuff 
pressure (mmHg) 
Restrictive cuff 
width (cm) 
(Barbosa et al. 2015) 25 200 X 
(Cocking et al. 2017) 20 220 13.5 
(Cruz et al. 2015) 90 220 X 
(Dankel et al. 2017) Applied during 3min rest 70% AOP 5 
(Fatela et al. 2016) X 40, 60, 80% AOP 13 
(Hittinger et al. 
2015) 
45 10-20 > SBP X 
(Husmann et al. 
2017) 
During 5min exercise 60% AOP 10 
(Kido et al. 2015) 5 >300 X 
(Kraus et al. 2015) 15 X X 
(Lauver et al. 2017) During exercise 130% SBP 6 
(Lisbôa et al. 2017) 60, 120 & 480 220 X 
(Marocolo et al. 
2015) 
15 200 X 
(Marocolo et al. 
2016) 
8 200 13 
(Paradis-Deschenes 
et al. 2016) 
20 200 X 
(Patterson et al. 
2015) 
45 220 14.5 
(Sabino-Carvalho et 
al. 2016) 
10 220 13.5 
(Seeger et al. 2017) 60, 24(h) 220 X 
(Tanaka et al. 2016) 5 >300 X 
(Teixeira et al. 2017) During exercise 80% AOP 17.5 
(Tocco et al. 2015) 5 50>SBP X 
Average 22min (exclude 24h)  11.8 
Range 5 min – 24h  5-17.5 
 
AOP – arterial occlusion pressure; SBP – systolic blood pressure 
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Previous research has shown knee extension exercise with intermittent blood flow restriction only 
produced a 3.4% increase in mid-thigh knee extensor cross sectional area and no significant 
increases in strength (Kacin & Strazar 2011).  In contrast, another study observed an 18% increase 
in force during a maximal voluntary contraction of the triceps surae after 4-weeks of training with 
intermittent blood flow restriction (Evans et al. 2010).  The latter study did not observe any 
increase in strength in the contralateral limb trained without any blood flow restriction suggesting 
that even intermittent blood flow restriction may augment strength adaptations. 
 
Fitschen et al. (2014) performed two studies to compare intermittent and continuous occlusion 
exercise. In study one, eleven participants randomly proceeded through three treatments of 
unilateral leg extensions to failure: (i) continuous occlusion, (ii) intermittent occlusion and (iii) 
control (exercise without occlusion). Continuous occlusion resulted in significantly greater pain 
than intermittent occlusion or control (p<0.05), yet pain did not significantly differ between 
intermittent occlusion exercise and the control condition during any set.  Both occlusion conditions 
resulted in significantly fewer repetitions to failure than control. This suggests that an acute bout 
of intermittent occlusion exercise may produce as much muscle fatigue as an acute bout of 
continuous occlusion exercise, but with less pain.  This is supported by a previous study comparing 
pain during continuous occlusion exercise with normal low-load exercise finding that participants 
experienced significantly more pain during continuous occlusion exercise (Fitschen et al. 2014).  
This suggests intermittent occlusion exercise may produce similar fatigue as continuous occlusion 
exercise, but with significantly less pain (Fitschen et al. 2014). 
 
2.6.5 Limb IPC dose 
The limb IPC procedures applied in the majority of literature relating to athletic performance 
mimicked that used by De Groot et al. (2010).  This process involved rendering the limb ischemic 
for five min, followed by five min of intermittent reperfusion and was based on previously 
published studies assessing the effects of brief cycles of limb ischemia-reperfusion in human 
participants on myocardial injury and endothelial function (e.g. Hausenloy & Yellon 2008).  Total 
occlusion periods range from 6 min up to >30 min, with complete limb IPC and vascular occlusion 
protocol lasting up to 40 min (Figure 2.6) (Marocolo et al. 2016).  Specifically for limb IPC and 
vascular occlusion for recovery, occlusion is applied in cycles dispersed with periods of 
reperfusion.  Generally, the protocol involves three or four cycles of five min occlusion above 
systolic blood pressure, followed by a five min reperfusion period, with a range of applied 
pressures previously reported (Thijssen et al. 2016) (Table 2.5).  Further, the numbers of ischemic 
reperfusion cycles have varied in previous studies with further disparity between limb IPC and 
vascular occlusion for recovery.  Studies have explored the impact of increasing the ‘dose’ of the 
traditional limb IPC protocol (i.e. 3-4 cycles) (Thijssen et al. 2016), specifically Cocking et al. 
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(2017) examined cycling performance following five different limb IPC protocols.  Responses to 
traditional limb IPC (4x5-min legs) were compared to: (i) 8x5-min legs and SHAM, (ii) 4x5-min 
unilateral legs, and (iii) 4x5-min arms.  It was identified traditional limb IPC was associated with 
a 17 s faster cycling time compared to SHAM.  However, applying increased ischemia (8x5-min) 
had no impact on performance.  Unilateral limb IPC was associated with 18 s slower performance 
compared to bilateral protocol and cycling times following remote and local limb IPC were not 
different.  Therefore, it was concluded the traditional 4x5-min limb IPC stimulus resulted in the 
fastest cycling time compared to SHAM, there was no benefit of applying a greater number of 
cycles or employing unilateral limb IPC (Cocking et al. 2017).   
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Figure 2.6 Prescription variables used in practice by performance scientists to implement limb 
ischemic preconditioning, identifying cuff width, restriction pressure and duration of applied 
pressure. (RES – resistance exercise; AER – aerobic exercise; PAS – passive) (From Patterson & 
Brandner 2017) 
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2.6.6 Summary 
Individual differences (e.g. limb size) as well as methodological differences, for example 
restrictive cuff size and cuff pressure are variables that must be considered with limb IPC and 
vascular occlusion (Fahs et al. 2012).  Manipulation of these variables will affect the degree to 
which blood flow is restricted and this may affect the acute responses (Fahs et al. 2012).  Results 
from previous literature highlight the variation in physiological response and tolerability of 
vascular occlusion and limb IPC dependent on the cuff width and cuff inflation pressure used 
(Sharma et al. 2014).  Currently, no optimal cuff width/pressure combination has been established 
for limb IPC or vascular occlusion; therefore, no standard exists regarding the application of this 
strategy. As such, potential issues arise in finding an optimal restriction pressure due to the 
numerous different cuff widths and pressures implemented (Jessee et al. 2016).  Although precise 
recommendations are not available, it is in agreement that cuff pressure should be individualised 
to ensure it is high enough to occlude venous return from the muscle, but low enough to maintain 
arterial inflow into the muscle when applied during exercise and reports suggest pressure needs to 
be above systolic blood pressure for limb IPC.  A balance between cuff width and cuff pressure 
needs to be established and determined within the literature to identify a suitable protocol to 
stipulate an optimal response to limb IPC and vascular occlusion and the effects it can have as a 
pre-competition and recovery strategy.  Limb circumference and blood pressure should be 
considered to individualise occlusion pressure or determined as a percentage of AOP.  Regarding 
dose of limb IPC and vascular occlusion, a consensus does not exist with regard to the protocol; 
the number of cycles, duration and the reperfusion periods vary considerably among studies, as 
well as period of cessation of the IPC procedure and onset of exercise.  Despite this, this modality 
has vast applications to many different populations, both trained and untrained, as such, it is 
necessary to thoroughly understand the stimulus applied to prescribe the appropriate pressure to 
facilitate the desired response. 
 
2.7 METHODLOGICAL CONSIDERATIONS 
 
2.7.1 Saliva as a diagnostic tool in sport and exercise 
Blood collection and muscle biopsies are considered gold standard for collection of biomarkers 
(Lindsay & Costello 2016).  However, as they are both invasive, saliva is becoming increasingly 
useful due to its relative ease, non-invasive and time efficient collection protocol (Lindsay & 
Costello 2016). In comparison to serum and plasma, saliva collection requires less medical training 
and is safer to collect in the field than blood collection (Pritchard et al. 2017), alongside the benefits 
of rapid, frequent collection without stress to the participant (Chicharro et al. 1998; Cadore et al. 
2008).  The measurement of physiological biomarkers in whole saliva can provide a significant 
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tool for assessing the immunological and endocrinological status associated with exercise and 
training (Papacosta & Nassis 2011) and provides researchers with the ability to conduct repeated 
sampling over the course of minutes, hours, days, or longer (Dabbs & La Rue 1991).  Saliva 
originates mainly from 4 pairs of glands; parotid, sublingual, submandibular and minor (Proctor 
& Carpenter 2007) with relative contributions ranging from 4 to 65% (Chicharro et al. 1998).  Each 
gland can produce variable amounts of salts, ions and proteins (Hu et al. 2004) which can be 
influenced by factors including psychological and hormonal status, physical exercise, flow rate, 
circadian rhythm, size and type of the stimulus (Chicharro et al. 1998; Schipper et al. 2007). 
 
Saliva is primarily composed of water with an abundance of weak and strong ions, where the 
concentration is dependent on secretion stimulation type (Chiappin et al. 2007), however, saliva 
composition also consists of hormones, peptides, electrolytes, mucus, antibacterial compounds and 
various enzymes (Chicharro et al. 1998).  The total concentrations of most of these compounds are 
much lower in saliva when compared with serum or plasma; however, they can provide a reliable 
reference for their respective blood concentrations (Cadore et al. 2008) as specific substances that 
circulate in the blood can enter into the salivary ducts by passive filtration through the membrane 
barrier (Bloomer 2015).  Steroid hormones detectable in saliva include C, androgens including T, 
estrogens and progesterone (Papacosta & Nassis 2011).  Therefore, saliva has been reported to be 
an ideal medium for the analysis and diagnosis of exercise stress, due to containing a variety of 
enzymes, hormones, antibodies, antimicrobial constitutes and growth factors (Zelles et al. 1995; 
Rehak et al. 2000).   
 
The use of salivary biomarkers allow prediction and evaluation (Lindsay & Costello 2016), 
offering potential in both acute assessment of physiological and psychological stress and chronic 
assessment.  Steroid hormones leak into saliva from plasma, however, only the free unbound 
fraction is involved.  Albumin and sex-hormone binding globulin do not allow the bound fraction 
of the hormones to get into the saliva due to their molecular weights (Celec et al. 2009).  Thus, 
salivary concentrations represent valuable markers for the free, unbound and bioactive fraction of 
the particular steroid (Arregger et al. 2007).  Specifically for C, literature has suggested saliva to 
be a more robust measure of stress than serum C because salivary C is a better measure of adrenal 
function (Aardal & Holm 1995).  For instance, significant correlations have been reported between 
blood and salivary C concentrations at rest (Lippi et al. 2009; Rantonen et al. 2000).  Post-exercise, 
significant correlations were found between salivary and blood concentrations of C following 
intense standardised exercise protocols (Cadore et al. 2008; Stupnicki & Obminski 1992; O’connor 
& Corrigan 1987), a 30 s wingate test (Crewther et al. 2010) and training matches (Moreira et al. 
2009; Doan et al. 2007). Gozansky et al. (2005) provided evidence to support that salivary C 
represents the biologically active, free fraction of blood C, in this study salivary C measures 
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displayed a greater relative increase in response to exercise and intravenous administration of 
corticotrophin-releasing hormone compared with blood C measures. Therefore, reports suggested 
C in saliva may provide a better measure for the assessment of dynamic hypothalamic–pituitary–
adrenal axis activity.  Further evidence has been provided by Crewther et al. (2010) who validated 
the use of salivary C measures in response to a short, high-intensity cycle bout, also displaying 
that the hormonal changes to exercise are greater in saliva than corresponding blood 
measurements; significant (p<0.001) strong correlations were demonstrated between salivary C 
and plasma C between individuals (r=0.81-0.84) and within individuals (r=0.83-0.84). 
 
Salivary hormone levels also reflect the free plasma concentration and biologically active fraction 
of T that is available to interact with androgen receptors (Kraemer & Ratamess 2005).  Several 
studies suggested that a relationship exists between measures of salivary T and strength-related 
performance capacity (Crewther et al. 2010; Beaven et al. 2008; Beaven et al. 2008; Crewther et 
al. 2009).  Monitoring salivary T levels in sports is a practical way to determine the preferred 
volume and intensity of exercise and this in turn should lead to enhanced functional gains (Beaven 
et al. 2008).  In males, significant correlations have been reported between salivary and blood 
concentrations of T at rest. (Vittek et al. 1981; Shirtcliff et al. 2002).  Salivary measures of T have 
provided a reliable indicator of serum or plasma concentrations, as salivary T concentrations were 
found to be strongly correlated with measures of bioavailable T (Morley et al. 2006).  In regard to 
acute exercise, Crewther et al. (2010) showed that the relative peak increase in salivary T to a short 
high- intensity sprint exceeded the relative increases in total and free T in plasma (between 
individuals T: r =0.57-0.61; C: r =0.83-0.84; within individuals T: r =0.71-0.73), suggesting that 
salivary measures are more sensitive for assessing the hormonal response to exercise.  
 
Unfortunately, not all studies use the same assay procedures to measure salivary T and this may 
be problematic when attempting to make comparisons across studies.  Likewise, differences in 
sample collection procedures, storage, and processing of saliva can influence.  For example, 
Arregger et al. (2007) noted that saliva measures of T were strongly correlated to blood measures 
in a sample of eugonadic (r =0.92) and hypogonadic (r =0.97) men.  However, in this study, an 
adapted radioimmunoassay procedure was used for the saliva T assay, rather than an enzyme-
linked immunosorbent assay (ELISA) procedure.  In comparison, Bloomer (2015) compared saliva 
and serum free T concentrations in 20 healthy men using ELISA procedures. Men provided both 
a saliva and blood sample on the same day in the morning hours following an overnight fast.  
Special care was taken in the collection, storage, and processing of samples.  Following complete 
thawing and mixing of samples, both fluids were analysed in duplicate using commercially 
available ELISA kits, both prior to and following centrifugation.  Saliva T values were 348.8 ± 
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210.0 pg·mL-1 with centrifugation, whereas serum T values were 8.3 ± 3.7 pg·mL-1 with 
centrifugation.  It was concluded, if utilising ELISA procedures, saliva and serum T values cannot 
be used interchangeably, at least when utilising the ELISA procedures employed in this study.  The 
results demonstrated that saliva and serum samples result in dramatically different values of free 
T when analysed using two commercially available ELISA procedures, as such, when measuring 
free T performance scientists should identify one method and maintain that method throughout all 
testing.  However, when assay method is consistent, reports have shown salivary T levels are 
modestly correlated with serum levels for males; positive correlations were reported for T levels 
between saliva and total serum T (r= 0.71) and free T (r= 0.67) (Shirtcliff et al. 2002). 
2.7.2 Summary 
Within previous research, saliva samples for measuring levels of endogenous steroid hormones, 
have claimed that salivary assays “do not meet the criteria for routine diagnostic tests and their 
introduction into laboratory repertoire cannot be justified at present” (Wood 2009, p. 193). 
Whereas others have argued that “saliva…has proven to be reliable and, in some cases, even 
superior to other bodily fluids” (Gröschl 2008, p. 1759) for measuring hormone levels (Liening et 
al. 2010).  However, specifically within sport, salivary T and C have previously been validated in 
response to short high-intensity exercise and are sensitive to changes caused by exercise (Crewther 
et al. 2010).  The saliva measures more accurately reflect (r =0.92-0.97) blood free T or C 
concentrations to provide valuable data on the biologically active portion (1-5% of total hormones) 
that is available to tissue (Crewther et al. 2010).   Therefore, these findings support the use of saliva 
as a medium for steroid determination in sport. 
2.7.3 Safety Considerations 
There has been extensive evidence that indicated vascular occlusion combined with training can 
provide a unique, beneficial mode of exercise, even in clinical settings, because it produces positive 
training adaptations equivalent to the physical activity of daily life (10-30% of maximal work 
capacity) (Abe et al. 2006).  There are several uncertainties regarding the interplay of various 
extrinsic and intrinsic factors on its safety and efficiency (Kacin et al. 2015).  Among extrinsic 
factors tourniquet cuff pressure, size and shape have been identified as key for safety and 
efficiency. Among intrinsic factors, limb anthropometrics, patient history and presence of cardiac, 
vascular, metabolic or peripheral neurologic conditions have been recognised as most important 
(Kacin et al. 2015).  A review by Kacin et al. (2015) identified the following variables as the most 
probable health-hazards: (i) mechanical injury to the skin, muscle, and peripheral nerves, (ii) 
venous thrombosis due to vascular damage and disturbed hemodynamics and (iii) augmented 
arterial blood pressure responses due to combined high body exertion and increased peripheral 
vascular resistance. 
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There are several safety considerations when using vascular occlusion in training when compared 
to regular exercise including the impact on the cardiovascular system (central and peripheral), 
muscle damage, oxidative stress and nerve conduction velocity (Loenneke et al. 2011).  Caution 
should be heeded as excess pressures could induce substantial compression of not only vasculature 
but also neural tissue, especially if the cuffs are inflated during muscle contraction (Clevidence et 
al. 2012) causing symptoms such as numbness.  Furthermore, research has reported that 
inappropriate implementation of vascular occlusion can result in detrimental effects, including 
petechial haemorrhage and dizziness (Scott et al. 2014). 
 
A survey on the safety of occlusion training was published by Nakajima et al. (2006) based on 
reports from 105 training centres in Japan.  A total of over 12600 individuals had trained using 
tourniquets in combination with different modes of exercise (walking, cycling, weight training).  
The most common side effects were subcutaneous hemorrhage (incidence 13.1%) and temporary 
numbness (1.3%).  More serious side effects were rare; venous thrombosis (0.055%), deterioration 
of ischemic heart disease (0.016%), cerebral infarction (0.008%), rhabdomyolysis (0.008%) and 
pulmonary embolism (0.008%).  Although the estimated risk of venous thrombus is very low, it is 
a real risk, consequently, consideration must be given to personal or family history of conditions 
affecting blood flow through local vessels or the wider cardiovascular system.  Furthermore, lack 
of blood perfusion to a limb and extreme physical exertion are both well-known causes of 
rhabdomyolysis. This is a clinical syndrome resulting from skeletal muscle damage and the release 
of potentially toxic substances into the circulation (Allison & Bedsole 2003). It may be caused by 
trauma or muscle hypoxia and manifests as muscle pain and weakness.  Therefore, consideration 
must be given in the case when other conditions associated with rhabdomyolysis are present (Kacin 
et al. 2015).  Caution must be taken in individuals who lack any previous training history as 
unaccustomed exercise can also be associated with an increased risk of rhabdomyolysis.  
Participants with a history of or an increased risk of cardiovascular disease should be thoroughly 
screened prior to implementation of vascular occlusion (Kacin et al. 2015). 
 
Vascular occlusion combined with training has also been associated with central responses of the 
cardiovascular system.  Fahs et al. (2012) highlight that during vascular occlusion with exercise, 
awareness should be present that reductions in arterial blood flow to skeletal muscle increase the 
chemoreflex causing greater elevations in heart rate and blood pressure during exercise.  For 
example, during walking exercise, occlusion has been shown to increase the heart rate and blood 
pressure response (Renzi et al. 2011).  Furthermore, higher (200mmHg) cuff pressures increased 
heart rate and blood pressure to a greater extent during exercise compared to lower (160mmHg) 
cuff pressures (Sakamaki et al. 2008).  Complete arterial occlusion (300mmHg) during unilateral 
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elbow flexion resistance exercise has been shown to increase heart rate to a greater extent than 
moderate arterial occlusion (160mmHg) (Fahs et al. 2012).  In support, low intensity vascular 
occlusion training (20% 1RM) has been found to result in slightly higher values for heart rate (109 
vs 96bpm) and systolic (182 vs 155mmHg), diastolic (105 vs 99mmHg) and mean arterial blood 
pressure (127 vs 113mmHg) (Takano et al. 2005); however these values are well below changes 
that occur during high intensity resistance training (Loenneke et al. 2011).  Nakajima et al. (2006) 
found that numbness was sometimes reported in response to a vascular occlusion exercise bout.  
This raises an important safety question, with respect to the numbness and possible nerve 
conduction blockage which is often seen following surgery  or when external compressions are 
applied to a limb causing both ischemia and a slowing of nerve conduction velocity (Mittal et al. 
2008).  Clark et al. (2011) reported that nerve conduction velocity was unchanged after 4 weeks 
of low intensity vascular occlusion training (30% 1RM).  This was an expected outcome because 
the overall length of the restrictive exercise bout only lasted approximately 10-15min.   
 
The potential concern with increasing pressures too high is that arterial blood flow maybe 
completely removed during the rest periods between sets and possibly during the exercise itself 
(Loenneke et al. 2014).  Complete arterial occlusion is a safety concern because this can cause the 
formation of a thrombus and can induce a microvascular occlusion even after reperfusion 
(Laurentino et al. 2008).  This post-reperfusion occlusion could result in muscle damage and/or 
cell necrosis (Laurentino et al. 2012; Loenneke et al. 2011). However, Madarame et al. (2010) 
reported that there was no increase in prothrombin fragments 1 + 2 or thrombin-antithrombin III 
complex (markers of thrombin generation) following continuous occlusion at 30% 1RM with 30 
sec rest. 
 
While low-load resistance exercise with occlusion can increase the strength and hypertrophy of 
skeletal muscle, concomitant increases in the strength of connective tissues may not occur due to 
decreased mechanical loading (Scott et al. 2014).  A disproportionate increase in muscle and 
connective tissue strength may result in musculotendinous injury, particularly if heavy loads are 
subsequently used which can be lifted by the muscles but not tolerated by connective tissues (Kubo 
et al. 2006).   
 
Despite the potential risks reported above, research to data has concluded that occlusion exercise 
is a safe method for training athletes, healthy persons (Clark et al. 2011) and potentially those 
individuals with varying medical concerns (Nakajima et al. 2006).  Supporting evidence by 
Loenneke et al. (2012), reports that vascular occlusion appears to be safe and poses no greater risk 
than traditional high intensity resistance exercise with respect to the cardiovascular system, muscle 
damage, oxidative stress and nerve conduction velocity.  There have been no long term negative 
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consequences of occlusion reported within the literature; it is important to acknowledge the method 
and protocol has been established and derived from a clinical environment where it is used to 
reduce myocardial infarct size and therefore has received a large body of research (Mattocks et al. 
2017).  For clinical application, tourniquet pressure above 170mmHg for upper and 270mmHg for 
lower limbs is usually used (Fitzgibbons et al. 2012).  However, within an athletic setting, the use 
of arbitrary pressures may place some individuals under complete arterial occlusion which may 
increase the potential risk of an adverse event and therefore highlights the importance, not only for 
efficacy of the intervention, but also safety, to individualise the occlusion protocol (Dankel et al. 
2017).  Furthermore, applying higher relative pressures results in the greatest cardiovascular 
response, higher perceptual ratings, and greater decrease in exercise volume compared to lower 
restriction pressures (Mattocks et al. 2017). Therefore, the perceptual responses from lower 
relative pressures may be more appealing and provide a safer and more tolerable stimulus for 
individuals. 
 
2.7.4 Summary 
Taken from Nakajima et al. (2006), it would be recommended to screen participants prior to 
completion of vascular occlusion for several contraindications, for instance, history of deep-vein 
thrombosis, pregnancy, varicose veins, and several other factors relating to the patient’s history of 
disease and inactivity. This approach may be beneficial for identifying those at risk of detrimental 
complications during vascular occlusion.  Nonetheless, when used in a controlled environment by 
trained and experienced personnel, vascular occlusion training appears to provide a safe training 
alternative for most individuals regardless of age and training status (Loenneke et al. 2011), with 
previous in depth reviews suggesting correct implementation of vascular occlusion presents no 
greater risk than traditional and heavy exercise modes ( Loenneke et al. 2011). 
 
2.8 CONCLUSIONS AND RECOMMENDATIONS 
 
Pre-competition and recovery are two areas that can improve athletic performance, in which 
performance scientists can implement strategies on the day prior to competition to optimise 
performance, for example through the attenuation of T by completing morning exercise prior to 
afternoon performance.  There is also opportunity to assist in the rate of recovery from exercise 
induced fatigue and muscle damage.  Previous strategies, although beneficial, maybe impacted by 
competition schedules, timings and equipment, therefore, vascular occlusion and limb IPC offer a 
strategy that may have the ability to be applied both for pre-competition performance improvement 
and increase rate of recovery. 
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Vascular occlusion and limb IPC were initially utilised within a clinical setting, derived from a 
medical technique to reduce myocardial infarct size, specifically through the release of adenosine 
which increases O2 delivery by dilation of blood vessels.  Expression of signalling molecules leads 
to activation of mediators that transmit a protective signal in the cytosol (Thijssen et al. 2016), 
ultimately converging at the mitochondria and crucially opening the mitochondrial permeability 
transition pore (Davidson et al. 2006).  The clinical literature highlights an early and late phase 
mediated by adenosine via different end-organ receptors (Fryer et al. 2002), in which the early 
phase provides protection 3-4 h after the initial ischemic stimulus, whereas the late phase appears 
24 h and lasts up to 72 h following brief periods of IPC (Baxter et al. 1997). 
 
This concept, based on assumption that a tissue with some history of ischemic conditions 
eventually becomes resistant to ischemia and its potential positive effects (Ovize et al. 2013) 
attracted researchers in sports medicine and exercise science, now applied in three distinct areas 
of performance; pre-competition, training and recovery. 
 
Within this review, the focus was on pre-competition and recovery strategies; the evidence 
supports the use of vascular occlusion as a pre-competition strategy, the studies examined showed 
a benefit to performance, when combining vascular occlusion with resistance exercise.  Although 
traditionally used for training purposes, research has identified the acute response of completing 
resistance exercise with vascular occlusion and sequential effect on physiological mechanisms 
including recruitment of fast twitch motor units and hormonal response, however application pre-
competition is yet to be assessed. 
 
When applied during supine rest, limb IPC has reported to improve exercise time to exhaustion, 
repeated sprints and single anaerobic performance, with consistent support for its application to 
improve swimming performance. The limb IPC strategy employed varies within the research, with 
differences in cycles of occlusion between sport modalities (3-4 cycles) and also the timeline of 
cessation of limb IPC to the onset of performance, varying from five min prior to endurance 
performance to 30-90 min prior to anaerobic performance.  There is limited support on the use 
prior to submaximal exercise and there is disparity in findings of implementing limb IPC prior to 
repeated sprint performance, therefore further research is required on the use of limb IPC, 
potentially the standardisation of a protocol regarding cuff pressure, width and timings may resolve 
some of the disparity within the literature to date.  Further research is also required on protocols 
and testing specific to sports competitions and ensuring protocols are individualised. 
 
Some positive results were identified using vascular occlusion as a recovery strategy, proposed to 
be due to increased blood flow associated with adenosine levels (Liu et al. 1994) and improved 
 90 
muscular O2 utilisation following reperfusion, leading to a more rapid return of muscle function 
(Beaven et al. 2012).  However, this is speculated, in addition to current inconsistent results, 
prevents provision of a definitive conclusion and application in an athletic environment.  Further 
research is required to identify the physiological mechanisms involved in vascular occlusion for 
recovery. 
 
Across both pre-competition (with and without resistance exercise) and recovery, large 
methodological differences exist, for example, restrictive cuff size and cuff pressures are variables 
that must be considered with limb IPC and vascular occlusion.  Manipulation of these variables 
will affect the degree to which blood flow is restricted, consequently affecting the acute response 
(Fahs et al. 2012).  No optimal cuff width/pressure combination has been established which is 
problematic as no standard exists regarding the application of this strategy when combined with 
resistance exercise, applied at passive rest for limb IPC pre-competition or use as a recovery 
strategy. 
 
To conclude, further research is required in athletes to determine the effects of vascular occlusion 
and limb IPC, taking into account emerging research on the effect of occlusion protocols (e.g. cuff 
pressure, time between occlusion and performance) and continued research into the underlying 
physiological mechanisms to determine how this strategy can be best applied to improve athletic 
performance.  Identified areas of research, as a consequence of this review, are specified below: 
 
- Future trials are required to identify the use of vascular occlusion with high intensity 
resistance exercise to be used a pre-competition strategy (Chapter 4). 
- Limited research (one study) has investigated the effect of early and late phase of limb 
IPC on athletic performance and therefore requires further attention both regarding 
physiological mechanisms and impact on performance (Chapter 5). 
- The use of vascular occlusion as a recovery strategy is unclear, data at present is not 
conclusive and the physiological mechanisms are unknown (Chapter 6). 
- The effect of limb IPC on repeated sprint is inconclusive and more information is required 
before applying in sport 
- Optimal cuff pressure, length of occlusion and rest time between vascular occlusion/limb 
IPC and onset of performance requires further investigation for both pre-competition and 
recovery 
- Performance tests need to be specific to elite competition performance and tested with 
athletes as currently practice is inferred from a healthy, un-trained population (Chapter 4-
6). 
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Chapter 3 – General methods  
 
3.1 INTRODUCTION 
 
This chapter provides details of methods that were used in two or more of the subsequent 
experimental chapters.  Methods that were unique to a particular study are presented in the 
methods section of the respective study chapter. 
 
3.2 PARTICIPANTS 
 
Swansea University ethics committee approved all of the studies in this thesis (Appendix A).  All 
participants were informed of the experimental procedures and the purpose of the study (Appendix 
B), along with possible risks associated with the study and provided written informed consent 
before participation (Appendix C).  All participants were free to withdraw at any time during the 
studies.  For all studies, elite, well-trained athletes were recruited to participate.  All participants 
had a minimum of five years training experience within their specific sport and were competitive 
at National standard or above.  The participant characteristics for each study can be seen in further 
detail in Table  3.1. 
 
Estimated day of menstrual cycle was calculated from the information that female participants 
provided at the first experimental trial.  Consistent with the method reported by Liening et al. 
(2010), the day of menstrual cycle at the subsequent experimental trials was calculated by adding 
seven days to the day of menstrual cycle after the first-time point, and repeated for subsequent 
sessions. The self-reported average cycle length was used to account for those participants who 
had begun a new cycle between the collection dates. 
 
3.3 BLOOD PRESSURE ASSESSMENT 
 
Blood pressure assessment was completed in all experimental chapters.  Participants were required 
to sit in a chair with a back support, with both feet flat on the floor for ten min prior to obtaining 
measurement (Pickering et al. 2005; Daskalopoulou et al. 2015).  Once this position was 
established, the cuff size was checked ensuring the bladder covered at least 2/3 of the distance 
around the arm and was not overlapping.  The cuff was placed on the bare arm, with the midline 
of the inflatable bladder positioned over the brachial artery at the mid-point of the upper arm, 
approximately two fingerbreadths above the arm crease (Frese et al. 2011).  Due to the effects of 
hydrostatic pressure, the position of the arm when blood pressure is measured can affect the 
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reading (Daskalopoulou et al. 2015).  Therefore, the arm was supported so that the cuff was at the 
level of the heart.  An automated blood pressure monitor (Omron Healthcare, Europe) was used to 
determine systolic and diastolic blood pressure.  Pickering et al. (2005) recommended the average 
of two readings taken at an interval of at least one min.  If the difference between the first and 
second reading was >5mmHg, an additional reading was taken and the average of the three 
recorded. 
 
3.4 OCCLUSION CUFFS AND PRESSURE 
 
Occlusion cuffs were applied to the most proximal point of the thighs in all studies (Figure 3.1).  
The cuffs (11cm; Sports Rehab Tourniquet, Sportsrehab) contained a pneumatic bag along its inner 
surface that was connected to a pressure gauge and manually inflated to either 15mmHg in control 
conditions or an individualised cuff pressure, consistent across all experimental chapters.  The 
individualised cuff protocol was selected as a stimulus likely to cause lower limb ischemia, but 
acknowledging that the same pressure may not restrict the same amount of blood flow in every 
individual since the amount of tissue surrounding the blood vessel may influence the pressure 
exerted on the vasculature and therefore the degree of blood flow restriction (Hargens et al. 1987).  
Initial investigations by Loenneke et al. (2012) suggested pressures to restrict blood flow of the 
lower body should be determined by limb circumference.  A more recent study (Loenneke et al. 
2015) replicated these previous findings that thigh circumference is the biggest predictor of arterial 
occlusion in the lower body (b=0.570).  This reinforces pressures in the lower body should be to 
some degree individualised according to thigh size, meaning bigger thighs required greater 
pressures, consistent for both sexes. However, this research also identified brachial systolic blood 
pressure may be an additional significant predictor (b=0.231).  Therefore, cuff pressure was 
calculated using Equation 3.1 from the research complete by Loenneke et al. (2015) using thigh 
girth and blood pressure measurements as detailed in 3.3 and 3.5.  This accounted for the reports 
suggesting pressures needed to be above systolic blood pressure for limb IPC (Horiuchi 2017; 
Pope et al. 2013).  Once cuff pressure was determined, 60% of arterial occlusion was calculated 
following previous research identifying no additional benefit of increasing pressure higher (e.g. 
Counts et al. 2016) (for further information see section 2.4.1). 
 
Equation 3.1:   
Arterial occlusion (mmHg) = 5.893 (cm - Thigh circumference) + 0.734 (mmHg - DBP) + 0.912 
(mmHg - SBP) − 220.046 
Where DBP is diastolic blood pressure and SBP is systolic blood pressure 
 
 93 
 
 
 
 
 
 
 
 
Table 3.1: Summary of participant characteristics for each study 
 Sport N Gender Age (yrs) Height (cm) Weight 
(kg) 
Study 1 
(Chapter 4) 
Weightlifting 
& athletics 
22 10 males 
12 females 
21 ± 3 
26 ± 5 
188 ± 9 
162 ± 8 
85 ± 10 
64 ± 9 
       
Study 2 
(Chapter 5) 
Rugby union 24 All males 21 ± 3 185 ± 9 97 ± 10 
       
Study 3 
(Chapter 6) 
Swimming 20 14 males 
6 females 
21 ± 2 
19 ± 1 
182 ± 3 
166 ± 6 
77 ± 5 
59 ± 7 
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Figure 3.1 Application of occlusion cuffs whilst in a supine position 
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The control condition was determined following previous research in which 10-20 mmHg has been 
previously used within a control condition (Jean-St-Michel et al. 2011; Bailey et al. 2012; Patterson 
et al. 2015; Tocco et al. 2015) and has been shown to cause no alteration to the arterial inflow but 
allows increased control over the placebo effect as cuffs are worn in both conditions.  
 
3.5 THIGH GIRTH ASSESSMENT 
 
Thigh girth measurements were required to estimate cuff inflation pressure.  The same individual 
completed the thigh girth measurements (CV<0.54% within-individual assessment); 
measurements followed the International Society for the Advancement of Kinathropometry 
protocol.  Circumference of the right thigh was measured at 33% of the distance from the inguinal 
crease and top of the patella on the midline of the thigh.  Circumferences were measured at this 
mark to try and capture an accurate representation of the site at which the cuffs would be applied, 
in accordance with Loenneke et al. (2015). Thigh girth was measured, rested and then re-tested; 
measurements were required to be within 5% otherwise a third measurement was to be completed. 
The average was recorded and used to determine cuff pressure. 
 
3.6 BLOOD COLLECTION 
 
Capillary whole blood samples were collected for all experimental chapters; to complete this a 
small incision was performed on the fingertip using a single-use disposable lancet (Accu-check, 
Roche Diagnostics, GmbH).  After applying gentle pressure to the finger, a blood sample was 
collected in a capillary tube, the volume was specific to the measurement device being used as 
detailed below. 
 
3.6.1 Blood Lactate 
For chapters 4 and 6, a 20 µl capillary tube was used to collect a blood sample as detailed above 
(Davison et al. 2000), this was immediately placed in a pre-filled reaction tube, mixed with a lysing 
stabilising agent in a safe-lock vial (Davison et al. 2000).  The sealed vial was shaken and analysed.  
The blood sample was analysed for lactate using an automated lactate analyser (Biosen C-Line 
Clinic, EKF Diagnostic GmgH, Barleben, Germany).  Prior to each testing session the analyser 
was calibrated with a standard known solution (12mmol×l-1) before any analysis was carried out  
(Davison et al. 2000).  Previous research has identified the Biosen as a valid and reliable analyser 
for a full range of blood lactate values collected from a series of maximal and submaximal exercise 
tests, at a range of intensities from rest (0.85mmol×L-1) to volitional exhaustion (16.37mmol×L-1) 
(Davison et al. 2000).  The Biosen was compared against Yellow Springs Instrument (YSI) across 
a range of samples taken from rest to after maximal exercise; test re-test of the Biosen for reliability 
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and stability of samples were assessed.  When compared against the YSI, a very strong relationship 
was evident with the Biosen (coefficient of determination 0.975), the average bias was 0.37 
mmol×L-1 and 95% limits of agreement were 1.59 to -0.85 mmol×L-1, with the bias consistent across 
a range of values.  For test re-test reliability, a high coefficient of determination was established 
(r2 =0.995), however paired t-test showed the second measurement was significantly higher (6.44 
± 3.62 mmol×L-1) than the first (6.41 ± 3.61 mmol.L-1), although the magnitude of increase was 
very small (0.03 mmol×L-1, 95% CI 0.01-0.05).  The coefficient of variation of test re-test data for 
the Biosen was 1.4% compared to 1.2-3.7% for YSI.  The benefit of the Biosen was also displayed 
when assessing stability, there were no differences between samples when measured immediately 
or after 7 h or 24 h when kept at room temperature (18-22°C). 
For chapter 5, blood lactate was assessed using an ISTAT 1 analyser (Abbott, point of care testing) 
as this was being used to determine additional blood gases and pH as well.  Further details of this 
analyser are provided in section 3.6.2. 
3.6.2 Blood pH and gases 
To measure pH and blood gases (blood lactate, pH, percentage oxygen saturation [sO2%], partial 
pressure of oxygen [PO2], partial pressure of carbon dioxide [PCO2], total carbon dioxide [TCO2], 
bicarbonate [HCO3] and Base Excess [BEecf]) in chapter 5, a 60 µl sample was taken from the 
finger as described above and was analysed using an ISTAT 1 analyser (Abbott, point of care 
testing) and CG4+ cartridges (Abbott, point of care testing).  Prior to data collection the ISTAT 
was calibrated according to the manufacturer’s specifications by an electronic simulator and level 
one and three ISTAT control solutions (Abbott, point of care testing).  Cartridges were stored prior 
to use as per manufacturer’s instructions (2-8°C) and removed to room temperature ~5 min prior 
to use.  Upon completion of collection, the capillary blood sample was immediately expelled from 
the capillary tube into the sample well of the cartridge to prevent exposure to PO2 and CO2, this 
was analysed immediately.  To allow for immediate analysis two ISTAT 1 analysers were used, 
however the same analyser was used for all data points of one individual to avoid inter-sample 
variation.   
In each disposable cartridge, the measurement is based on ion-selective electrodes with 
potentiometric measurement for pH and PCO2 (analytical range pH; 6.5-8.0, PCO2; 0.67-17 kpa) 
and on a Clark electrode and amperometric measurement for PO2 (analytical range PO2; 0.67-107 
kpa), then comparison with an internal calibrator (Verwaerde et al. 2002).  Oxygen saturation is 
calculated using an algorithm involving pH, PO2 and PCO2; further measurements are calculated 
using the according equations (Verwaerde et al. 2002): 
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Equations: 
(3.2) Log HCO3- = pH + logPCO2 – 7.608 
(3.3) TCO2 = HCO3- + 0.03PCO2 
(3.4.) BEecf = HCO3- - 24.8 + 16.2 (pH 7.4) 
 
Blood gases and pH analysed with ISTAT have previously been compared against two auto-
calibrated bench top analysers (Radiometer analysers ABL 700 and 520) (Verwaerde et al. 2002).  
The ISTAT correlated well with the two control analysers (r >0.993), with differences of 0.010 for 
pH, 0.19 kpa PCO2 and 0.41 kpa for PO2 showing accuracy in comparison to alternative analysers 
(Verwaerde et al. 2002).  This is supported by Kok et al. (2015) comparing the ISTAT CG4+ to 
clinical laboratory analysers (e.g. XE-5000, ABL800 FLEX). There was a good correlation 
(defined as a bias of <10% between the ISTAT and the reference method) for pH, PCO2, HCO3 
and sO2%.  Dascombe et al. (2007) also confirmed intra-test reliability of the ISTAT analyser; ICC 
for all analytes were observed to be strong following maximal intensity exercise (ICC = 0.77-0.95; 
where 0.7-0.7 deemed strong correlation) and technical error of measurement (TEM) of <15% was 
deemed acceptable (pH; 0.24%, Blood lactate; 3.12%, all other measured blood gas parameters 
2.02-8.85%) confirming reliable analysis when using the ISTAT portable analyser.  
 
3.6.3 Creatine Kinase 
EIMD has frequently been examined using CK activity as an indirect marker in sport (Peake et al. 
2005; Russell et al. 2016).  Creatine kinase is an enzyme that catalyses the transfer of phosphate 
from PCr to ADP (Koch et al. 2014).  The associated morphological changes of skeletal muscle 
damage within the muscle cell is accompanied by the leakage of proteins out of the cell and into 
the blood circulation (Hortobagyi & Denahan 1989), therefore increases in CK in the blood stream 
are considered to be the result of increased membrane permeability due to damage.  Despite 
suggested limitations associated with CK responses that are presented within literature (e.g. 
variance across individuals due to ethnicity, gender and age) (Baird et al. 2012), CK has been 
reported to be an indirect marker of EIMD (Koch et al. 2014).  
For determination of CK in chapter 6, a 120 µL capillary blood sample was collected as descried 
above and immediately centrifuged (Labofuge 400R, Kendro Laboratories, Germany) at 3000 rpm 
for 10 min for the extraction of plasma.  This was subsequently stored at −80 °C until later analysis. 
The plasma samples were left to thaw before 6 µL was used in the analysis of CK using an 
automated analyser (ABX Pentra 400, Horiba ABX, Montpellier, France), determined 
spectrophotometrically according to manufacturer procedures using a commercial kit.  Prior to any 
analysis, calibration was completed using ABX Pentra multical and controls (ABX Pentra CK 
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Control, N control, P control) and ensured this was within the defined range according to the 
manufacturer.  Sample testing was carried out in duplicate, intra sample CV values were <2.0%. 
Coudene et al. (2005) have previously reported ABX Pentra 400 CV values were within expected 
values when within-run imprecision (0.79%) and between-run imprecision for serum and plasma 
assay (2.61%).  When compared with the Olympus AU640 a very strong correlation was reported 
(r =0.98).  It was concluded the Pentra 400 had good reliability and practicality (Coudene et al. 
2005). 
3.7 HORMONAL ANALYSIS 
 
Saliva collection, for chapter 4 and 6, required passive drooling (~2 ml) into a sterile vial 
(SalivaBio, Salimetrics LLC, USA) following research suggesting this as the most reliable option 
(Granger et al. 1994) and steroid hormones not affected by flow rate (Papacosta & Nassis 2011).  
Participants were required to refrain from brushing of teeth, drinking hot fluids, or eating hard 
foods in the 2 h before sampling to minimise the possibility of any blood contamination of saliva.  
This is a result of research showing concentrations of T increase in saliva following tooth brushing 
(Schramm et al. 1993) and research highlighting blood steroid hormone concentrations are 
generally an order of magnitude higher than that found in saliva (e.g. plasma cortisol is typically 
200–800 n×mol-1 but in saliva is only 3–30 n×mol-1), therefore blood leakage into the mouth might 
lead to increased concentrations of steroids, which is in proportion to the leakage of blood into 
saliva (Schwartz & Granger 2004). ELISA can detect concentrations of salivary steroids as a low 
as 2 pg×ml-1 with sensitivity of 1pg×ml-1 (Lindsay & Costello 2016).  As a result, large concentration 
differences between blood and saliva exist, therefore robust saliva collection (as detailed above) is 
imperative for precise and accurate results as contamination of blood e.g. bleeding of gums from 
biting hard foods can significantly alter concentrations of specific analytes (Hofman 2001; Lindsay 
& Costello 2016). 
Furthermore, food or drink high in sugar content, caffeine or acidity can cause increased acidity, 
lowering mouth pH levels and leading to compromised antibody–antigen binding and enzyme 
activity thus leading to invalid immunoassay results (Granger et al. 2004).   
All samples were chilled on ice immediately after collection, were stored at -15°C within one h 
after collection to avoid bacterial growth and were transferred to -80°C within 4-12 h of collection 
as previously recommended (Hansen et al. 2008).  Post thawing, centrifugation (Micro Centaur, 
MSE, London, United Kingdom; five min at 3000 revolutions·min-1) preceded duplicate analysis 
of T and C concentrations due to known reliable reflections of gonadal function (Vittek et al. 1987; 
Dabbs 1990) using indirect ELISA kits (Salimetrics Europe Ltd., Suffolk, U.K.) and optical 
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density, determined on a plate reader at 450 nm in accordance to the manufacturer.  The lowest 
detection limits for T and C were 6.1 pg·ml-1 and 0.012 µg·dl-1 respectively, and inter-assay CV 
values were <10.0%.  To eliminate inter-assay variance, each athlete’s samples were run within 
the same assay. 
Saliva is becoming increasingly useful due to its relative ease, non-invasive and time efficient 
collection protocol (Lindsay & Costello 2016) which is safer in the field than blood collection 
(Pritchard et al. 2017).  Saliva has been reported to be an ideal medium for the analysis and 
diagnosis of exercise stress, C and T whose concentrations represent serum-free levels (Kumar et 
al. 2005) are reliable in comparison to serum for reflecting gonadal function and circadian patterns 
(Johnson et al. 1987; Dabbs 1990).   Validation studies have demonstrated moderate to strong 
correlations (r =0.7-0.92) between salivary T and C concentrations and the corresponding blood 
total hormones at rest (Arregger et al. 2007; Vining et al. 1983).  The saliva measures more 
accurately reflect (r =0.92-0.97) blood free T or C concentrations to provide valuable data on the 
biologically active portion (1-5% of total hormones) that is available to tissue (Crewther et al. 
2010).  Although there is some disparity in the literature between saliva and plasma (between 
individuals T: r =0.57-0.61; C: r =0.83-0.84), significant strong correlations have been observed 
between salivary T and plasma T within individuals (r =0.71-0.73) and similarly for salivary C and 
plasma C within individuals (r =0.83-0.84) (Crewther et al. 2010).  Therefore, salivary T and C 
has previously been validated in response to short high-intensity exercise, sensitive to changes 
caused by exercise (Crewther et al. 2010) (Further information refer to section 2.7.1). 
3.8 NEUROMUSCULAR PERFORMANCE 
 
Neuromuscular performance assessment was completed in chapters 4 and 6. 
3.8.1 Data collection  
The ground reaction force (GRF) was collected using a portable force platform with a built-in 
charge amplifier (Type 9286BA, Kistler Instruments Ltd., Farnborough, UK).  In agreement with 
previous research (Owen et al. 2014), the vertical force range was set at 20 kn and the GRF was 
sampled at 1000 Hz through a 16-bit analogue to digital converter (Kistler instruments Ltd., 
Farnborough, UK) using Kistler bioware software.  The equipment was factory calibrated and its 
calibration was checked prior to each testing session using known masses.  Both CMJ (chapter 4 
and 6) and isometric mid-thigh pull (IMTP) (chapter 4) were performed. 
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3.8.2 Determination of body weight  
As identified in previous research (Owen et al. 2014), body weight was determined by taking the 
mean GRF value, as measured by the force platform, for one and half s of the stance phase 
immediately before the signal to jump being given. 
3.8.3 Countermovement jump  
All participants were familiar with CMJ testing and received verbal instructions prior to testing.  
To isolate the lower limbs, participants were instructed to stand with arms akimbo (Hatze 1998).  
Participants remained stationary for at least 2 s in an upright position for determination of body 
mass and as a reference from which jump initiation time was determined.  After the initial 
stationary phase, participants performed a CMJ, dipping to a self-selected depth and then 
performing a vertical jump to achieve maximum height.  Participants landed on the force platform 
and arms kept akimbo throughout the movement.  Participants completed two maximum jumps 
with 90 s rest between efforts.  Before completion, all participants performed a standardised warm-
up protocol (~5 min) consisting of activation exercises and dynamic stretches (Appendix D). 
The vertical component of the GRF and the participant’s body mass was used to determine 
instantaneous velocity and displacement of the centre of gravity.  Jump height (JH) was defined as 
the difference in vertical displacement of the centre of gravity between take-off (toes leave the 
force plate) and maximum displacement (West et al. 2011).  Instantaneous power output was 
determined using Equation 3.5 and the highest value produced was deemed PPO in accordance 
with previous methods (Owen et al. 2014; West et al. 2011). Peak velocity (Vmax) was taken as the 
highest rate of force development (RFD) during the concentric or eccentric phase of the jump.  The 
concentric phase was defined as succeeding the point that the instantaneous velocity of the centre 
of gravity equaled zero after the initiation of the jump (West et al. 2011).  
Equation 3.5 
Power (W) = vertical GRF (N) x Vertical velocity of center of gravity (m·s-1) 
 
3.8.4 Isometric mid-thigh pull  
For IMTP testing, participants stood on a portable force platform (Kistler Instruments Ltd., 
Farnborough, United Kingdom), which was positioned in the base of a portable power rack, 
directly under the bar.  Participants assumed a body position like the second pull of a power clean 
with a flat trunk position and their shoulders in line with the bar; maintaining knee angles of ~120–
130º (checked with goniometry, Smith & Nephew, Hull, United Kingdom) (West et al. 2011).   
Once the bar height was established, to allow for differences in participant statures, the participants 
stood on the force platform and were strapped to the bar (West et al. 2011).  A quiet standing phase 
of 5 s was completed before initiation of the IMTP.  Participants were instructed to pull as hard 
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and as fast as possible on the bar for a period of 5 s. West et al. (2011) provides evidence that the 
IMTP test can be used to measure maximal strength and explosiveness, both of which are related 
to jump and sprint acceleration performance.  The vertical component of the GRF during the IMTP 
was measured using the portable force platform; the peak force was determined from the vertical 
component of the GRF-time history during the IMTP minus the participant’s body weight (West 
et al. 2011).  The force at 100 ms (F100ms) was defined as the absolute value of the vertical 
component of the GRF minus the participants body weight 100 ms after start time.  The RFD was 
taken as the maximum value of the first derivative of the vertical component of the GRF–time 
history after start time (West et al. 2011). 
 
3.9 STATISTICAL ANALYSIS 
 
All data is presented as mean ± standard deviation (SD).  Statistical analyses were carried out using 
SPSS (SPSS Chicago, IL) with significance being accepted at p≤0.05.  Following confirmation of 
parametric assumptions, and tests of sphericity, a time x trial repeated measures analysis of 
variance (ANOVA) assessed between-trial differences for variables assessed on multiple occasions 
per trial at matched time points (i.e., salivary T and C) was complete for chapter 4.  Indices 
measured only in the experimental trial (i.e. blood lactate, and T and C measured pre-and post-
exercise only) or once per trial (i.e., variables from CMJ and IMTP analyses) were compared using 
paired t-tests.  Post hoc comparisons (Bonferroni adjustments) were made where necessary and 
effect sizes (ES) were calculated (Cohen 1988). ES were deemed small (0.1), moderate (0.3) and 
strong (0.5) as per Cohen (1988). Analyses were completed for the combined group, males, 
females and weightlifting only.  Correlations between physiological and performance measures 
were investigated using Pearson’s product-moment correlation coefficients.  
 
For chapter 5 and 6, following confirmation of parametric assumptions, repeated measures 
multivariate analysis of variance (MANOVA) with Bonferroni adjustment assessed between-trial 
differences for variables with multiple time points per trial (i.e. chapter 5: blood lactate, pH, sO2%, 
PO2, PCO2, HCO3 and BEecf; chapter 6: T, C, perception muscle soreness, perception recovery, 
CK, blood lactate, PPO and JH).  For chapter 5, one-way ANOVA assessed between-trial 
differences for all performance variables from the swimming TT and RPE recorded post-TT; 
completed for the combined group, 100 m and 200 m also.  Smallest worthwhile change in 
performance was calculated as the difference in performance from the control to 2 h IPC and 24 h 
IPC.  In chapter 6, paired samples t-tests were performed for between-trial comparisons of data 
expressed over a single time point within a trial (i.e. mean and total sprint times, T and C pre-and 
post-stress test).  
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Chapter 4 - The effects of morning exercise with vascular occlusion on 
afternoon performance 
 
4.1 STUDY INFORMATION 
 
Opportunities exist on the day of competition to influence subsequent performance as athletes may 
be susceptible to changes in their physical performance as a function of time.  Previous research 
has investigated the use of prior morning exercise to improve afternoon strength performance, 
associated with an attenuation of T throughout the day.  However, practicalities of implementing 
previously researched protocols exist and limit application in elite sport and use on the morning of 
competition.  Therefore, alternative strategies are sought after. 
 
Aim: investigate the use of vascular occlusion during resistance exercise in the morning (5 h prior) 
as a priming strategy to improve afternoon strength/power performance 
 
Objectives:  
- To identify the effect of resistance exercise combined with vascular occlusion on 
hormone response regarding attenuation of a circadian decline in T 
- To identify if there is a difference in T response in male and female athletes 
- To identify if an attenuation of T has a subsequent impact on afternoon performance in 
male and female athletes 
  
Hypothesis: completing resistance exercise combined with vascular occlusion, performed in the 
morning, will reduce the decline in T over 5 h, consequently improving strength/power 
performance in the afternoon  
 
Outcome measures: T, CMJ, IMTP 
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4.2 INTRODUCTION 
 
Physical performance can vary over the course of the waking day (Drust et al. 2005; Ammar et al. 
2014).  Accordingly, circadian rhythmicity of specific physiological responses such as core 
temperature and endocrine release have been proposed to modulate characteristics deemed key to 
sport performance (Teo et al. 2011).  As competitions commence over a wide range of times (e.g., 
11:00 h – 22:00 h), opportunities exist to attenuate circadian-related performance decrements 
(Chtourou et al. 2012).  Therefore, the day of competition has recently been proposed as an 
opportunity to enhance subsequent performance (Kilduff et al. 2013; Russell et al. 2015). 
 
Testosterone levels are predictive of physical performance (T Crewther et al. 2012); therefore, this 
biomarker is of interest in athletic performance (Cook & Crewther 2012; Crewther et al. 2013).  In 
the case of T, circadian rhythmicity displays an early morning (AM) peak before declining (Al-
Dujaili & Sharp, 2006; Kraemer et al. 2001; Teo et al. 2011) across times corresponding to the 
start of afternoon/evening (PM) competitions for example over 4 h a decline of -10.2 ± 2.4pg×ml-1 
(Cook et al. 2014) and -53 ± 23 pg×ml-1 over 5 h (Russell et al. 2015) have been reported. Research 
has highlighted beneficial effects of offsetting a PM decline in T by performing AM priming 
exercise and enhancing PM performance (Cook et al. 2014; Ekstrand et al. 2012; Russell et al 
2015; McGowan et al. 2016; refer to section 2.2.3, Table 2.1).  Cook et al. (2014) reported an 
attenuated decline in T and improved (~3%) lower body strength and power performances 6 h 
following an AM training session that incorporated heavy resistance exercise (bench press and 
back squat routines up to 100% of 3RM) in male rugby union players. Similarly, a 2% 
improvement in PM sprint performance occurred following heavy AM upper body resistance 
exercise (bench press: five sets, 10 repetitions, 75% one repetition maximum; 1RM), also in male 
rugby union players; a response which corresponded to increased T responses of +17 ± 18% above 
control values (Russell et al. 2015).  Whilst the use of heavy (>75% 1RM) and relatively high 
volume (up to 50 repetitions) resistance exercise in the hours preceding subsequent exercise is 
supported as a means of offsetting the circadian decline in T (direct stimulatory effect of lactate 
leading to an increase in T release (Lu et al. 1997) and improving PM performance (Russell et al. 
2015; Cook et al. 2014), such approaches may not be practical to pre-competition routines. For 
example, weightlifters would not favour the completion of the high volume of repetitions 
previously reported on competition day.  
 
Vascular occlusion is an emerging pre-competition strategy, when combined with resistance 
exercise, vascular occlusion has demonstrated utility for stimulating training effects with lower 
volumes (i.e., 25 repetitions at 70% 1RM [Cook et al. 2014]) of exercise than used in previous 
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priming studies (i.e., 50 repetitions at 75% 1RM [Russell et al. 2015]).  Proposed mechanisms (see 
section 2.5.2) that may benefit pre-competition use include increased metabolic stress (Suga et al. 
2012) and muscle fibre recruitment (Takarada et al. 2000; Yasuda et al. 2009).    Research identifies 
a relative intensity and volume threshold must be reached to induce a T response (Cumming et al. 
1987), for instance (Ratamess et al. 2005) recognised 6x10 but not 1x10 repetitions of resistance 
exercise increased T and thus volume and intensity are required to be sufficient to induce this 
response.  Vascular occlusion is suggested to increase metabolic response due to restricted venous 
outflow which subsequently enhances the duration of metabolic acidosis via the trapping and 
accumulation of intramuscular protons (H+) and stimulation of metabaroceptors possibly eliciting 
an exaggerated acute systemic hormonal response (Pope et al. 2013).  Schoenfeld (2013) reported 
a greater accumulation of metabolites, due to increased production in a more hypoxic state and 
limited removal, may act as a primary moderator of anabolic response.  Results published by (Cook 
et al. 2014) support this; the use of vascular occlusion combined with exercise resulted in an 
occlusion-dependent elevation in salivary T immediately after exposure.   
 
Acknowledging the practicalities associated with the pre-competition practices of professional 
athletes, methods of priming PM performances with lower exercise volumes may be better 
accepted by athletes and coaches on competition day.  The use of vascular occlusion may therefore 
provide an opportunity to reduce the decline in T from AM to PM and contribute to improved PM 
performance, using lower volumes of resistance exercise than examined previously in AM priming 
studies (Russell et al. 2015; Cook et al. 2014). Therefore, this study sought to ascertain whether, 
in comparison to a passive rest control condition (Con), completion of AM resistance exercise with 
vascular occlusion (RE+VO) elicits improved PM performance in field athletics and weightlifting 
athletes.  It was hypothesized that the inclusion of morning RE+VO would reduce the decline in T 
from AM to PM and thus transfer to improved PM performance.   
 
In addition to the primary aim, previous research into morning priming and the T response to 
vascular occlusion have been predominately completed in male participants including circadian 
rhythmicity research is sport.  Ekstrand et al. (2012) and Ingham et al. (2013) investigated AM 
exercise on PM performance in both male and females, identifying a positive response, however 
results were reported as a group, not distinguishing between sexes and hormonal responses were 
not measured.  Specifically regarding circadian rhythmicity, Kraemer et al. (2001) investigated the 
effect of heavy resistance exercise on the circadian rhythm of salivary T in men and Hatfield et al. 
(2016) examined the effects of circadian rhythm on power, force and hormonal response in young 
men.  To date, no investigation exists regarding the use of AM exercise in females and limited 
research exists in elite athlete, female response to exercise and circadian rhythmicity.  Cook et al. 
(2012) and Cook & Beaven (2013) provide two investigations in female athletes; comparison of 
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baseline free T and C concentrations between elite and non-elite female athletes and salivary T is 
related to self-selected training load in elite female athletes.  Findings suggesting elite female 
athletes have higher baseline T levels than non-elite females and secondly individual T 
concentrations demonstrated strong relationships with self-selected workloads during training, 
similar to results reported in male participants (Cook & Beaven 2013). This evidence suggests AM 
exercise may improve performance and hormone response as identified in male counterparts, 
however, no previous research exists in females or specifically with female athletes.  Therefore, 
this study also aimed to provide novel research on the effect of AM exercise on PM performance 
and diurnal changes in T concentration in female athletes. 
 
4.3 METHOD 
 
4.3.1 Experimental overview 
In a group of internationally competitive athletes, the effects of AM exercise completed prior to 
PM exercise performance were investigated using a crossover, randomised control trial. The study 
consisted of two interventions; Con and RE+VO.  In both conditions, AM and PM (~9.00 h and 
~14.00 h) saliva samples were provided to assess hormone responses.  The AM procedures 
consisted of participants randomly assigned to the Con or RE+VO, followed by ~5 h rest until PM 
measures of CMJ and IMTP were completed.  The RE+VO condition consisted of five sets of five 
repetitions of back squat at 70% 1RM with bi-lateral occlusion cuffs placed at the most proximal 
point of the thigh inflated to an individualised cuff pressure that was determined beforehand from 
thigh girth, and systolic and diastolic blood pressures.  Testing procedures were completed at a 
consistent time to limit circadian variation and were separated by seven days.   
 
4.3.2 Participants 
Following ethical approval and informed consent being attained, 22 international standard athletic 
(pole vault and high jump) and weightlifting athletes were recruited through the Welsh Institute of 
Sport (10 males, 12 females; Age: 24 ± 6 years, mass: 74 ± 15 kg, stature: 168 ± 14 cm, competition 
level: Welsh International; training history: 5 ± 4 years; training 1-2 times daily, 6 x week; refer 
to Table 4.1 for male and female split), completed the study protocol.  Testing was conducted in 
the participant’s maintenance phase of training and rested and abstained from alcohol for 24 h 
before each main trial. As part of consent procedures, female participants were asked about current 
hormone contraceptive use, of which three participants were currently using oral contraceptive 
pills; all other female participants reported regular menstrual cycling, determined according to 
section 3.2. 
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4.3.3 Main trial procedures 
Upon arrival for each main trial (~09:00 h), participants rested for 10 min before blood pressure 
and thigh girth measurements were taken (Omron Healthcare, Europe; systolic >140 mmHg and/or 
diastolic >90 mmHg precluded further study involvement) (section 3.3).  A baseline saliva sample 
was collected before the experimental interventions and female participants provided detail on the 
stage of menstrual cycle.  A 5 h passive rest period followed, during which unnecessary ambulation 
was minimised. Thereafter, PM (~14:00 h) assessments of salivary hormones and physical 
performance tests (CMJ and IMTP) were completed. 
 
For RE+VO, participants provided a 20 µL fingertip capillary blood sample to determine baseline 
values (analysed retrospectively for lactate concentrations; Biosen C-Line Clinic, EKF Diagnostic 
GmgH, Barleben, Germany) before undertaking a standardised warm-up (5-min cycle, six sets of 
back squat from 30-65% 1RM). Following 5-min of recovery, five sets of five repetitions of back 
squat (70% 1RM, 60 s intra-set recovery) (Cook et al. 2014) were performed while wearing 11 cm 
wide occlusion cuffs (Sports Rehab Tourniquet, Sportsrehab) on the most proximal point of each 
thigh.  Immediately prior to each set, cuffs were inflated to 60% of individually calculated 
pressures (147-240mmHg) (Table 4.2), before being deflated during recovery.  Individual 
pressures were calculated from thigh girth and resting blood pressure measurements and calculated 
in accordance with Loenneke et al. (2015) (see section 3.4).  Immediately after the final set, saliva 
and capillary blood samples were collected.  Such procedures took ~30 min to perform.  For Con, 
no morning exercise was undertaken, participants presented themselves for baseline measures only 
and were instructed to remain seated for ~30 min whilst the RE+VO were undertaking the 
intervention.  All participants returned after 5 h rest period for PM measures, a saliva sampled was 
completed first, prior to CMJ and IMTP.   
 
Saliva collection was completed as detailed in Chapter 3, section 3.7.  Assessment of CMJ and 
IMTP performance was completed using a force platform (type 92866AA, Kistler Instruments 
Ltd., Farnborough, UK), in accordance with the described methodology specified in Chapter 3, 
section 3.8, PPO, JH and peak force were calculated.   
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Figure 4.1: Timeline of data collection. Con; control: RE+VO; resistance exercise with vascular occlusion: RM; repetition maximum. Measurements: blood 
pressure (•), testosterone and cortisol (´), blood lactate (à), Countermovement jump & isometric mid-thigh pull ( ) 
 
 
 
Time 
Con – no exercise 
RE+VO – 5x5 back squat @ 70% 
1RM with occlusion cuffs during 
exercise 
Immediately 
post ´à 
AM Baseline •´à 
Rest 
5h post 
´  
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Table 4.1: Participant characteristics  
Baseline Characteristics Males  Females  
Age (yrs) 21.2 ± 3.8 26.2 ± 5.8 
Height (cm) 188.4 ± 9.2 161.9 ± 8.1 
Weight (kg) 85.3 ± 10.2 63.9 ± 9.4 
Resting systolic blood pressure 
(mmHg) 
138.1 ± 13.3 121.4 ± 10.6 
Thigh girth (cm) 61.7 ± 4.3 57.8 ± 4.6 
Training history (yrs) 3.9 ± 2.9 5.9 ± 4.9 
Cuff Pressure (mmHg) 218.1 ± 12.2 189.2 ± 24.0 
Values are expressed as Mean ± standard deviation 
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4.3.4 Statistical analysis 
All data is presented as mean ± SD.  Following confirmation of parametric assumptions and 
sphericity, a time x trial repeated ANOVA assessed between-trial differences for variables 
assessed on multiple occasions per trial at matched time points (i.e., salivary T and C) was 
complete.  Indices measured only in RE+VO trial (i.e. blood lactate, and T and C measured pre-
and post-exercise only) or once per trial (i.e., variables from CMJ and IMTP analyses) were 
compared using paired t-tests.  Correlations between physiological and performance measures 
were investigated using Pearson’s product-moment correlation coefficients.  Where appropriate 
results were analysed in homogenous groups e.g. males and females. Please refer to Chapter 3, 
section 3.9 for more detail. 
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Table 4.2: Individual cuff pressures  
 
Individual cuff pressures (mmHg) 
Male Participants Female Participants 
194.1 172.2 
227 161.9 
192.7 195 
240 200 
219.8 200 
220 163.9 
210.9 147.7 
219 185 
220 217 
223.9 206.7 
 220 
 206.6 
216.7±14.4 189.7±23.4 
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4.4 RESULTS 
 
4.4.1 Combined group results 
Salivary T concentrations (Figure 4.2) were influenced by condition (Time x trial interaction: 
F(1,20)=9.658, p=0.006) and time of sample (Time effect: F(1,20)=25.537, p<0.001).  Following 
paired samples analysis; although pre-exercise differences were observed (Con; 120.43 ± 40.42 
pg·ml-1, RE+VO; 101.94 ± 31.30 pg·ml-1, p=0.012, ES=0.51) the delta values (p=0.006, ES=0.89) 
in T from AM to PM in Con (-32.02 ± 28.32 pg·ml-1, -23.6 ± 19.9%, p<0.001, ES=0.94) was larger 
than the decrease in RE+VO (-9.60 ± 21.77 pg·ml-1, -5.8 ± 22.1%, p=0.086, ES=0.33).  Post 
exercise T following RE+VO condition increased significantly (+18.51 ± 32.52 pg·ml-1, +10.7 ± 
21.5%, p=0.014, ES=0.45).  
 
Salivary C concentrations demonstrated significant time (F(1,21)=39.983, p<0.001) but not time x 
trial interaction effects AM to PM (F(1,21)=2.765, p=0.111).  Measured in RE+VO only, a 
significant post-exercise increases in C occurred (+0.094 ± 0.16 ug·dL-1, +29.8 ± 43.5%, p=0.014, 
ES=0.48). 
 
Blood lactate concentrations increased post exercise in RE+VO (5.03 ± 2.7 mmol·l-1, 78.9 ± 13.6%, 
p<0.001, ES=2.94).  The delta changes in blood lactate and T concentrations pre-to post exercise 
showed a significant, large positive correlation (r=0.559, p=0.007) (Figure 4.3).  The ΔT values 
from pre- to post-exercise were significantly correlated with occlusion cuff pressure (r=0.437, 
p=0.042).  The data also identified a significant positive correlation between Δblood lactate 
concentration and occlusion cuff pressure in RE+VO (r=0.423, p=0.05).   
 
Performance measures are presented in Table 4.3 and 4.4.  There were no significant differences 
in CMJ PPO (p=0.832), JH (p=0.422) or Vmax (p=0.445) between conditions, nor were there any 
significant differences in IMTP peak force (p=0.120), F100ms (p=0.734) and RFD (p=0.802).  
However, there were large individual differences in IMTP peak force (2 to 17%) (Figure 4.5).  
There were no significant relationships between the percentage changes in T concentrations from 
AM to PM in the occlusion trial and the percentage change in CMJ PPO (p=0.750) or IMTP peak 
force (p=0.119).  However, a significant correlation was observed between change in T 
concentration from pre-to post exercise and the difference in IMTP peak force between conditions 
(r=0.488, p=0.021). 
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Figure 4.2: ΔTestosterone concentrations (mean ± SD) throughout the control (Con) and resistance 
exercise with vascular occlusion (RE+VO) condition. (A) All participants, (B) male participants 
only, (C) female participants only, (D) weightlifting only participants * indicates significant 
(p<0.05) delta change measured AM to PM.  
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Figure 4.3: Correlation between the change in blood lactate and Testosterone pre-to post-
exercise 
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Figure 4.4: Individual response in performance of peak power output determined from 
countermovement jump for the control and occlusion conditions. (A) All participants, (B) male 
participants, (C) female participants 
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Figure 4.5: Individual response in performance of peak force determined from isometric mid-
thigh pull for the control and occlusion conditions. (A) All participants, (B) male participants, 
(C) female participants 
 
1500.0
2000.0
2500.0
3000.0
3500.0
4000.0
4500.0
5000.0
Control Occlusion
Pe
ak
 F
or
ce
 (N
)
2000.0
2500.0
3000.0
3500.0
4000.0
4500.0
5000.0
Control Occlusion
Pe
ak
 F
or
ce
 (N
)
1500.0
1700.0
1900.0
2100.0
2300.0
2500.0
2700.0
2900.0
3100.0
Control Occlusion
Pe
ak
 F
or
ce
 (N
)
Condition
 116 
4.4.2 Male participants 
In male participants, T concentrations were influenced by condition (Time x trial interaction; 
F(1,8)=7.040, p=0029) and time of sample (Time effect; F(1,8)=42.409, p<0.001) (Figure 4.2).  
Testosterone concentrations declined significantly from AM to PM in the control trial (-50.55 ± 
29.39 pg·ml-1, -32.2 ± 15.3%, p=0.001), displaying very large effect sizes (ES=1.50), but not 
following RE+VO (-14.78 ± 21.21 pg·ml-1, -10.9 ± 17.2%, p=0.110, ES=0.59).   
 
Although T concentrations were higher after completion of RE+VO, this did not reach significance 
(+27.94 ± 44.14 pg·ml-1, +13.6 ± 26.3%, p=0.076) despite a medium to large effect size (ES=0.74).  
Blood lactate was significantly higher following RE+VO (6.37 ± 2.52 mmol·l-1, 80.9 ± 16.55, 
p<0.001) with a positive significant correlation between the change in blood lactate and occlusion 
cuff pressure (r=0.722, p=0.018). The change in blood lactate did not correlate with the change in 
T concentration (r=0.522, p=0.122). 
 
Salivary C concentrations were not affected by condition (Time x trial interaction; F(1,9)=0.289, 
p=0.604), but there was a significant effect of time of measurement (F(1,9)=25.843, p<0.001) in 
response to trials.  Cortisol concentrations decreased from AM to PM in both the control (-0.257 
± 0.18 ug·dL-1, -49.9 ± 21.1%, p=0.001, ES=1.62) and RE+VO (-0.304 ± 0.26 ug·dL-1, -51.3 ± 
18.6%, p=0.005, ES=1.50) conditions.  
 
Neither conditions had an effect on any performance measures reported in Table 4.3 and 4.4 
(p<0.05).  However, as displayed in figure 4.4 and 4.5 there was individual variation in 
performance. There were no significant associations between percentage change in T 
concentrations from AM to PM in the occlusion trial and percentage change in CMJ PPO (p=0.864) 
or IMTP peak force (p=0.630).   
 
4.4.3. Female participants 
In female only participants, T concentrations were not affected by condition (Time x trial 
interaction; F(1,11)=3.452 p=0.090), but did vary due to sampling time (Time effect; F(1,11)=6.035, 
p=0.032) (Figure 4.2).  Testosterone concentrations declined from AM to PM in the control 
condition (-18.12 ± 18.41 pg·ml-1, -17.2 ± 21.1%, p=0.006, ES=0.76), however results did not 
significantly decline following RE+VO (-5.28 ± 22.18 pg·ml-1, -1.6 ± 25.5%, p=0.427, ES=0.21).   
 
There were significant differences in T concentration pre-to post RE+VO (+10.65 ± 16.64pg·ml-1, 
+8.3 ± 17.5%, p=0.049, ES=0.34).  Blood lactate also significantly increased pre-to post RE+VO 
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(3.92 ± 1.59 mmol·l-1, 77.2 ± 11.0%, p<0.001).  However, there was no significant correlation 
between the change in T concentration and the change in blood lactate (r=0.521, p=0.083).   
 
Salivary C concentration was significantly affected by condition (Time x trial interaction; 
F(1,11)=8.654, p=0.013) and time of sampling (F(1,11)=15.928, p=0.002).  Cortisol concentrations 
declined from AM to PM under the control (-0.381 ± 0.32 ug·dL-1, 60.9 ± 17.9%, p=0.002, 
ES=1.39) and RE+VO (-0.143 ± 0.20 ug·dL-1, 30.2 ± 36.9%, p=0.027, ES=0.84) condition.   
 
There were no significant differences in any performance measures reported in Table 4.3 and 4.4, 
for example CMJ PPO (p=0.709) and IMTP peak force (p=0.254). There was also no significant 
relationship between percentage change in T from AM to PM in occlusion trial and the percentage 
change in CMJ PPO (p=0.776) or IMTP peak force (p=0.124). 
 
4.4.4 Weightlifting participants 
Salivary T concentrations were influenced by condition (F(1, 17) = 25.264; p<0.001) and time of 
sample (F(1, 17) = 0.278, p<0.001) (Figure 4.2).  There was a significant decline in T from AM to 
PM in the control (-25.27 ± 30.25 pg·ml-1, -16.2±21.3%, p<0.001), larger than the decrease 
identified in RE+VO (-4.67 ± 22.77 pg·ml-1, -1.1 ± 21.7%).  A significant difference was displayed 
between the decline in T from AM to PM in the control compared to RE+VO (p=0.024).  Post 
exercise T following RE+VO increased significantly (+22.0 ± 27.9 pg·ml-1, +13.9 ± 16.2%, 
p=0.031). 
 
Blood lactate significantly increased following exercise (p<0.001) and was significantly correlated 
to the DT pre-to post exercise (r=0.475, p=0.047). 
 
Salivary C concentrations were not affected by condition (F(1, 17) = 0.398, p=0.537) but was affected 
by time of sample (F(1, 17) = 33.371, p<0.001). 
 
An increase in CMJ PPO was observed (0.6 ± 3.5%), although consistent with other results this 
did not reach significance (p=0.507), similarly for JH an increase was observed following RE+VO 
(0.9 ± 4.6%) but was not significantly different between conditions (p=0.329) and Vmax (p=0.408).  
Peak force from IMTP was not significantly different between conditions (p=0.069), despite an 
increase of 3.2 ± 7.7%, this was consistent for F@100ms (p=0.965) and RFD (p=0.850). 
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Table 4.3: Performance outcomes from countermovement jumps for the control and vascular 
occlusion conditions  
Condition Participants Performance   
  CMJ PPO (W) Jump Height (cm) Vmax (m.s-1) 
Control Group 4295.0 ± 1086.0 37.5±5.6 2.8 ± 0.2 
Vascular Occlusion Group 4301.4 ± 1051.8 37.8±5.6 2.8 ± 0.2 
Percentage change   0.3 ± 0.0% 0.7 ± 4.4% 0.3 ± 2.1% 
Control Males 5299.1 ± 652.9 36.7 ± 9.0 3.0 ± 0.1 
Vascular Occlusion Males 5292.1 ± 590.2 36.8 ± 9.0 3.0 ± 0.1 
Percentage change  0.0 ± 2.2% 0.3 ± 4.0% -0.3 ± 2.0% 
Control Females 3458.2 ± 471.4 35.7 ± 8.1 2.7 ± 0.2 
Vascular occlusion Females 3475.8 ± 437.2 36.2 ± 8.2 2.7 ± 0.2 
Percentage change  0.5 ± 4.4% 1.5 ± 4.0% 0.9± 2.0% 
 
Mean ± standard deviation. CMJ - countermovement jump; PPO - peak power output; Vmax – peak 
velocity 
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Table 4.4: Performance outcomes from isometric mid-thigh pull for the control and vascular 
occlusion conditions  
Condition Participants Performance   
  Peak force (N) F100ms (N) RFD (N.s-1) 
Control Group 2614.9 ± 718.6 711.4 ± 345.1 12379.1 ± 5552.1 
Vascular Occlusion Group 2689.9 ± 752.6 773.0 ± 378.4 13315.5 ± 5502.9 
Percentage change   2.3 ± 7.6% 0.8 ± 38.6% 1.6 ± 32.3% 
Control Males 3174.0 ± 619.9 920.3 ± 215.6 16113.3 ± 5611.8 
Vascular Occlusion Males 3265.0 ± 621.1 1027.3 ± 290.6 17343.4 ± 4901.8 
Percentage change  2.6 ± 7.8% 1.9 ± 39.2% 2.0 ± 32.0% 
Control Females 2148.9 ± 387.6 521.4 ± 336.2 9578.4 ± 3630.1 
Vascular occlusion Females 2210.7 ± 463.1 541.8 ± 294.7 10294.7 ± 3788.7 
Percentage change  2.0 ± 7.8% 0.1 ± 39.8% 1.3 ± 34.0% 
 
Mean ± standard deviation. F100ms – force at 100 ms, RFD – rate of force development 
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4.5 DISCUSSION 
This study examined the influence of combining morning exercise with vascular occlusion on 
afternoon performance and associated hormonal changes of internationally competitive field 
athletics and weightlifting athletes.  Although no combined group performance effects were 
observed, AM exercise combined with vascular occlusion attenuated the AM to PM decline in 
salivary T concentrations over a 5 h period and caused an acute increase in T concentrations post-
exercise.  No significant effects were observed for C concentrations from AM to PM.  The results 
displayed mainly consistent patterns when males, females and weightlifting only groups were 
analysed. Such findings suggest the use of resistance exercise combined with vascular occlusion 
as a method of attenuating the decline in T, but further research is required to determine its potential 
efficacy for performance following the individual responses observed (Figures 4.4 and 4.5).   
 
Completing AM exercise has formerly been demonstrated to be beneficial to reduce a circadian 
decline in T over the day and consequently positively impact afternoon performance (Russell et al. 
2015; Cook et al. 2014).  Consistent with previous results (Russell et al. 2015; Cook et al. 2014), 
the current study identified a decline in T by -32.02 ± 28.32 pg·ml-1 (-23.6 ± 19.9%) between 09:00 
h and 14:00 h in the control.  Conversely, this decline was attenuated by performing RE+VO, 
where reductions of -9.60 ± 21.77 pg·ml-1 (-5.8 ± 22.1%) were observed.  Testosterone has 
previously been associated with quality of work performed by regulating Ca2+ handling, muscle 
contractility and motor cortex outputs, further contributing to human performance through its 
putative actions on mood, behaviour and cognition (Crewther et al. 2012).  Therefore, T can have 
a positive impact on performance and as such has received signficiant attention on methods of 
increasing T response and also preventing circadian decline in T throughout the day to enable 
afternoon performance to be completed with higher T levels.  Reagrdng the acute response, 
previous research has discussed the requirement of high intensity and volume thresholds to be 
reached in order to achieve a hormone (T) response with examples from Ratamess et al. (2005) 
suggesting 6x10 repetitions but not 1x10 resulted in a T response.  This has been linked to the 
metabolic accumulation required to induce a T response.  Consequently, previous research 
implemting morning exercise to influence afternoon T and performance have implemented high 
volumes of resistance exercise (e.g. 5x10 bench press; Russell et al 2015), however, this lacks 
practicality for completion the day of competition especially for particular sports such as 
weightlifting.  The use of combining resistance exercise and vascular occlusion was hypothesized 
to attentuate the circadian decline in T, due to mechanisms associated with increased metabolic 
accumulation, the result of decreased venous outflow and conquently increasing hormone response 
with a  lower volume and intensity of resistance exercise, which was achieved.   
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Unfrotunately, intramsuclar measurements of muscle lactate, H+, ATP and PCr concentrations 
were not possible in this study to delineate mechanisms resulting in attentuated T concentrations. 
Nevertheless, blood lactate data, as also completed by (Teixeira et al. 2017), provided a superficial 
insight into the metabolic response to RE+VO.  Notably, the 78.9 ± 13.6% increase in blood lactate 
concentrations that occurred immediately after RE+VO exposure, when the whole group was 
analysed, correlated positively (r=0.559) with ΔT concentrations (i.e., 10.7 ± 21.5%; pre-to post 
exercise).  As maximal exercise elicits a rapid endocrine response that normally relates to exercise 
intensity (Buśko & Opaszowski 2005), and correlations between blood lactate and T changes exist 
following heavy resistance exercise (Kraemer et al. 1991), a direct stimulatory effect of lactate 
may lead to increased release of T (Lu et al. 1997). Notably, the magnitude of change in T 
immediately after RE+VO was equivocal of those seen following acute androgenic stimulating 
activities (Cook et al. 2014).  These results are supported by Cook et al. (2014) observing an acute 
increase in T, despite previous literature into vascular occlusion failing to observe a T response 
(Reeves et al. 2006; Madarame et al. 2008; McCall et al. 1999).  It was proposed that the more 
intense nature of the exercise prescribed (five sets of five repetitions with 70% 1RM) along with 
vascular occlusion stimulus contributed to these results.  Interestingly, in the combined group 
results, the DT and Dblood lactate results both correlated to cuff pressure, therefore, the pressure 
applied may be speculated to have been the additional stimulus to exercise to increase metabolic 
accumulation and affected blood lactate.  However, as a resistance only condition was not included 
in the study design, conclusions cannot be drawn whether a similar metabolic response and 
consequent increase in T would have resulted without the addition of vascular occlusion. 
 
When examining homogenous groups, in both male and female only groups, DT pre-to post-
exercise and Dblood lactate was not significantly correlated which may suggest alternative 
mechanisms other than metabolic response were influencing T.  For example, additional reports 
have suggested hemoconcentration and decreased metabolic clearance as two potential 
mechanisms to explain exercise associated T increases (Keizer et al. 1980).  As neither 
mechanisms were measured in the current study, conclusions cannot be drawn and only speculated 
that either of these mechanisms may have influenced T response.  It would have been beneficial 
to measure heart rate and blood pressure to determine cardiovascular response to identify if this 
was having any additional impact.  Cardiovascular response is variable within the literature and 
dependent on training status and mode of exercise.  Renzi et al. (2011) identified a greater increase 
in HR when walking was completed with occlusion in contrast to a control condition.  Similar 
results were also stated for the impact on blood pressure.  However, these results were completed 
with 17 ‘healthy volunteers’.  Whereas Bunevicius et al. (2016) reported a slightly higher HR in 
the control group, compared to exercise completed at 40% 1RM with vascular occlusion.  
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However, a small increase in systolic blood pressure was observed with vascular occlusion 
compared to the control.  These results were completed within well-trained athletes and concluded 
low intensity exercise with occlusion did not result in significant overload of cardiac function.  It 
would be beneficial to establish HR and cardiac response to higher intensity (i.e. 70% 1RM) with 
vascular occlusion in future research to identify if this would increase cardiovascular stress and 
subsequent positive or negative effects on performance immediately and 5 h post exercise. 
 
A novel aspect of the current study was the investigation of morning exercise and hormonal 
priming in female athletes.  A large portion of research into the effect of exercise on T response is 
completed in males as previously outlined.  However, the results are not equivocal in women, with 
both increases (Nindl et al. 2001; Copeland et al. 2002) and no changes (Linnamo et al. 2005; 
Consitt et al. 2001; Kraemer et al. 1993) in T response to exercise.  For example, Kraemer et al. 
(1991) measured serum T levels before, during, and after resistance exercise and found that 
circulating T is significantly increased in males and is not changed in females throughout the 
duration of the exercise.  However, within the current study, female T response followed a similar 
reaction to males and combined group results; a decrease of 17.2 ± 21.1% was displayed in the 
control from AM to PM whereas morning exercise attenuated this decline to 1.6 ± 25.5% within 
RE+VO. Similarly, females also showed an acute increase in T response (8.3 ± 17.5%) to exercise 
with vascular occlusion, which is comparable to the increase seen in male participants (13.6 ± 
26.3%).  The aforementioned studies investigated females that were active, however research 
completed by Cook et al. (2012) identified baseline measures of T were significantly higher at 
weekly time points over 12 weeks in elite (international level athletes) (87 pg·ml-1) than non-elite 
(national level athletes) (41 pg·ml-1) female athletes.  This may support the results of this study as 
the average baseline for females involved was 97.9 ± 24.5 pg·ml-1, providing evidence for the 
international calibre of athletes tested as well as highlighting reasons for comparisons of T 
response in females to previous research.  Furthermore, only three females were using oral 
contraceptives, which as previously determined by Crewther et al. (2015), lowers baseline and T 
response to exercise, potentially influencing previous research and explaining variation in results 
of the current research.  Therefore, the current results suggest the use of morning exercise to 
attenuate the circadian decline in T in elite female athletes, however this did not translate into 
improved afternoon performance, consistent with combined group results. 
 
Cortisol response between conditions varied in females compared to other examined groups.  
Within the control condition, C declined by 60.9 ± 17.9%, whereas only a decrease of 30.2 ± 36.9% 
was observed following RE+VO.  Afternoon C levels were lower in Control (0.190 ± 0.08      
ug·dL-1) compared to 0.246 ± 0.15 ug·dL-1 in RE+VO consistent with previous research (Cook et 
al. 2014).  Cortisol is the major stress hormone which targets an array of both peripheral and central 
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processes (Lupien et al. 2007).  The regulation of stress-induced as well as basal C secretion is 
thus essential for the maintenance of homeostasis (McEwen 2000; Tsigos & Chrousos 2002).  
Cortisol is released from the adrenal cortex in response to stress during exercise (Kon et al. 2012) 
and promotes catabolism via decreased protein synthesis and increased protein degradation 
(Kraemer & Ratamess 2005).   Contrasting results have reported the influence of C on 
performance.  Sale et al. (2008) provided evidence of the negative effects of increased C on 
neuromuscular functioning, but this was in the mornings in comparison to afternoon performance.  
Opposing research by Teo et al. (2011) found acute diurnal variations of C did not display strong 
relationships with the circadian rhythm of force or power output.  Although both hormonal 
response (C) and physical performance displayed a circadian pattern, no correlation was found 
between the two variables, therefore, the acute elevation in C may not negatively impact 
performance in the current study.  Of further interest was the difference in response of females 
compared to males and combined group results.  Previous research has shown no difference in 
diurnal C patterns between contraceptive users and non-users (Vibarel-Rebot et al. 2015) and 
furthermore menstrual cycle stage has not influenced stability of C (Liening et al. 2010).  
Therefore, differences in C response are likely to be a result of resistance exercise combined with 
vascular occlusion and females displaying an increased stress response.  If performance scientists 
are applying this strategy with females either for pre-competition or training it should be 
considered that females may display an elevated C response which may impact training adaptation 
or affect subsequent performance. 
 
Despite RE+VO reducing the circadian decline in T, across all groups, no PM performance effects 
were observed for CMJ or IMTP; findings which contradict previous work (Russell et al. 2015; 
Cook et al. 2014).  Results were similar in performance change between all groups, except the 
improvement in IMTP peak force was greater in weightlifting only athletes (3.2 ± 7.7%).  Previous 
research has suggested baseline strength and power may determine responsive properties for 
example, a significant effect of baseline strength on the relationship to T and performance in squat 
performance has been observed; T correlated to squat performance (r=0.92) in strong participants 
compared to weaker counterparts (r=0.35) (Crewther et al. 2012).  The expression of force and 
power may be dependent on individual variation in salivary free T concentration and/or existing 
strength and power levels (Crewther et al. 2012) which may support that weightlifting athletes 
have increased baseline strength and power compared to field athletics and thus this group alone 
showed (although not significant) a greater improvement in PM performance in a test specific to 
their competition performance.  This may also explain the individual variation observed in results, 
especially of the IMTP in which 13 out of 22 subjects improved peak force (2 to 17%).   
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Alternatively, individual variation in factors associated with the efficacy of RE+VO, such as the 
balance between muscle activation and fatigue (contractile/metabolic impairment), may have 
contributed to such findings.  Vascular occlusion with resistance exercise implicates greater 
muscular activation to maintain the same total work output (Takarada et al. 2000; Takarada et al. 
2002; Yasuda et al. 2008; Fahs et al. 2015) and additional motor unit activity and enhanced 
recruitment of type II motor units (Moore et al. 2004)  is required to maintain force levels following 
resistance exercise combined with vascular occlusion (Fatela et al. 2016); even when muscle 
damage remains unchanged (Wilson et al. 2013).  Also to acknowledge, Kluess & Wood (2005) 
observed more pronounced vagal withdrawal concomitant with increased sympathetic activity 
following vascular occlusion.  As the recovery of heart rate variability after exercise with vascular 
occlusion was delayed, this indicates a greater autonomic disruption when blood flow is occluded 
during exercise (Okuno et al. 2014), consequently impacting PM performance and highlighting the 
importance of balance between muscle activation and fatigue.  Therefore, further research is 
required to identify individual factors that contribute to the optimisation of resistance exercise with 
vascular occlusion for use prior to subsequent exercise whether implemented immediately or 5 h 
before.  
 
Several methodological inconsistencies have generated conflicting findings between studies.  For 
example, the vast majority of studies have implemented an occlusion protocol prescribing an 
arbitrary restrictive pressure for all participants or based on systolic blood pressure at rest (Fatela 
et al. 2016).  Recent findings however indicate that neither one of these previously used approaches 
represents an effective strategy for controlling the magnitude of blood flow restriction in the lower 
body (Loenneke et al. 2012).  If restrictive pressures are too low, muscular responses may not be 
significantly augmented (Scott et al. 2015).  Furthermore, extremely high pressures (i.e. those that 
occlude arterial inflow during inter-set rest and/or exercise) may not enhance muscular 
development more than moderate pressures (Scott et al. 2015).  It is accepted that vascular 
occlusion pressure should be high enough to occlude venous return from the muscles, yet low 
enough to maintain arterial inflow into the muscle (Loenneke et al. 2014).  Logic therefore dictates 
that vascular occlusion should not be universally applied at an absolute pressure, but should vary 
relative to each individual (Loenneke et al. 2013).   
 
In both males and females, previous research has suggested thigh girth and arterial blood pressure 
are important determinants for vascular occlusion (Loenneke et al. 2015), offering a practical 
approach to individualising cuff pressure, consequently the present study used these two 
determinants to individualise cuff pressure.  This was an important step, considering required 
individualisation of strategies for elite athletes and also considering Hunt et al. (2016) highlighted 
60% reduction in popliteal blood flow was achieved at lower external pressures in females 
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compared to males.  Reports suggest this is likely to be due to differences between sexes in local 
vascular function (Hunt et al. 2016).  Contrasting previous research, Hunt et al. (2016) also 
highlighted mean arterial pressures and adipose thickness were the largest independent 
determinants of lower partial occlusion pressures.  Less is understood about the impact of tissue 
type (muscle or fat) on the level of vascular occlusion, but it is likely the degree of intramuscular 
pressure depends on the architecture features of the muscle (Hunt et al. 2016).  Previous research 
has investigated protocols in non-athletic groups, therefore the impact of tissue type and other 
determining factors may vary the effectiveness of the protocol for elite athletes.  Extended research 
is required to determine the efficacy of best practice in elite athletes to optimise cuff pressure if 
ultrasound Doppler is not viable. 
 
Despite providing a novel insight into the use of AM resistance exercise combined with vascular 
occlusion on PM performance in elite athletes, several experimental limitations are acknowledged.  
The study design limits conclusions which can be drawn from the results; a traditional 
experimental study design of control versus one manipulation was completed (similar to design 
used by Cook et al. 2012), however this inherently prevents identifying if the combined effect of 
resistance exercise and vascular occlusion attenuated the decline in T.  Only from the use of 
previous research recommending the requirement for volume/intensity threshold to be achieved 
for an increase in T response and previous morning exercise results can speculations be made; 
however, it cannot be inferred if occlusion was responsible for the T response.  The addition of a 
non-occluded AM resistance exercise-only trial would have allowed further delineation of the 
effects of AM resistance exercise with vascular occlusion on physiological and performance 
responses. However, the recruitment of the international standard of participants to the study 
design, while a strength of the protocol, inherently posed significant time-pressures which 
precluded the addition of a third experimental condition.  Additionally, hypertrophied muscles 
have a greater thickness and volume and subsequently vascular occlusion may occur at relatively 
lower pressures when compared to applying pressure to adipose tissue (Hunt et al. 2016).  Despite 
our attempts to individualise the occlusion pressures implemented in this study (Loenneke et al. 
2015), there may have been between-participant variation in the degree of occlusion experienced 
during vascular occlusion. Further research into individual factors modulating the degree of 
pressure experienced by participants in vascular occlusion will likely better inform the use of this 
ergogenic modality in an athletic environment. 
 
4.6 PRACTICAL IMPLICATIONS 
This study has shown that resistance exercise combined with vascular occlusion can reduce the 
decline in T from AM to PM.  However, this data did not improve PM performance in all athletes.  
For practical application, resistance exercise combined with vascular occlusion can be used by 
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performance scientists, coaches and athletes to reduce the decline in T from AM to PM that is 
caused by the circadian decline, by completing resistance exercise at 70% 1RM with vascular 
occlusion.  Due to the variability of individual responses, this should be trialled with each athlete, 
consequently, the response will be directly applicable to the individual athlete and can be 
implemented into a pre-competition routine for those individuals which show a positive 
performance response in the afternoon.  It should also be practiced, ensuring tolerance of resistance 
exercise with vascular occlusion, this may result in enhanced performance once the individual has 
increased familiarity and use of vascular occlusion. 
 
4.7 CONCLUSION 
To conclude, the current study identifies a reduced decline in T over 5 h when resistance exercise 
combined with vascular occlusion was completed in the morning.  This is believed to be a result 
of an increased metabolic response which caused a consequential increase in T concentration after 
exercise.  However, a reduced decline in T concentration at the time of PM performance measures 
did not result in an improved performance, with results showing variability in individual 
performance.  This study offers novel findings into the use of resistance exercise with vascular 
occlusion for AM hormonal priming for male and females, but further research is required prior to 
practical implementation. 
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Chapter 5 - The effect of ischemic preconditioning on maximal swimming 
performance 
 
5.1 STUDY INFORMATION 
 
Information presented in the previous chapter was specific for sports involving strength and power, 
and therefore investigated an appropriate pre-competition strategy specific for the nature of these 
sports.  Other sports contrast in underpinning mechanisms which influence performance and 
therefore the previously discussed pre-competition strategy may not be appropriate to impact 
performance.  Aerobic/anaerobic energy requirements are important for swimming performance 
and therefore pre-competition strategies specific to these mechanisms are of primary importance.  
Consistent with the previous chapter, the following chapter aimed to explore the use of limb IPC 
as a pre-competition strategy but adjusting the protocol to apply the strategy during passive rest 
and focus on mechanisms specific to improve swimming performance. 
 
Aim: Investigate the use of limb IPC applied in the early (2 h) and late phase (24 h) on swimming 
TT performance 
 
Objectives: 
- To identify whether the effect of IPC on swimming performance is time dependent  
- To identify if improvement in swimming performance is achieved following limb IPC 
implemented 24 h prior to performance to harness the mechanisms associated with the late 
phase of IPC 
- To identify if limb IPC at 2 h or 24 h influences physiological mechanisms associated with 
blood lactate and gases 
 
Hypothesis: limb IPC will improve swimming TT performance at both 2 h and 24 h in comparison 
to a control condition 
 
Outcome measures: blood lactate and gas measurements, RPE and swimming TT 
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5.2 INTRODUCTION 
 
During international swimming events athletes are required to perform two to three maximal 
efforts following months or even years of training and preparation, with marginal differences of 
<0.5% separating medal and non-medal positions (e.g. difference between sixth and third place in 
the men’s and women’s 100 m at World Championships; FINA, World Championship results 2017 
- http://www.fina.org/event/17th-fina-world-championships/results).  In addition to the benefits of 
training, previous research has shown the importance of competition warm-up intensity (Neiva et 
al. 2014), timing of warm-up (West et al. 2013b) and use of active heating and land-based 
activation exercises (McGowan, Pyne, et al. 2016; McGowan, Thompson, et al. 2016) as 
competition-day strategies to improve subsequent swimming performance. Limb IPC has also been 
reported to improve indices of athletic performance when used between 15 min and 8 h before 
performance assessments (Horiuchi 2017).  
 
The benefits of limb IPC to improve athletic performance have been previously observed in time 
to exhaustion (e.g. De Groot et al. 2010), anaerobic specific performance tests (e.g. Jean-St-Michel 
et al. 2011) and repeated sprint ability (e.g. Patterson et al. 2015) (Refer to Section 2.5.3).  It has 
been reported that limb IPC induces acute vascular adaptations, resulting in local vasodilation and 
enhanced blood flow (Tapuria et al. 2008).  Consequently, enhanced functional sympatholysis may 
speed and increase O2 extraction by means of matching demand with supply (Horiuchi et al. 2015), 
facilitating an increased aerobic contribution during subsequent exercise.  Reports suggest that 
limb IPC can cause a faster uptake of acetyl-CoA by mitochondria thus maintaining lactate 
accumulation at a metabolically acceptable level due to greater contribution of aerobically 
generated ATP for exercise (Jean-St-Michel et al. 2011).  Recruitment of higher order motor units 
via enhanced central motor efferent command also results from limb IPC (Crisafulli et al. 2011), 
allowing for exercise to be completed beyond the individual’s critical threshold by increasing or 
maintaining the rate of force development and improving subsequent performance.   
 
However, only one study (Seeger et al. 2017) relating to sports performance has differentiated 
between the observed early and late phase of limb IPC reported within the clinical literature, 
implementing limb IPC 24 h prior to a 5 km running TT.  Research suggests that there are two 
phases resulting from limb IPC; the early phase which begins soon after reperfusion and lasts 3-4 
h, whereas the late phase starts 12–24 h after limb IPC (Kuzuya et al. 1993) and last 48–72 h (Pell 
et al. 1998; Singh & Chopra 2004).  The release of endogenous substances is thought to stimulate 
post-translational modifications in proteins within the early phase, whereas in the late phase this 
leads to synthesis of new proteins and altered gene expression (Tapuria et al. 2008).  Furthermore, 
upper limb IPC confers an improvement in endothelial function in the contralateral arm 24-48 h 
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later (Hausenloy & Yellon 2008).  Accordingly, owing to the timing of pre-competition practices 
and regulations in athletic competitions (e.g., the use of pre-competition call-rooms within 20 min 
of competition starting), the late phase of limb IPC may offer another practical option, to coincide 
with competition timings to further optimise swimming performance on the day of competition.  
 
With a specific emphasis on swimming performance, limb IPC may be beneficial for 100 to 400 
m swimming performance due to the resultant increase in contribution of ATP generated from the 
aerobic system (Rodriguez & Mader 2003).  To date, three studies (Jean-St-Michel et al. 2011; 
Lisbôa et al. 2017; Marocolo et al. 2015) have identified a positive effect of implementing limb 
IPC prior to swimming performance.  For example, Jean-St-Michel et al. (2011) reported that five 
min of ischemia followed by five min of reperfusion, repeated for four cycles, implemented 45 
min prior to 100 m swimming TT improved personal best swimming times by 1.1%. Most recently, 
Lisbôa et al. (2017) applied limb IPC 1 h, 2 h and 8 h preceding a 50 m TT performance, with 
performance improvements of 1.0% and 1.2% in 2 h and 8 h conditions, respectively.  The previous 
research relating to limb IPC and swimming performance has investigated the effects of the early 
phase of limb IPC on performance as application has been <12 h prior to performance.  However, 
for short duration events (i.e. 10-90 s), a recent meta-analysis showed that a longer duration 
between limb IPC and exercise resulted in a higher effect size; suggesting that limb IPC may be 
dependent on the timing of the preconditioning strategy relative to the start of subsequent 
performance (Salvador et al. 2016).  Research is yet to investigate if the delayed phase of limb IPC 
can enhance swimming performance when applied at least 12 h prior to competition, a strategy 
which may be attractive for coaches and swimmers.  Consequently, the purpose of this study was 
to investigate the impact of limb IPC on swimming TT performance 2 h (early phase) and 24 h 
(late phase) after eliciting limb IPC in competitive swimmers. 
 
5.3 METHOD 
 
5.3.1. Experimental overview 
Twenty National and International-level swimmers participated in a randomised, crossover design 
that involved three sessions (Con, IPC-2h, IPC-24h) separated by seven days.  Timing of limb IPC 
completed in conditions were implemented in line with previous research complete by Seeger et 
al. (2017) and Lisbôa et al. (2017).  Occlusion cuffs were applied bi-laterally at the most proximal 
point of each thigh and intermittently inflated to an individualised cuff pressure determined from 
thigh girth and resting blood pressure for a total of 40 min in IPC-2h and IPC-24h.  In Con, cuffs 
were applied for the same duration (total 40 min), however cuff pressure was inflated to 15 mmHg.  
A self-selected (100 or 200 m) swimming TT (assessing total time, 50 m split times, stroke count; 
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SC, and stroke rate; SR, time underwater off starts and turns) followed intervention administration 
and physiological markers (pH, blood gases and lactate concentrations) assessed at pre-limb IPC, 
post-limb IPC, pre-TT and post-TT.    
 
5.3.2 Participants 
Following ethical approval, 18 (6 females, 12 males) National-and International-level swimmers 
(age; 20 ± 2 y, mass; 71.1 ± 9.6 kg, stature; 178.4 ± 9.6 cm, Training experience; 9.6 ± 2.7 y) 
participated in the study. All participants had qualified for and competed at British swimming 
National competitions.  Participants were informed of the experimental procedures, the purpose 
and possible risks associated with the study, and provided written informed consent before 
participation.  
 
5.3.3 Main trial procedures 
After familiarisation, participants were required to attend the testing venue on three occasions 
(Con, IPC-2h, IPC-24h) in a randomised order.  Main trials were performed in an enclosed 50 m 
swimming pool within the participants normal training environment.  To minimise the effects of 
biological rhythms, the timing of measurements was consistent between trials.  To control for 
varying levels of weekly fatigue, testing was conducted on the same day of the week in a stable, 
maintenance phase of training.  Participants were required to refrain from alcohol and intense 
physical exercise in the 24 h preceding trials and between limb IPC and swimming TT 
performance.   
 
On arrival for main trials, participants were required to rest for ten min to allow for resting blood 
pressure to be recorded (Omron Healthcare, Europe; systolic >140 mmHg and/or diastolic >90 
mmHg precluded further study involvement).  Once blood pressure was recorded, thigh girth was 
measured for determination of cuff pressure and a capillary blood sample was taken.  Occlusion 
cuffs, as detailed in section 3.4, were then applied to the most proximal point of the thighs, with 
participants assuming a supine position. Cuffs were manually inflated to either 15 mmHg (Con) or 
an individualised cuff pressure as determined in section 3.4 (IPC-2h, IPC-24h), for a total of 40 
min consisting of four cycles of five min occlusion and five min reperfusion.  The individualised 
cuff pressures ranged from 160 to 228 mmHg, whereas cuff pressure was 15 mmHg in the Con 
condition. 
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Figure 5.1: Overview of timeline of data collection. IPC – ischemic preconditioning, WU – warm up, TT – time trial, (◇) blood sample, (◼) 
ischemic preconditioning, (●) RPE 
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Following the completion of the limb IPC protocol, participants rested accordingly for 24 h or 2 
h; intense physical activity was restricted during the 24 h and all participants arrived at the 
swimming pool and rested for 3 h prior to TT regardless of the condition, cuffs were applied during 
this period for IPC-2h and Con.  A standardised race swimming warm up (40-min; Appendix E) 
was performed 1 h prior to a swimming TT as prescribed by the coaches and followed the structure 
of individuals race warm up, variance existed in warm up regarding stroke which was specific to 
the stroke being used to complete the swimming TT.  A 20-min post-warm-up rest period at the 
swimming pool replicated pre-competition call room requirements.  This was immediately 
followed by a maximal swimming TT (100 m: n=15, 200 m: n=5), completed on the participants’ 
chosen stroke, in accordance with FINA rules.  Participants completed the TT individually, starting 
from a block and taking off after an audible starting signal.   During study design it was discussed 
whether time trials were to be completed individually or in a simulated competition setting.  
However, due to randomisation of the conditions, a competition format may have resulted in 
differences in performance due to racing opponents rather than due to the effects of interventions, 
making it hard to draw conclusions of the effect of limb IPC on performance.  Rating of perceived 
exertion was recorded using the Borg (1982) scale (Appendix F) on completion of the race.  From 
the TT, SR, SC, 50 m split times, time underwater off the start and turns and total time were 
calculated retrospectively from video recordings.  Equation 1 was used to determine SR; for each 
25 m of the TT SR was calculated, the mean ± SD was then calculated for each 50 m.  To ensure 
acceptable reliability of the SR measurement, intra-observer tests were completed.  The analyst 
viewed two randomly selected TT performances ten times over a two-week period under the same 
conditions.  The CV was calculated to identify the measurement error; this resulted in a low, 
acceptable percentage of error (CV = 0.2%). 
 
Equation 4.1: Stroke rate = (Number of complete strokes over 25 m x 60) 
      (Time of hand entry 1 – time of hand entry 2) 
Where hand entry 1 is the first-hand entry at the start of 25 m and hand entry 2 is the hand entry at 
the end of 25 m, recorded in seconds.   
 
A capillary blood sample was taken pre-limb IPC, post-limb IPC, pre-TT and post-TT to measure 
pH and blood gases as specified in section 3.6.2.  The measurements were taken immediately pre 
and post; post measurements were all completed within 2 min of end of IPC and also after finishing 
swimming TT performance.  This was analysed using a portable analyser (ISTAT 1; 300G) and 
associated cartridges (CG4+; Abbott, point of care testing, Arbroath, UK) and calibrated as 
detailed in section 3.6.2.  Blood gases and pH were analysed using these methods which have 
previously been compared (Verwaerde et al. 2002) against two auto-calibrated analysers (r>0.993) 
(section 3.6.2).  
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5.3.4 Statistical analysis 
All data is presented as mean ± SD.  Following confirmation of parametric assumptions, repeated 
measures MANOVA with Bonferroni adjustment assessed between-trial differences for variables 
with multiple time points per trial (i.e. blood lactate, pH, sO2%, PO2, PCO2, HCO3 and BEecf).  
One-way ANOVA assessed between-trial differences for all performance variables from the 
swimming TT and RPE recorded post-TT.  Smallest worthwhile change was calculated according 
to Hopkins et al. (1999) in which 0.3 of the coefficient of variation (CV) gives the smallest 
important change in performance and increase chances of a medal.  0.3 of the coefficient was 
calculated for Control/IPC-2h and Control/IPC-24h and was compared to the change in 
performance between the control and both conditions.  If the change in performance was greater 
than the smallest important change calculated, it was deemed to have a smallest worthwhile 
change.  Please refer to Chapter 3, section 3.9 for more detail. 
 
5.4 RESULTS 
 
5.4.1 Physiological responses 
In the whole group, exercise significantly affected blood parameters; following swimming TT, pH 
decreased by 0.22 ± 0.08 (2.9 ± 1.1%) in all conditions (p<0.001; η2 = 0.866) and blood lactate 
increased pre-to post-TT (p<0.001; η2 = 0.923) by 12.87 ± 3.62 mmol×L-1, 12.41 ± 4.02 mmol×L-1 
and 13.27 ± 3.81 mmol×L-1 in IPC-2h, Con and IPC-24h, respectively (88-89%) (Figure 5.2).  Base 
excess, HCO3 (Figure 5.2), TCO2 (IPC-2h: -12.90 ± 3.92 mmol×L-1; Con: -11.55 ± 7.61 mmol×L-1; 
IPC-24h: 9.90 ± 8.40 mmol×L-1; p<0.001; η2 = 0.939) and sO2% (IPC-2h: -0.16 ± 1.86 %; Con: 
+0.20 ± 1.93 %; IPC-24h: +0.47 ± 2.10 %; p<0.001; η2 = 0.130) were significantly different pre-
TT to post-TT (Table 5.1).  However, there were no differences between trials in any of the blood 
parameters (p>0.05). 
 
When examining results split into 100 m and 200 m disciplines physiological responses showed 
the same responses as the group data (Table 5.1), blood parameters displayed a time response from 
swimming TT (p<0.001) but were not affected by condition (Figure 5.3). 
 
5.4.2 Performance responses 
Trial did not affect performance for 100 m (p=0.995; IPC-2h: 64.94 ± 8.33 s; IPC-24h: 64.67 ± 
8.50 s; Con: 64.94 ± 8.24 s), 200 m (p=0.405; IPC-2h: 127.70 ± 10.66 s; IPC-24h: 129.26 ± 12.99 
s; Con: 130.19 ± 10.27) or combined total time (IPC-2h: 84.27 ± 31.52 s; IPC-24h: 79.87 ± 29.72 
s; Con: 80.55 ± 31.35 s).  Combined group differences from Con to IPC-2h was 0.3 ± 2.2% and 
0.2 ± 1.4% for the difference in performance between Con and IPC-24h.  When divided into 
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distances there was no difference between Con and IPC-2h performance in 100 m (0.0 ± 1.2%) or 
between Con and IPC-24h (0.1 ± 1.1%).  Performance of 200 m TT was negatively affected by 
both IPC-2h (-0.5 ± 1.3%) and IPC-24h (-1.5 ± 2.0%).   
 
Variation in individual performance was observed as displayed in Figure 5.4; the individual 
performance differences displayed 9 participants had a smallest worthwhile change in performance 
following the use of IPC-2h (Table 5.3), with variation in change required ranging from 0.00-
0.29%.  Whereas 11 participants showed a smallest important change after completion of IPC-24h 
(Table 5.4) with a required change ranging from 0.01-0.45%. 
 
No significant effects between conditions for any of the performance variables were observed 
when analysed as a group, displayed in Table 5.2; being, split time for the first 50 m (p=0.968), 
start time (p=0.817) and turn time at 50 m (p=0.924) for instance. RPE also did not vary between 
conditions (p=0.723) or when exploring specifically for 100 m (p=0.408) and 200 m TT (p=0.260). 
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Table 5.1: Physiological responses across data collection time points, displayed for three conditions tested 
 
 IPC-2h    pH Base excess 
(mmol.l-1) 
HCO3 
(mmol.l-1) 
TCO2 
(mmol.l-1) 
sO2 (%) Blood La 
(mmol-l-1) 
RPE HR (bpm) 
 Pre-occlusion Average 7.41 0.05 24.79 25.95 94.47 1.45 
  
 
 
SD 0.01 1.31 1.38 1.39 1.61 0.46 
  
 Post occlusion Average 7.42 0.32 23.57 25.80 94.65 1.55 
  
 
 
SD 0.02 1.67 4.95 1.47 1.35 0.39 
  
 Pre TT Average 7.42 0.32 23.57 25.80 94.65 1.55 
  
 
 
SD 0.02 1.67 4.95 1.47 1.35 0.39 
  
 Post TT Average 7.20 -13.79 12.54 13.58 90.53 13.44 17.5 184.43 
 
 
SD 0.07 8.23 2.81 2.93 20.74 3.08 0.86 8.27 
 Control 
         
 Pre-occlusion Average 7.41 -0.13 23.43 24.63 94.38 1.38 
  
 
 
SD 0.02 1.54 5.09 5.62 1.71 0.44 
  
 Post occlusion Average 7.41 0.33 25.07 25.22 94.24 1.43 
  
 
 
SD 0.02 2.03 1.61 5.12 1.52 0.34 
  
 Pre TT Average 7.41 0.33 25.07 25.22 94.24 1.43 
  
 
 
SD 0.02 2.03 1.61 5.12 1.52 0.34 
  
 Post TT Average 7.19 -15.35 12.88 13.12 94.94 12.52 17.3 186.46 
 
 
SD 0.08 4.80 3.72 5.02 1.43 3.18 1.14 8.13 
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Table 5.1 Continued         
 IPC-24h 
         
 Pre-occlusion Average 7.40 -1.47 23.39 24.53 94.00 1.10 
  
 
 
SD 0.02 1.37 1.27 1.33 2.15 0.63 
  
 Post occlusion Average 7.40 -0.94 23.69 25.00 93.17 1.10 
  
 
 
SD 0.03 1.35 1.20 1.28 2.09 0.72 
  
 Pre TT Average 7.41 0.00 23.15 25.81 89.06 1.55 
  
 
 
SD 0.02 1.55 5.55 1.42 22.20 0.57 
  
 Post TT Average 7.18 -16.53 11.82 12.65 95.18 13.39 17.3 183.17 
 
 
SD 0.10 5.35 3.71 3.69 1.01 3.12 0.95 9.16 
IPC – ischemic preconditioning; TT – time trial; HCO3 – bicarbonate; TCO2 – total carbon dixoxide; sO2 % - percentage of oxygen saturation; 
 RPE – rate of perceived exertion; HR – heart rate. 
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Figure 5.2: Change in blood markers from pre-ischemic preconditioning (IPC) to post-IPC and 
Pre-time trial (TT) to post-TT. (A) Bicarbonate, (B) Base excess, (C) Blood lactate, (D) pH. * 
indicates significance difference at sampling time point (p<0.05) 
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Figure 5.3: Change in blood markers from pre-ischemic preconditioning (IPC) to post-IPC and 
Pre-time trial (TT) to post-TT for 100 m (right) and 200m (left). (A) Bicarbonate, (B) Base 
excess, (C) Blood lactate, (D) pH. * indicates significance difference at sampling time point 
(p<0.05) 
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Table 5.2: Performance variables from the swimming time trial (100 m, 200 m and combined) for the three conditions 
Condition Participants SC 50 SC 100 SR 50 (SPM) SR 100 (SPM) Start (s) Turn 50 (s) 
Con Group 19.3 ± 2.4 22.2 ± 3.2 45.3 ± 8.0 42.5 ± 7.1 4.9 ± 1.4 4.2 ± 1.6 
 100 m 19.4 ± 2.6 22.7 ± 3.2 44.6 ± 8.8 43.1 ± 7.5 5.0 ± 1.3 4.3 ± 1.6 
 200m 19.7 ± 1.5 20.5 ± 2.7 47.9 ± 4.1 40.5 ± 5.5 4.2 ± 1.8 3.9 ± 2.1 
IPC-2h Group 18.8 ± 2.6 21.3 ± 3.2 43.9 ± 8.1 42.3 ± 7.4 4.9 ± 1.4 4.2 ± 1.7 
 100m 18.9 ±2.7 22.1 ± 3.1 43.6 ± 8.9 43.0 ± 8.4 5.1 ± 1.4 4.4 ± 1.6 
 200m 18.0 ± 2.8 19.4 ± 3.2 43.4 ± 5.9 40.7 ± 5.4 4.2 ± 1.5 3.6 ± 2.0 
IPC-24h Group 18.4 ± 2.6 21.1 ± 3.7 43.4 ± 8.7 42.1 ± 6.3 5.1 ± 1.1 4.4 ± 1.7 
 100m 18.9 ± 2.3 22.3 ± 3.2 43.6 ± 9.1 44.0 ± 6.0 5.0 ± 1.2 4.3 ± 1.7 
 200m 16.8 ± 3.3 17.0 ± 1.4 42.6 ± 8.3 36.6 ± 2.8 5.4 ± 1.4 4.9 ± 1.9 
 
*SC50 - stroke count for the first 50 m; SC 100 - stroke count for the second 50 m; SR 50 - stroke rate for first 50 m; SR 100 - stroke rate  
for second 50 m; start - time from dive start to first stroke; Turn 50 - turn time at 50 m. Ninety-five-percent confidence intervals. 
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Figure 5.4: Individual responses of swimming time trial for the combined group (A), 100 m (B) 
and 200 m (C). IPC – ischemic preconditioning 
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Table 5.3: Change in results between control and ischemic preconditioning applied 2 h prior to 
performance when compared to 0.3 of the coefficient of variation to determine smallest 
worthwhile change 
 
0.3 of CV (%) Performance Con:IPC-2h (%) SWC Y/N 
0.00 0.00 N 
0.13 0.59 Y 
0.14 0.66 Y 
0.36 1.68 Y 
0.16 0.73 Y 
0.17 -0.81 N 
0.12 -0.57 N 
0.11 0.53 Y 
0.05 0.24 Y 
0.16 -0.77 N 
0.29 8.18 Y 
0.16 0.74 Y 
0.00 0.00 N 
0.06 0.00 N 
0.14 -0.68 N 
0.27 -1.26 N 
0.06 0.30 Y 
0.14 -0.64 N 
CV – coefficient of variation; Con – control; IPC – ischemic preconditioning; SWC – smallest 
worthwhile change; Y – yes; N - No 
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Table 5.4: Change in results between control and ischemic preconditioning applied 24 h prior to 
performance when compared to 0.3 of the coefficient of variation to determine smallest 
worthwhile change 
 
0.3 of CV (%) Performance Con:IPC-24h (%) SWC Y/N 
0.22 1.05 Y 
0.35 1.62 Y 
0.07 0.33 Y 
0.43 1.98 Y 
0.09 -0.44 N 
0.35 -1.68 N 
0.03 0.14 Y 
0.04 0.18 Y 
0.13 0.61 Y 
0.19 -0.9 N 
0.78 3.61 Y 
0.09 -0.44 N 
0.04 0.18 Y 
0.21 0.99 Y 
0.10 -0.47 N 
0.01 0.03 Y 
0.02 -0.11 N 
0.45 -2.16 N 
CV – coefficient of variation; Con – control; IPC – ischemic preconditioning; SWC – smallest 
worthwhile change; Y – yes; N - No 
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5.5 DISCUSSION 
 
In this study, limb IPC did not improve 100 or 200 m swimming performance in National and 
international-level swimmers when applied 2 h or 24 h prior to performance assessment.  These 
findings, particularly for IPC-2h, oppose previous research that found limb IPC applied acutely 
improved subsequent swimming performance (Jean-St-Michel et al. 2011; Lisbôa et al. 2017; 
Marocolo et al. 2015).  Consistent with previous research (Seeger et al. 2017), no change in 
swimming performance was identified when limb IPC was applied 24 h before the TT when 
reporting combined distance results.  Likewise, no differences were identified in physiological 
markers following IPC-2h or IPC-24h.  Therefore, combined results of limb IPC, applied 2 h or 24 
h, did not improve swimming performance or physiological markers. 
For short duration events (i.e. 10-90 s), a recent meta-analysis showed that a longer duration 
between limb IPC and exercise resulted in a higher effect size; suggesting that limb IPC may be 
dependent on the timing of the preconditioning strategy relative to the start of subsequent 
performance (Salvador et al. 2016).  Previous research in swimming has implemented limb IPC 
between 10 min and 8 h (Jean-St-Michel et al. 2011; Lisbôa et al. 2017; Marocolo et al. 2015) 
before performance assessment and found beneficial effects; findings which contradict those 
reported here when limb IPC was applied 2 h before exercise and furthermore the negative effect 
that was observed in the 200 m following both conditions compared to a control.  However, it 
should be considered only 5 participants completed 200 m, one of which decreased performance 
by 4% negatively skewing results.  This large variation in performance is unusual for elite athletes, 
supported by research completed by Pyne et al. (2004) in which variation in performance is 
reported to be 0.8% between competitions.  Therefore, additional unknown variables may be 
influencing this individual performance.  Within the current results variation in individual 
performance was observed as displayed in Figure 5.4; the individual performance differences 
displayed 9 participants had a smallest worthwhile change in performance following the use of 
IPC-2h (Table 5.3), with variation in change required ranging from 0.00-0.29%.  Whereas 11 
participants showed a smallest important change after completion of IPC-24h (Table 5.4) with a 
required change ranging from 0.01-0.45% when results were combined as a group.  The individual 
variation in performance, although speculative may be consequence of different training 
backgrounds in which some athletes training has focussed more aerobically or anaerobically 
affecting the impact of limb IPC or potential impact of the differences in stroke technique, however 
no patterns have been identified within the current results providing support of this.   
 
Alternatively, several methodological differences between the present study and previous literature 
may explain this lack of agreement in findings. Specifically, there is little consensus regarding 
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optimal cuff pressures used in limb IPC as different pressures have been reported (i.e., 200-230 
mmHg or 15-50>SBP) which are universally applied across all individuals within previous studies.  
This is an important consideration as the percentage of blood flow restriction may affect the 
success of limb IPC as a pre-competition strategy (Hargens et al. 1987).  A standardised cuff 
pressure may not cause the same percentage of blood flow restriction in every individual, which 
was highlighted as a limitation when completing a review of the literature and was not practical to 
apply into elite sport.  In some instances cuff pressure has been individualised according to systolic 
blood pressure as previous reports have recommended pressures to be higher than blood pressure 
(Horiuchi 2017; Pope et al. 2013), however the volume and type of tissue surrounding the blood 
vessels may influence the pressure exerted on the vasculature (Loenneke et al. 2012).    Recent 
research by Loenneke et al. (2015) recommended the use of individualised cuff pressure calculated 
from thigh girth and resting blood pressure, which was adopted in the current study.  However, 
blood flow restriction was not confirmed using a Doppler (e.g. Laurentino et al. 2008), due to 
practicality, which offers a limitation to the current study as limb IPC was individualised from 
estimated calculations rather than according to a measured pressure.  This may be an attributing 
factor to individual variation identified in performance as some participants may have experienced 
more or less blood flow restriction, consequently affecting mechanisms hypothesized to be 
beneficial to swimming performance.  Determination of the most suitable protocol for cuff pressure 
needs to be established, investigating comparisons between standardised cuff pressures, the use of 
thigh girth and blood pressure to calculate individual pressures and Doppler assessment for 
required percentage of blood flow restriction are required.  The results of these three methods to 
determine cuff pressure need to be identified and the resultant effect on performance tested to 
establish recommendations for practical use.   
 
To explain the current results, another methodological difference should be considered regarding 
the location of the cuff, with application previously reported on the lower or upper body.  The 
present study applied occlusion cuffs to the thighs which contrasts previous research in swimming 
whereby cuffs were applied to the upper body (Jean-St-Michel et al. 2011; Lisbôa et al. 2017;  
Marocolo et al. 2015).  Although limited research still exists on the working mechanism of limb 
IPC and athletic performance, it has been suggested that limb IPC induces a systemic change in 
blood flow through a change in sympathetic activity; some studies suggest a humoral hypothesis 
postulating that an ischemic event leads to the production of substances that could reach another 
tissue (Marocolo et al. 2016).  It has been hypothesized that limb IPC may have potential to 
improve exercise performance via both local effects (i.e. to the limb) and remote effects (via 
cardiovascular or nervous system).  Due to the nature of swimming and controlled breathing, which 
can result in exercise induced arterial hypoxemia, decreased pH (Craig 1986; Sharp et al. 1991) 
and consequently a significant contributor of fatigue (Noakes 2000), a systemic increase in blood 
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flow and O2 delivery could be speculated to improve performance, reducing hypoxemia and 
metabolic acidosis.  However, in the current study no differences were identified between 
conditions in the physiological measures.  Alternative research has suggested that limb IPC may 
also cause local changes in the muscle at the site of the cuff (e.g. increase O2 uptake or change in 
mitochondrial activity) which may contribute to an increase muscle oxygenation (Horiuchi et al. 
2015; Kjeld et al. 2014; Saito et al. 2004). In swimming, the contribution of propulsive force is 
approximately 90% for the upper extremities (Deschodt et al. 1999; Morouço et al. 2011), 
therefore, the local changes achieved by application of the cuffs to the upper limbs, may increase 
effectiveness of limb IPC to improve swimming performance.  In comparison to previous results, 
applying cuffs to the thighs to induce a systemic response, this may help to explain the 
inconsistency in the current results.  Consistent with the current results, Lalonde & Curnier (2014) 
reported that remote IPC on the arm did not improve exercise performance during a Wingate test.  
Whereas remote IPC on the leg has previously improved time to failure during rhythmic handgrip 
exercise (Barbosa et al. 2015).  Interestingly, despite the significant benefits in exercise tolerance, 
no differences in physiological variables, such as blood flow, vascular conductance, and muscle 
deoxygenation profiles, were observed between IPC and CON in the same study. However, no 
other studies have directly compared the effects of different locations with limb IPC on exercise 
performance; thereby, it is difficult to derive a conclusion.  Consequently, this is an area that 
warrants further investigation to determine the impact of systemic versus local blood flow 
restriction on athletic performance.  
 
To date, one study has examined the use of limb IPC applied 24 h prior to performance to determine 
if the late phase of limb IPC, originally used in a clinical setting, may also improve athletic 
performance.  The current study replicated research complete by Seeger et al. (2017) but within 
swimming, with the only other methodological difference being individualising cuff pressures.  
Similarly, no difference in performance time between conditions was identified.  However, results 
from the current study were not consistent with previous research investigating limb IPC in 
swimming, previously a benefit has been identified in the early phase (10 min – 2 h) within the 
literature which was not consistent in our study.  Additional physiological measures may have 
delineated the results to determine if limb IPC affected endothelial dysfunction (through 
measurement of FMD), as one of the predominant mechanisms influencing performance.  Limb 
IPC has shown to prevent endothelium dysfunction (Dawson et al. 2013; Bailey et al. 2012), 
increasing aerobic contribution to performance.  Considering reported aerobic contribution in 
swimming this mechanism was deemed important.  Loukogeorgakis et al. (2005) reported RIPC 
applied immediately before induced ischemia, prevented endothelial dysfunction (FMD before 
9.4% and after 8%) and also applied 24 h prior, FMD was preserved and prevented dysfunction 
(8.7% before and 8.4% after).  Due to practicality, FMD was unable to be measured and therefore 
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only speculative as to whether this mechanism was not influenced by the limb IPC protocol.  As 
suggested methodological differences could have influenced these findings as stated above 
regarding cuff pressure and location, consequently limb IPC applied 24 h prior to performance 
should be further investigated in swimming while ensuring that cuffs are applied to the upper body 
and where practically possible complete additional physiological measures to delineate why large 
individual differences occur. 
 
Limitations of the research should be acknowledged; the placebo effect is not accounted for, which 
may be an important factor as previous research has highlighted the ability of the placebo effect to 
improve performance (Cook & Beaven 2013). Within Con, cuffs were still applied which was still 
novel in comparison to lying and resting with the absence of cuffs and it is difficult to blind 
participants from the conditions due to the obvious difference in cuff pressure.  Therefore, a further 
condition would be optimal to identify the impact of vascular occlusion, determining whether there 
is a placebo or physiological effect on performance when compared against a control in which 
cuffs are absent.   
 
5.6 PRACTICAL APPLICATIONS 
 
Despite this study concluding swimming performance was not improve following limb IPC applied 
at 2 h or 24 h, there are several practical points of relevance for application in sport.  These results 
provide baseline data for the use of limb IPC in swimming when cuffs are applied to the thighs, 
identifying that this strategy had no detrimental effect on physiological responses.  Most 
prominently, the combination of previous research and the current study suggest recommendations 
for application of the cuffs to the upper body to improve swimming performance. 
 
5.7 CONCLUSION 
 
In conclusion, the current study demonstrated swimming TT performance of 100 or 200 m was not 
improved when it was preceded 2 h or 24 h by four cycles of limb IPC, at an individualized cuff 
pressure.  Speculatively, this may have been due to the difference in cuff placement on the lower 
limbs as opposed to upper limbs as in previous IPC and swimming research.  Therefore, the use of 
limb IPC 24 h prior to swimming TT performance should be investigated with cuffs applied to the 
upper limbs to identify if the late phase of limb IPC can also improve performance, as this would 
have greater practical application completing the limb IPC protocol 24 h before competition rather 
than in close proximity to the start of an athletic event. 
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Chapter 6 - The effect of lower limb occlusion on recovery following sprint 
exercise in academy rugby union players 
 
 
6.1 STUDY INFORMATION 
 
In contrast to the previous experimental chapters, the following study focuses on the use of 
vascular occlusion as a recovery strategy.  Short term fatigue resulting from athletic performance 
has been negatively linked to subsequent performance, therefore recovery is an integral part of 
training and competition.  Consequently, recovery strategies are frequently applied to increase the 
rate of recovery to optimise performance.  Many researched strategies are limited in applied 
practice due to cost, equipment and time, as a result alternative options are pursued by performance 
scientists to implement in elite sport.  As highlighted in the introduction and review of literature, 
vascular occlusion offers an alternative recovery modality, but requires further investigation prior 
to realisation in sport. 
 
Aim: Investigate the effects of vascular occlusion on recovery rate (2 h and 24 h) using 
individualised cuff pressure, on physiological and neuromuscular assessment following maximal 
sprint exercise, whilst also considering hormonal reactivity to a subsequent exercise challenge 
performed at 24 h. 
 
Objectives: 
- To determine the effect of vascular occlusion, as a recovery strategy, on physiological 
markers previously used within the literature (CK, T, C, NMF, perception muscle 
soreness) 
- To identify if vascular occlusion improves recovery time of physiological measures after 
2 h and 24 h to coincide with the timeline of second rounds of competition and/or return 
to training 
- To identify if a physical stress test performed after 24 h provides further denote if players 
are adequately recovered to return to training/preparedness for next competition 
 
Hypothesis: Application of vascular occlusion following repeated sprints to induce muscle damage 
(i.e. post exercise) would facilitate the recovery of biochemical, neuromuscular and hormonal 
markers measured after 24 h 
 
Outcomes measures: CK, T, C, PPO, perception muscle soreness and recovery 
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6.2 INTRODUCTION  
 
Physical and metabolic disturbances result from team sport match-play (Bangsbo et al. 2006).  
Accordingly, various measures are used in applied practice to indicate the presence of EIMD and 
the efficacy of recovery interventions (Ferguson et al. 2014).  Elevated CK concentrations 
(Cunniffe et al. 2011; Takarada 2003; Russell et al. 2016), disruption in the T and C hormonal 
milieu (Shearer et al. 2015), and impairments in NMF occur post-match (West et al. 2014); with 
measurements showing perturbation for at least 48 h after (Russell et al. 2016; West et al. 2014).  
The use of hormonal responses as additional surrogate markers for readiness-to-train or 
competition-preparedness is an emerging concept in the recovery paradigm to help indicate levels 
of fatigue (Crewther et al. 2017).  The reasoning for measuring hormonal response is associated 
with free T/C ratio providing a diagnostic or preventative test to detect overtraining as it gives an 
indication of the anaerobic/catabolic balance in response to training and competition, which are 
known to affect the recovery state and duration of recovery after exercise (Fry et al. 1991). 
 
As short-term fatigue after match-play has been negatively linked to subsequent performance, 
recovery strategies are an integral component in the weekly training regimen (Kellmann 2010) 
especially as multiple games are played in the week.  The post-exercise recovery effects of cold 
water immersion, contrast water therapy, active recovery, neuromuscular electrical stimulation and 
compression garments have been investigated (for review see Nédélec et al. 2013).  However, 
many of these strategies have limitations for application due to required equipment, space, time 
and cost, with literature also reporting contrasts in the effectiveness of each of these strategies.  Ice 
baths for instance decrease muscle temperature which may be negative for multiple efforts or 
games performed in one day of competition.  Also, athlete perception of recovery strategies is key, 
it is known that players’ beliefs of the efficacy of an intervention can influence subsequent 
responses (Cook & Beaven 2013) therefore knowledge of all available strategies and efficacy on 
recovery rate are important for performance scientists and achieving success of implementing 
recovery strategies to improve performance.   
 
More recently, vascular occlusion (the use of blood pressure cuffs applied on specific limbs to 
restrict blood flow) has been suggested as a recovery strategy (Beaven et al. 2012; Northey et al. 
2016; Garcia et al. 2017; Page et al. 2017; Borne et al. 2016) (section 2.6).  While the exact 
mechanisms are unclear, vascular occlusion is purported to elevate adenosine concentrations and 
activation of KATP, increasing blood flow (Goto et al. 1995) and benefiting O2 and nutrient delivery 
via vasculature dilation; a response likely exaggerated during reperfusion, possibly improving 
substrate re-synthesis (Byrne et al. 2004).  Alternatively, Konstantinov et al. (2004) showed 
diminished expression of inflammatory genes in neutrophils following limb IPC.  Since 
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neutrophils are one of the key mediators of IRI responsible for oxidative stress and injury to organs, 
modulation of neutrophil activation is important to reduce IRI.  Furthermore, attenuated 
inflammatory responses and reductions of muscle oedema and intramuscular pressure decrease 
nocioreceptor stimulation, potentially reducing muscle soreness (Howatson & van Someren 2008). 
 
Unfortunately, the evidence for vascular occlusion as an effective post-exercise recovery modality 
is currently inconsistent.  Two investigations have identified improvements in recovery (Beaven 
et al. 2012; Page et al. 2017) whereas others disagree (Garcia et al. 2017; Northey et al. 2016; 
Borne et al. 2016) (refer to section 2.6.1).  This disparity may be explained by methodological 
differences in the implementation of vascular occlusion, variance in participant activity levels and 
variability in the stimulus for EIMD.  Borne et al. (2016) applied 24 min of continual pressure 
using elastic wraps versus the intermittent application of pressure for 12 min in other studies 
showing accelerated recovery (Beaven et al. 2012).  Moreover, standardised cuff pressures have 
been used irrespective of participant characteristics despite recommendations regarding 
individualisation of cuff pressures relative to thigh girth and resting blood measurements 
(Loenneke et al. 2015).  Similarly, inconsistencies in the timing of recovery markers (1-72 h post 
occlusion) have occurred between studies.  Previous research has also required players to remain 
rested for the duration of post exercise recovery; this has limited application to applied practice 
where football or rugby players are frequently required to play multiple games within a week (i.e 
<72 h separating games) and train when complete physical recovery may not be achieved (Nédélec 
et al. 2012).  Accordingly, identification of the physiological response to a subsequent physical 
stressor may denote if players are adequately recovered to return to training.  Notably, stress 
induced hormone reactivity can provide an indication of the anabolic/catabolic balance in response 
to training and competition (Adlercreutz et al. 1986).  Specifically, T is a stress biomarker; 
consequently, the monitoring of T in response to a physical stress test could provide information 
on readiness to train/compete (Crewther & Cook 2012).  Rapid bioavailability of T and effects on 
CNS, such that human behaviour towards physical performance may be modified through acute 
perturbations (Crewther et al. 2011) has been related to increased winning (vs losing); Crewther et 
al. (2017) identified a larger T response to a mid-week stress test before winning.  Thus, the 
primary aim of the study was to investigate the effects of vascular occlusion on recovery rate (2 h 
and 24 h), using individualised cuff pressure, on physiological and performance assessment 
following maximal sprint exercise, whilst also considering hormonal reactivity to a subsequent 
exercise challenge performed at 24 h. 
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6.3 METHOD  
 
6.3.1 Experimental overview 
Within rugby union, a crossover, randomised control trial allowed for examination of vascular 
occlusion applied as a recovery strategy, after completion of repeated sprints.  The study consisted 
of two interventions, separated by seven days; Control (Con) and vascular occlusion (Recovery).  
In both conditions, a blood and saliva sample were completed along with CMJ and subjective 
ratings of recovery and muscle soreness prior to completing six 50 m sprints.  Measures were 
repeated prior to application of cuffs on the most proximal point of the thighs, and inflated to either 
15mmHg (Con) or an individualised cuff pressure (Recovery) for a total of 12 min.  At 2 h and 24 
h measures were repeated with the addition of a physical stress test performed at 24 h, after which 
an additional saliva sample was provided to assess hormone reactivity (Figure 6.1). 
 
6.3.2 Participants 
Following ethical approval and informed written consent being obtained, twenty-four male 
professional rugby union academy players (age: 21.8 ± 3.0 y, mass: 96.9 ± 10.1 kg, stature: 1.85 ± 
0.09 m) participated in the study during pre-season (1-2 sessions per day, 4-5 days a week) 
including strength, power and speed training sessions which were stable and consistent the week 
prior to and during the two weeks when trials were performed. All participants were informed of 
the experimental procedures and the purpose of the study, along with possible risks.  
 
Participants attended the testing venue on four occasions. Main trials were performed inside on a 
3G surface to minimise environmental influences (temperature 20°C; humidity 41%).  To limit 
circadian variation, measurement timings were consistent between trials and participants refrained 
from alcohol and intense physical exercise in the 24 h preceding trials.  No exercise was permitted 
between days one and two of testing.   
 
6.3.3 Main trial procedures 
On arrival for main trials, participants rested for 10 min before blood pressure was recorded 
(Omron Healthcare, Europe; systolic >140 mmHg and/or diastolic >90 mmHg precluded further 
study involvement).  Thigh girth was measured for determination of cuff pressure and 
physiological (capillary blood and saliva) and perceptual (soreness and recovery) assessments 
followed. After a 10-min standardised warm-up, participants performed two maximal effort CMJ 
separated by 90 s (portable force platform: Type 92866AA, Kistler, Germany) to assess NMF.  A 
further 10 min warm-up followed (20 m dynamic exercises and acceleration sprints, two 50 m 
sprints at 80% and 100% effort) with five min of enforced rest before six 50 m (each separated by 
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five min rest) timed sprints (Brower Timing System, Salt Lake City, Utah, USA) were performed 
to induce muscle damage (Taylor et al. 2014; Johnston et al. 2015).  This was performed as a group; 
however, participants ran separately to prevent competition influencing competition time.  
Instruction prior to both sessions explained maximal effort was required across all six sprints, no 
encouragement was provided during the sprints with coaches and participants blinded from time 
of completion to all sprints until both sessions were completed.  Average time and cumulative 
sprint times for the six sprints were recorded. 
 
Immediately post-exercise, all baseline measures were repeated (within 5 min of sprints finishing) 
before occlusion cuffs were applied to the most proximal point of the thighs while participants lay 
supine.  The cuff was manually inflated to 15 mmHg (Con), this reflects previous research (Beaven 
et al. 2012), or to 60% of individually calculated pressures (171 to 266 mmHg; Recovery), 
determined from thigh girth and blood pressure measurements (Loenneke et al. 2015) (see section 
3.3-3.5).  Cuffs were applied for a total of 12 min (two cycles of three min occlusion, three min 
reperfusion).  The rationale behind this protocol, as reported by (Beaven et al. 2012), identified 
three min cycles of occlusion and reperfusion fulfil the duration threshold criterion that has been 
reported previously (for further information see section 2.6).  After 2 h and 24 h baseline measures 
were repeated, consistent with previous research (Taylor et al. 2015; Johnston et al. 2015) and are 
representative of the time between competition and return to training. 
 
To assess hormonal reactivity to a subsequent exercise stimulus performed after 24 h, saliva was 
collected five min before and immediately after the completion of a 30-min physical stress test 
(three sets of power cleans and back squats, and four sets of bench press and bench pull at relative 
loads of 60 to 85% 1RM; one and three min rest between sets and exercises, respectively).  
Participants were accustomed to resistance exercise from their normal training and testing 
procedures and these protocols were deemed sufficient to elicit a stress response (Crewther & Cook 
2012).  Coaches supervising the sessions were not aware of the conditions participants had 
completed 24 h prior and provided technical support only.  Feedback was not provided regarding 
within-session performance. 
 
Saliva collection was completed as detailed in Chapter 3, section 3.7.  Participants provided a 20 
µL fingertip capillary blood sample for blood lactate analysis and a 120 µL sample was collected 
for analysis of CK.  Refer to Chapter 3, section 3.6.3 for details on timings, sample preparation 
and analysis. 
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Figure 6.1: Timeline of data collection. Con; control trial, Recovery; occlusion trial, RE; resistance exercise. Measurements: salivary testosterone, 
salivary cortisol (•), blood sampling for blood lactate and Creatine Kinase ( ), perception muscle soreness questionnaires (¨), countermovement 
jump (à) 
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Perceived lower body muscle soreness was assessed using a 7-point Likert scale (Appendix G) 
ranging from 0 (complete absence of soreness) to 6 (severe pain that limits movement) which is 
reliable and valid (Impellizzeri & Maffiuletti 2007).  Perception of recovery status was assessed 
using a 11-point likert scale (Appendix H) (Laurent et al. 2011) organised from 0 (very poorly 
recovered/extremely tired) to 10 (very well recovered/highly energetic) which reflects changes in 
total sprint time relative to prior exercise (Laurent et al. 2011).  Participants were familiar with the 
scales and were asked to base scores on perceived soreness during normal movement and were 
alone when recording scores to reduce the influence of peers.  Assessment of CMJ performance 
was completed on a portable force platform (Kistler instrument Ltd., Farnborough, UK), analysis 
was completed as described in section 3.8 to calculate PPO and JH. 
6.3.4 Statistical analysis 
All data is presented as mean ± SD.  Following confirmation of parametric assumptions, repeated 
measures MANOVA with Bonferroni adjustment assessed between-trial differences for variables 
with multiple time points per trial (i.e. T, C, T:C ratio, perception muscle soreness and recovery, 
CK, blood lactate, PPO and JH). A one-way ANOVA was performed to assess between-trial 
differences in response to the physical stress test (T, C, T:C ratio and perception muscle soreness).  
Paired samples t-tests were performed for between-trial comparisons of data expressed over a 
single time point within a trial (i.e. mean and total sprint times, T and C pre-and post-stress test).  
For further detail see Chapter 3, section 3.9. 
 
6.4 RESULTS 
 
There were no significant differences between conditions for total (Recovery: 39.86 ± 2.87 s; Con: 
40.26 ± 2.77 s, p=0.238) or average (Recovery: 6.69 ± 0.47 s; Con: 6.71 ± 0.46 s, p=0.674) sprint 
times.  The Δlactate concentrations from pre-to-post sprinting also showed no significant 
difference between conditions (Recovery: 6.88 ± 2.53 mmol·L-1, 85 ± 6%; Con: 6.76 ± 2.04 
mmol·L-1, 86 ± 5%, p=0.807, Figure 6.2). 
 
There was a significant time effect for CK (F(1,48)=72.928, p<0.001, Figure 6.2) with significant 
increases at 24 h compared to pre-sprints in both Recovery (408.19 ± 291.45 µ·L-1, 55 ± 33%, 
p<0.001) and Con (506.02 ± 359.14 µ·L-1, 56 ± 34% p<0.001).  However, there was no significant 
interaction effects between condition and time (F(1, 48)=1.157, p=0.293). 
 
Muscle soreness (F(2, 95)=7.714, p<0.001) and perception of recovery (F(2, 88)=70.931, p<0.001) 
were affected by sprinting, with the greatest change in muscle soreness occurring 24 h post exercise 
(Recovery: 1.5 ± 1.0; Con: 1.6 ± 1.1).  There was no significant interaction effects between time 
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and condition for muscle soreness (F(2, 95)=0.009, p=0.993) or perception of recovery (F(2, 88)=0.158, 
p=0.924). 
 
Sprint exercise affected PPO (F(2, 96)=42.141, p<0.001) and JH (F(2, 82)=58.353, p<0.001) with PPO 
(Recovery: 417.74 ± 293.09 W, 8 ± 4%, p<0.001; Con: 401.46 ± 332.69 W, 7 ± 5%, p < 0.001) 
and JH (Recovery: 5.49 ± 3.24 cm, 13 ± 7%, p<0.001; Con: 5.38 ± 3.66 cm, 13 ± 8%, p<0.001) 
decreasing immediately post-sprints.  No further timing effects and no effect of Recovery on PPO 
(F(2, 96)=0.304, p=0.757) or JH (F(2, 82)=0.304, p=0.436) occurred. 
 
Sprinting increased T (F(2, 100)=20.127, p<0.001, Figure 6.3), whilst a decrease in T, C (F(2, 
89)=32.651, p<0.001) and increase in T:C ratio (F(2, 95)=19.200, p<0.001; Figure 6.3) occurred 2 h 
post sprinting.  However, condition did not affect the recovery of T (F(2, 100)=2.159, p=0.114), C 
(F(2, 89)=0.640, p=0.531) or T:C ratio (F(2, 95)=0.299, p=0.759).   
 
Testosterone significantly changed pre-to post, in response to the physical stress test in the 
Recovery (+21.58 ± 44.90 pg·ml-1, 7 ± 17%, p=0.031) but not the Con (+10.62 ± 36.57 pg·ml-1, 4 
± 13%, p=0.178) with no differences in baseline values between conditions (p=0.232); however, 
ΔT was not significantly different between conditions (p=0.109).  Cortisol declined over time 
(F(1,46)=7.806, p<0.001), pre-to post physical stress test (Recovery: -0.14 ± 0.23 µg·dl-1, 38 ± 72%, 
p=0.007; Con: -0.17 ± 0.27 µg·dl-1, 50 ± 94%, p=0.006), with similar results for T:C ratio (F(1, 
46)=29.836, p<0.001).  Recovery had no impact on hormonal response as no differences were 
observed between conditions (T; p=0.226, C; p=0.679, T:C; p=0.421). 
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Figure 6.2: Blood markers (A) Creatine Kinase (B) Blood lactate collected pre, post, 2 h and 24 
h post sprint protocol * (p<0.001) 
 
 
 
 
 
 
 
 
 
 
 
 
 
100
200
300
400
500
600
700
800
900
1000
C
re
at
in
e 
K
in
as
e 
(µ
·L
-1
) 
0.0
2.0
4.0
6.0
8.0
10.0
12.0
Pre Post 2h 24h
B
lo
od
 L
ac
ta
te
 (m
m
ol
·l-
1 )
Time point
Recovery Control
* 
* 
 156 
 
 
(A) 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
(C) 
 
 
 
 
 
 
 
Figure 6.3: Saliva markers (A) Testosterone, (B) Cortisol (C) T/C ratio, collected pre, post, 2 h 
and 24 h post sprint * (p<0.001) 
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Figure 6.4: Neuromuscular function variables determined from countermovement jump (A) peak 
power output, (B) jump height, collected pre, post, 2 h and 24 h post sprint * (p<0.001) 
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6.5 DISCUSSION 
 
The primary aim of this study was to investigate the effects of vascular occlusion on recovery rate 
(2 h and 24 h), using individualised cuff pressures, on physiological and neuromuscular indices 
following sprint exercise, while also considering hormonal reactivity to subsequent exercise.  
Vascular occlusion did not influence the physiological or neuromuscular markers measured in the 
2 h or 24 h after sprint exercise in rugby union players.  Repeated sprints were consistent across 
both trials (Recovery: 39.84 ± 2.87; Con: 40.26 ± 2.77 s) and induced EIMD in both conditions 
reflected by the perturbations in physiological (e.g. CK, Recovery: 55 ± 33%; Con: 56 ± 34%) and 
neuromuscular (e.g. PPO, Recovery: 8 ± 4%; Con: 7 ± 5%) responses, consistent with previous 
research (refer to section 2.2.4).  Perception of muscle soreness was not different between 
conditions, sprinting increased muscle soreness 24 h post exercise.  Moreover, no significant 
differences existed in response to a physical stress test at 24 h between conditions.  Therefore, 
within the current study, vascular occlusion did not facilitate recovery following 2 h and 24 h of 
rest, nor change the hormonal response to a subsequent physical stress test.  Likewise, it is notable 
that vascular occlusion did not have a detrimental effect on any physiological or neuromuscular 
markers assessed, recovery rate was not negatively influenced in comparison to Con, thus 
alleviating any concerns of detriment using this ergogenic strategy, acutely, within season.  
 
Total (p=0.238) and average (p=0.674) sprint times were consistent between conditions with 
similar physiological responses being observed.  Johnston et al. (2015) highlighted CK values 
increased by 570 µ·L-1 (current results +506.02µ·L-1) compared to match responses, increases of 
586.6 µ·L-1 (24 h post soccer match) and 431 µ·L-1 (16 h post rugby match) have been reported.  
However, time and distance of maximal sprint completed in a match cannot be controlled and 
varies depending on position, therefore comparison against match outcome is difficult as many 
factors may influence performance on match day.  Nevertheless, previous reports suggest that six 
50 m sprints reflect normal training sessions (Francis, 2008). 
 
The current study individualised cuff pressure (171-226mmHg) as a standard pressure applied to 
different individuals may non-uniformly influence the pressure exerted on the vasculature and thus 
impact the degree of blood flow restriction.  The amount of tissue surrounding the blood vessels 
influences the pressure exerted on the vasculature and impact the degree of blood flow restriction 
(Hargens et al. 1987).  Initial investigations by Loenneke et al. (2012) suggested pressures to 
restrict blood flow of the lower body should be determined by limb circumference, supported by 
findings that thigh circumference is the biggest predictor of arterial occlusion in the lower body 
(b=0.570) (Loenneke et al. 2015).  This reinforces that pressures in the lower body should be 
 159 
individualised according to thigh size, meaning bigger thighs required greater pressures, consistent 
for both sexes. However, this research also identified brachial systolic blood pressure may be an 
additional significant predictor (b=0.231) (Loenneke et al. 2015) (see section 2.4.1), consequently 
this approach was adopted in the current study.  However, our study found no improvement in 
recovery rate which contrasts findings of Beaven et al. (2012) who identified improved recovery 
of peak power, 24 h after occlusion relative to a control trial.  Although comparable durations of 
vascular occlusion were used (i.e. two cycles of three min occlusion and three min reperfusion), a 
significant contrast was cuff pressure in which a standardised 220 mmHg was applied.  However, 
since Northey et al. (2016) replicated the occlusion protocol of Beaven et al. (2012) with 
standardised cuff pressures, and found no improvement in recovery, conclusions cannot be drawn 
regarding optimal cuff pressure for recovery protocol. Accordingly, alternative methodological 
factors must be influencing the resulting outcome of using vascular occlusion as a recovery 
modality.  For instance, cuff pressure was determined from a regression equation (Loenneke et al. 
2015) based on non-elite participants, although this protocol considers thigh girth, tissue type 
(muscle or fat) may impact the level of blood flow restriction, a variable which will be different 
between elite trained and untrained participants.  
 
An alternative and large methodological discrepancy existing between studies using occlusion for 
recovery is the training status of the participants.  Research completed by Beaven et al. (2012) 
investigated healthy, active non-sport participating males and found vascular occlusion improved 
recovery, similar in Page et al. (2017).  However, research completed by Northey et al. (2016) and 
within the current study investigated the use of vascular occlusion in well trained individuals, 
identifying no effect on recovery. This potentially suggests training status may impact upon the 
success of vascular occlusion as a recovery strategy and speculatively is supported by the 
difference in CK values reported in the current study at 24 h (Occlusion: 409 µ·L-1;  Con: 506   
µ·L-1) in contrast to results reported by Page et al. (2017) (Occlusion: 335 µ·L-1; Con: 656 µ·L-1).  
A review by Meneghel et al. (2013) indicated there is a reduction in the magnitude of indirect 
markers of muscle damage when the trained populations conduct repeated exercise sessions 
compared to untrained and/or sedentary participants (Chen et al. 2006) and Falvo et al. (2009), 
reported the magnitude of changes is small without significant differences when trained individuals 
are investigated.  Newton et al. (2008) supports this when comparing untrained to resistance trained 
men completing 6 sets of maximal eccentric exercise of 6 repetitions elbow flexors at constant 
speed.  Maximal voluntary contraction, range of motion, plasma CK and delayed onset of muscle 
soreness were measured before, immediately and 5 days after exercise.  The trained group showed 
significantly (p<0.05) smaller changes in the measured variables and faster recovery of muscle 
function when compared to the untrained group.  Even with a group of active or well-trained 
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participants, high inter-individual variability in EIMD marker responses has been found even when 
participants perform the same exercise (Damas et al. 2016).  Research suggests that the large inter-
individual variability including non-modifiable factors (ethnicity, age, and gender) could be 
responsible for most of the equivocal findings and uncertainties regarding EIMD etiology (Damas 
et al. 2016); another variable potentially explaining variation between the current study and 
previous work investigating the use of vascular occlusion for recovery.  Therefore, it may be 
important to examine the use of vascular occlusion on an individual basis as it may be a practical 
recovery option for some athletes/players and at some levels of performance. 
 
A novel aspect of this research was the response of a physical stress test as an indicator of recovery 
status and readiness-to-train following sprint exercise at 24 h. Within the literature, previous 
recovery studies have assessed response to a recovery strategy when the athlete is rested, however 
players are frequently required to return to training 24 h after a match. Therefore, hormonal 
response to a physical stress test may indicate if the players are adequately recovered and able to 
return to training.  In the current study, T increased pre-to post stress test in both conditions 
(Recovery: 21.58 ± 44.90 pg·ml-1, 7 ± 17%, p=0.031; Con: 10.62 ± 36.57 pg·ml-1, 4 ± 13 %, 
p=0.178), but ΔT was not significantly different between conditions, suggesting Recovery in 
comparison to Con had no impact on hormonal response.  Furthermore, C showed a significant 
decline from pre-to post-stress test in both the Recovery (0.14 ± 0.23 µg·dl-1, 38 ± 72%, p=0.007) 
and Con (0.17 ± 0.27 µg·dl-1, 50 ± 94%, p=0.006).  Therefore, within the current study, consistent 
with rested results, there was no difference between conditions regarding rate of recovery 
following a physical stress test. 
Limitations of the research should be acknowledged; the placebo effect is not accounted for, as 
also specified in Chapter 5, which may be an important factor as previous research has highlighted 
the ability of the placebo effect to improve performance (Cook & Beaven 2013). Within Con, cuffs 
were still applied which was still novel for the players in comparison to lying and resting with the 
absence of cuffs and it is difficult to blind participants from the conditions due to the obvious 
difference in cuff pressure.  Therefore, a further condition would be optimal to identify the impact 
of vascular occlusion, determining whether there is a placebo or physiological effect on 
performance when compared against a control in which cuffs are absent as completed by Marocolo 
et al. (2015).  Similarly, it is difficult to blind testers to conditions due to variation in cuff pressure, 
however, all testers and coaches were informed that no verbal encouragement was to be given 
during exercise (sprints, jumps, stress test).  An additional limitation lies with thigh girth 
measurements which were taken pre-sprints to reduce time from completion of sprints to applying 
occlusion cuffs (as would be completed within a practical setting).  However, previous research 
has reported the impact of exercise on interstitial fluid; plasma volume may fall ~20% with intense 
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exercise over 15 min due to fluid movement towards active muscle (Astrand et al. 1986).  
Alterations in the osmolality of skeletal myocyte cytoplasm and interstitial fluid due to local 
release of metabolic factors from skeletal muscle increase solutes in the interstitial fluid (Astrand 
et al. 1986).  Also, an increase perfusion of capillary beds in active muscles increase capillary 
hydrostatic pressure, which drives more fluid from the plasma to the interstitum (Brooks et al. 
2005).  Therefore, thigh girth may be affected and should be measured post-sprint, immediately 
prior to cuff placement to determine inflation pressure, this will ensure pressure is correctly applied 
for each individual. 
 
6.6 PRACTICAL IMPLICATIONS 
 
The current research offers practical application to coaches and performance scientists, despite 
vascular occlusion not influencing recovery time at rest or increasing readiness-to-train after 24 h.  
Physiological and performance markers were consistent across both conditions and thus alleviates 
any concerns around using this ergogenic strategy within season as there was no negative impact.  
It would be suggested to test individual response, considering previous research highlighting the 
importance of individual perception of recovery strategies on subsequent performance (Cook & 
Beaven 2013) to identify any beneficial effects for individuals considering the ease of use, low 
cost and minimal time requirement.  This is further emphasised as variables such as EIMD 
protocol, cuff pressure, duration of occlusion and training status may impact the effectiveness of 
vascular occlusion as a recovery strategy and therefore, should be tested on an individual basis to 
determine if vascular occlusion may be an effective recovery strategy to implement. 
 
6.7 CONCLUSION 
 
In conclusion, the data presented in this investigation suggest that the application of two cycles of 
three min intermittent vascular occlusion administered following maximal sprint exercise did not 
improve recovery but was also not detrimental to physiological or neuromuscular markers of 
recovery at 2 h or 24 h following rest or after a physical stress test.   
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Chapter 7 - Synthesis of findings 
 
7.1 SYNTHESIS OF FINDINGS 
 
In the following synthesis the main findings from the three experimental chapters and their 
practical application to coaches and performance scientists will be discussed in relation to the main 
themes of this thesis, acknowledging limitations, practical implications and future research prior 
to providing final conclusions.  The series of studies comprising this thesis have endeavoured to 
add to the existing body of literature concerning the use of vascular occlusion and limb IPC to 
improve elite sport performance and contributing information to performance scientists to inform 
applied practice. 
 
Pre-competition and recovery are two areas, in addition to training and competition, that 
performance scientists can implement to improve athletic performance.  Vascular occlusion/limb 
IPC are emerging strategies, providing the overriding theme of this thesis, implemented as a 
strategy to improve athletic performance through trying to optimise preparation and recovery.  
Vascular occlusion/limb IPC has been previously defined as application of cuffs to the proximal 
limbs, inflated and deflated either during exercise and rest periods respectively or for cycles of 
ischemia and reperfusion whilst lying at rest in the supine position.  The external pressure aims to 
maintain partial arterial inflow to the muscle while occluding venous return (Pope et al. 2013).  
However, the lack of specific research in elite athletes, as identified in the review of literature, 
provided difficulties applying previous research as positive effects of these strategies examined in 
a healthy population may not transfer into performance improvements in elite athletes due to 
differences in physiological responses in comparison to un-trained participants (Marocolo et al. 
2016).  The majority of research had examined healthy participants in their samples, while this 
population are more accessible and overcomes difficulties of accessing elite athletes to complete 
research into vascular occlusion and limb IPC, it is difficult to transfer a positive effect seen with 
vascular occlusion/limb IPC to elite populations due to differences in physiological responses as a 
result of training (Marocolo et al. 2016).  For example, statistically significant differences have 
been observed in systolic blood pressure and HR both before and after exercise (p<0.001) between 
trained and untrained males.  Trained athletes are able to increase their systolic blood pressure with 
relatively lower HR as compared to untrained individuals (Vandavasi & Sukumar 2016).  Also, 
unlike untrained individuals, elite athletes present only a small window for adaptation or 
improvement in performance, requiring a higher dose to generate a response in highly trained 
athletes to improve performance (Cormie et al. 2011).  Therefore, this thesis completed three 
investigations into the use of vascular occlusion/limb IPC with elite athletes to contribute to the 
body of literature and offering insight for performance scientists for practical application.  Data 
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collection was successfully completed with elite athletes in all experimental chapters as evidenced 
by competition standards, however, this inherently limited sample size and posed significant time-
pressures which precluded the addition of a third experimental condition, for instance, in Chapter 
4 examining the effect of morning exercise without vascular occlusion to replicate previous 
research in athletes would have improved conclusions and advice for performance scientists, 
however this was restricted by coaches and athletes.     
 
Alternative methodological limitations have previously impacted application in sport, specifically 
relating to research not individualising cuff pressure which is personally deemed important as 
within elite sport it is essential to individualise strategies.  Despite previous research 
acknowledging the same pressure may not restrict blood flow similarly in each individual, related 
to tissue surrounding the blood vessels.  Previous studies had implemented an occlusion protocol 
prescribing an arbitrary restrictive pressure for all participants or based on systolic blood pressure 
at rest (Fatela et al. 2016).  Recent findings however indicate that neither one of these approaches 
represented an effective strategy for controlling the magnitude of blood flow restriction in the 
lower body (Loenneke et al. 2012).  If restrictive pressures are too low, muscular responses may 
not be significantly augmented (Scott et al. 2015).  Furthermore, extremely high pressures (i.e. 
those that occlude arterial inflow during inter-set rest and/or exercise) may not enhance muscular 
development more than moderate pressures (Scott et al. 2015).  It is accepted that vascular 
occlusion pressure should be high enough to occlude venous return from the muscles, yet low 
enough to maintain arterial inflow into the muscle (Loenneke et al. 2014).  Logic therefore dictates 
that vascular occlusion should not be universally applied at an absolute pressure, but should vary 
relative to each individual (Loenneke et al. 2013).  Therefore, to ensure practical application for 
elite athletes, both male and females, this was an important area investigated in this thesis.  The 
decision to individualise cuff pressure was based on Loenneke et al. (2015) regression model 
ensuring factors of blood pressure and thigh girth were considered, which as tissue surrounding 
the vessel may impact occlusion pressure provides increased precision in comparison to blood 
pressure alone.  Furthermore, it offers a practical method to use in the field in comparison to 
Doppler measurements which would be difficult in an applied setting for performance scientists to 
complete with a squad of swimmers or rugby team, for instance.  The ranges, 147-266mmHg, 
across the experimental chapters highlight the variance between individuals and requirement for 
the protocol to acknowledge that a standard occlusion pressure may not reduce blood flow to the 
same degree in different individuals.   
 
As chapter 2 highlighted, cuff width can also impact on occlusion pressure, the same cuffs were 
utilised for all studies, enabling consistent application of occlusion pressure to the thighs in all 
experimental chapters.  Wider cuffs (11cm) were applied following research suggesting more 
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effective restricting of arterial blood flow at lower inflations (Crenshaw et al. 1988) and 
recommendations by Wernbom et al. (2006).  While an individual approach was adopted, no 
performance improvements were identified as a result of this strategy.  This may either be linked 
to the training status and small window for improvement as discussed.  However, individualisation 
was based upon Loenneke et al. (2015) which determined factors that should be accounted for 
when setting cuff pressure or level of blood flow restriction, but completed in non-elite male and 
female population (reported absence of cardiovascular or metabolic disease as criteria).  Although 
this protocol considers thigh girth, tissue type (muscle or fat) may impact on the level of blood 
flow restriction, a variable which will be different between elite trained and untrained participants.  
Hunt et al. (2016) have recently reported the degree of intramuscular pressure depends on the 
architecture features of the muscles; hypertrophied muscles have a greater thickness and volume, 
subsequently blood flow occlusion may occur at relatively lower pressures (Wernbom et al. 2006).  
Fat as opposed to muscle cross sectional area have explained most of the variance in the cuff 
pressure required to completely occlude arterial flow (Loenneke et al. 2011).  Despite attempts to 
individualise the occlusion pressures implemented in this study (Loenneke et al. 2015), there may 
have been between-participant variation in the degree of occlusion experienced during vascular 
occlusion. Variance in research on the impact of tissue composition needs to be addressed and 
research completed in trained compared to untrained participants to determine differences in 
occlusion pressures, if required.   Further research into individual factors modulating the degree of 
pressure experienced by participants in vascular occlusion will likely better inform the use of this 
ergogenic modality in an athletic environment for coaches, athletes and performance scientists.   
 
The decision for the focus on practical application for elite populations and use of vascular 
occlusion/limb IPC determined three specific research questions, implementing individualised cuff 
pressure across a range of individual and team sports.  One of the important considerations for all 
three experimental studies was to ensure that all interventions could feasibly be implemented into 
real-world competition settings. Therefore these were established in accordance to the models 
proposed by Jones et al. (2017) and Coutts (2016) in which models have been proposed to 
undertake and integrate research within practice: 
i. Investigate the use of vascular occlusion combined with resistance exercise in the morning 
(5 h prior) as a priming strategy to improve afternoon strength and power performance 
including identifying hormone responses and differences in responses between sexes 
(Chapter 4) 
ii. Investigate the use of limb IPC applied in the early (2 h) and late phase (24 h) on swimming 
performance (Chapter 5) 
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iii. Investigate the use of vascular occlusion as a recovery strategy following sprint exercise 
in team sports (Chapter 6) 
 
When considering findings of Chapter 4, AM exercise with vascular occlusion had no statistically 
significant effect on PM performance, but a decline in salivary T concentration over the 5 h period 
was attenuated (Con: -23.6 ± 19.9%; RE+VO: -5.8 ± 22.1%), with significant increases in T post 
exercise (10.7 ± 21.5%).  Regarding acute T response, previous research has discussed the 
requirement of high intensity and volume thresholds to be reached in order to achieve a hormone 
(T) response with examples from Ratamess et al. (2005) suggesting 6x10 repetitions but not 1x10 
resulted in a T response.  This has been linked to the metabolic accumulation required to induce a 
T response.  Consequently, previous research implementing morning exercise to influence 
afternoon T and performance have implemented high volumes of resistance exercise (e.g. 5x10 
bench press; Russell et al 2015), however, this lacks practicality for completion the day of 
competition especially for particular sports such as weightlifting.  The use of combining resistance 
exercise and vascular occlusion was hypothesized to attentuate the circadian decline in T, due to 
mechanisms associated with increased metabolic accumulation, the result of decreased venous 
outflow and consequently increasing hormone response with a  lower volume and intensity of 
resistance exercise, which was achieved.  As maximal exercise elicits a rapid endocrine response 
that normally relates to exercise intensity (Buśko & Opaszowski 2005), and correlations between 
blood lactate and T changes exist following heavy resistance exercise (Kraemer et al. 1991), a 
direct stimulatory effect of lactate may lead to increased release of T (Lu et al. 1997).  Notably, 
the 78.9 ± 13.6% increase in blood lactate concentrations that occurred immediately after RE+VO 
exposure, when the whole group was analysed, correlated positively (r=0.559) with ΔT 
concentrations in chapter 4.  Such findings corroborate the use of vascular occlusion combined 
with resistance exercise to be used as a method to immediately increase and also attenuate the 
decline in T from AM to PM in elite athletes. 
 
A novel aspect of this study investigated the female response to AM exercise and hormonal 
priming.  A large portion of research into the effect of T concentrations in response to exercise has 
been completed in males as discussed in Chapter 2 and 4 in which it was highlighted results are 
not consistent between males and females.  Within the current thesis, female T response followed 
a similar pattern to males and combined group results; a decrease of 17.2 ± 21.1% was displayed 
in the control from AM to PM whereas morning exercise attenuated this decline to 1.6 ± 25.5% 
within RE+VO. Similarly, females also showed an acute increase in T response (8.3 ± 17.5%) to 
exercise with vascular occlusion, which is comparable to the increase seen in male participants 
(13.6 ± 26.3%).  The aforementioned studies investigated females that were active, however 
research complete by Cook et al. (2012) identified baseline measures of T were significantly higher 
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at weekly time points over 12 weeks in elite (international level athletes) (87 pg·ml-1) than non-
elite (national level athletes) (41 pg·ml-1) female athletes.  This may support the results of this 
study as the average baseline for females involved was 97.92 ± 24.46 pg·ml-1.  The results highlight 
a similar circadian decline from AM to PM, and the use of morning exercise can attenuate this 
decline in T in elite female athletes. 
 
Despite RE+VO reducing the circadian decline in T, across all groups, no PM performance effects 
were observed for CMJ or IMTP; findings which contradict previous work (Russell et al. 2015; 
Cook et al. 2014).  Results were similar in performance change between all groups, except the 
improvement in IMTP peak force was greater in weightlifting only athletes (3.2 ± 7.7%).  Previous 
research has suggested baseline strength and power may determine responsive properties, for 
example, a significant effect of baseline strength on the relationship between T and squat 
performance has been observed; T correlated to squat performance (r=0.92) in strong participants 
compared to weaker counterparts (r=0.35) (Crewther et al. 2012).  The expression of force and 
power may be dependent on individual variation in salivary free T concentration and/or existing 
strength and power levels (Crewther et al. 2012) which may support that weightlifting athletes 
have increased baseline strength and power compared to field athletics and thus this group alone 
showed (although not significant) a greater improved PM performance in a test specific to their 
competition performance.  The relationship between baseline strength and responsive properties 
of T may also explain the individual variation observed in results, especially of the IMTP in which 
13 out of 22 subjects improved peak force (2 to 17%).   
 
Alternatively, individual variation in factors associated with the efficacy of RE+VO, such as the 
balance between muscle activation and fatigue (contractile/metabolic impairment), may have 
contributed to such findings.   Vascular occlusion with resistance exercise implicates greater 
muscular activation to maintain the same total work output (Takarada et al. 2000; Takarada et al. 
2002; Yasuda et al. 2008; Fahs et al. 2015) and additional motor unit activity and enhanced 
recruitment of type II motor units (Moore et al. 2004)  is required to maintain force levels following 
resistance exercise combined with vascular occlusion (Fatela et al. 2016).  Also the level of 
vascular occlusion will influence hemodynamic signals, O2 and nutrient delivery and the 
accumulation and clearance rate of local metabolic by-products during exercise (Takarada et al. 
2000; Karabulut et al. 2011) therefore ensuring an equal and appropriate level of vascular occlusion 
between participants is important to achieve consistent gains.  Implementation of Doppler 
ultrasound measurements would increase control over the level of vascular occlusion and ensure 
specificity for each individual but may not be practical to use within the field.  Despite our attempts 
to individualise occlusion pressures there may have been between-participant variation in the 
degree of occlusion, muscle activation and fatigue experienced.  Therefore, further research is 
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required to identify individual factors that contribute to the optimisation of resistance exercise with 
vascular occlusion for use prior to subsequent exercise whether implemented immediately or 5 h 
before. At present, performance scientists should trial this individually with athletes, consequently, 
response will be directly applicable to individual athletes and should be practiced ensuring 
tolerance of vascular occlusion to enhance performance, adjustment of volume and intensity for 
individuals can therefore be completed as required to ensure the balance between muscle activation 
(and hormone response) and fatigue are achieved.  
 
Despite providing a novel insight into the use of AM resistance exercise combined with vascular 
occlusion on PM performance in elite athletes, several experimental limitations are acknowledged.  
The study design limits conclusions which can be drawn from the results; a traditional 
experimental study design was completed; however, this inherently prevents identification of the 
combined effect of resistance exercise and vascular occlusion attenuating the decline in T.  Only 
from previous research recommending the requirement for volume/intensity threshold to be 
achieved to increase T, and previous morning exercise results, can speculations be made; however, 
it cannot be inferred if occlusion was responsible for the T response.  The addition of a non-
occluded AM resistance exercise-only trial would have allowed further delineation of the effects 
of AM resistance exercise with vascular occlusion on physiological and performance responses. 
This study did not identify short term performance response following vascular occlusion and 
resistance exercise as the focus was to look at exercise priming, due to increased practical 
application for the sports and athletes involved.  However, further application may identify 
immediate performance response, considering previously reported increased muscle activation 
with this strategy (Fatela et al. 2016).  Further investigation of muscle activation in response to 
exercise with vascular occlusion, in elite athletes, may inform potential application of this strategy 
to be performed in sport where opportunity exists to complete immediately prior to performance.  
Finally, it would have been relevant due to the focus on practical application to determine smallest 
worthwhile enhancement in performance.  Ideally it would have been preferred for participants to 
complete CMJ and IMTP due to reliability of measures followed by performance measures specific 
to competition i.e. weightlifting to complete maximal snatch.  However, due to the phase of 
training coaches and athletes were reluctant to lift 100% of maximal effort both due to risk of 
injury and psychological impact.  Changes in performance between control and RE+VO could 
have been contrasted to the percentage differences between competitions to determine if the 
improvement was greater than the variation observed and consequently deemed if a worthwhile 
enhancement was achieved according to Hopkins et al. (1999). 
 
Findings of Chapter 5 suggest swimming performance was not improved by limb IPC when 
applied 2 h or 24 h prior to performance.  Additionally, no influence either positive or negative 
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was observed on physiological markers examined.  The results at 2 h oppose previous research 
that found limb IPC acutely improved swimming performance (Jean-St-Michel et al. 2011; 
Marocolo et al. 2015; Lisbôa et al. 2017).  However, consistent with previous research (Seeger et 
al. 2017), no change in combined swimming performance was observed when limb IPC was 
applied 24 h prior to the time trial (+0.2 ± 1.4%).  Furthermore, the negative effect that was 
observed in the 200 m following both conditions compared to a control contrasted previous results.  
However, it should be considered only 5 participants completed 200 m, one of which decreased 
performance by 4%, negatively skewing results.  This large variation in performance is unusual 
for elite athletes, supported by research completed by Pyne et al. (2004) in which variation in 
performance is reported to be 0.8% between competitions.  Therefore, additional unknown 
variables may be influencing individual performance observed.  Calculation of smallest 
worthwhile change revealed 9 participants had a smallest worthwhile change in performance 
following the use of IPC-2h, with variation in change required ranging from 0.00-0.29%.  Whereas 
11 participants showed a smallest important change after completion of IPC-24h with a required 
change ranging from 0.01-0.45% when results were combined as a group.  Within the current 
results the individual variation in performance, although speculative may be consequence of 
different training backgrounds in which some athletes training has focussed more aerobically or 
anaerobically affecting energy system contribution during TT performance and the impact of limb 
IPC, or potential impact of the differences in stroke technique, however no patterns have been 
identified within the current results providing support of this.   
 
Alternatively to individual responses to limb IPC, disparity in results might be explained by 
considering location of the cuff in comparison to previous research.  Within this thesis, cuffs were 
applied to the thighs following evidence of a systemic change in blood flow.  However, no 
differences between conditions were identified regarding physiological measures.  Alternative 
research has suggested limb IPC may cause local changes in the muscle at the site of the cuff 
(Horiuchi et al. 2015; Kjeld et al. 2014).  As discussed in Chapter 5, in swimming, the contribution 
of propulsive force is approximately 90% for the upper extremities (Deschodt et al. 1999; Morouço 
et al. 2011) therefore the local changes achieved by application of the cuffs to the upper limbs may 
increase effectiveness of limb IPC to improve swimming performance rather than a systemic 
response due to the large emphasis required on the upper body. 
 
To date, only one study had examined the use of limb IPC 24 h prior to performance to identify 
the impact of the late phase on subsequent performance.  Results of the current study were 
consistent with this, however, acknowledging previous methodological limitations of these 
findings, application of cuffs on the thighs rather than upper body may have affected these results.  
Future research is recommended to apply cuffs to the upper body and implement limb IPC 24 h 
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prior to performance due to the practical application of this strategy in elite sport.  Additional 
physiological measures may have delineated the results to determine if limb IPC affected 
endothelial dysfunction (through measurement of FMD), as one of the predominant mechanisms 
influencing performance.  Limb IPC has shown to prevent endothelium dysfunction (Dawson et 
al. 2013; Bailey et al. 2012), increasing aerobic contribution to performance and giving a greater 
understanding to enable application.  For instance, both FMD and NIRS have previously been 
investigated as measures to examine physiological responses associated with limb IPC (outlined 
in section 2.5.4). Practical implications of measuring FMD and NIRS in a swimming environment 
provided difficulty, but furthermore, due to working with elite athletes, although a strength and 
focus of this thesis, restricted access and time available to complete the investigations.  Both 
athletes and coaches requested limited disruption and minimal time distracted from training; this 
was achieved but inherently limited time for data collection.  
 
Practically, the results provide baseline data for use of limb IPC in swimming when investigated 
with well-trained to elite athletes.  In comparison to previous research, this study identifies 
swimming performance may only benefit when cuffs are applied to the upper body to achieve local 
adaptations rather than on the thighs where a systemic response would be anticipated.  Limitations 
of the research were acknowledged; the placebo effect is not accounted for, which may be an 
important factor as previous research has highlighted the ability of the placebo effect to improve 
performance (Cook & Beaven 2013). A further condition would be optimal to identify the impact 
of vascular occlusion, determining whether there is a placebo or physiological effect on 
performance when compared against a control in which cuffs are absent.  While separate analyses 
of the male and female results would have been preferable, the limited number of swimmers 
available within the experimental investigation did not permit this.  
Of interest, both chapter 4 and 5 included male and female participants, whereas the majority of 
previous research in IPC and sport performance has focussed on male only participants, with the 
exceptions of Gibson et al. (2013) who identified no improvement in performance in males and 
females and Paradis-Deschênes et al. (2017) which is the only study to really investigate if 
differences in gender exist between the effect of IPC on sport performance.  Within clinical 
literature, Abete et al. (2011) reported IPC is effective for younger but not aged hearts, supported 
by further research proposing that post ischemic functional recovery and infarct size (in rabbits) 
are affected by age but not by gender (McCully et al. 2006), providing initial suggestions that IPC 
may be more effective in some populations than others.  However, it has also been noted that 
females appear to display smaller clinical benefits compared with male counterparts.  In a cohort 
of 382 participants, failure to induce preconditioning effects during percutaneous coronary 
intervention was observed in females (Laskey & Beach 2003), speculated to be due to the innate, 
multiple, protective actions of estrogen (Pitcher et al. 2005).  Additionally, in a sporting context, 
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females have been reported to exhibit less fatigue than males during intense exercise (Parker et al. 
2007; Hunter 2016) but not under conditions of ischemia (Russ & Kent-Braun 2003) suggesting 
that muscle perfusion and oxygenation may be involved in sex-related differences.  Females 
exhibit greater vasodilation in the limbs during single knee extensions (Parker et al. 2007) and 
greater capacity for utilising oxidative metabolism than males (Kent-Braun et al. 2002).  Thus, 
females exhibit a greater reliance on oxidative metabolism compared with males, which could 
challenge the ergogenic impact of IPC (Paradis-Deschênes et al. 2017).  This is indeed supported 
by the findings of Paradis-Deschênes et al. (2017) in which limb IPC improved physical 
performance in strength-trained males through improved O2 delivery and utilisation in comparison 
to female counterparts during repeated, maximal efforts of knee extension exercise.  Results 
showed IPC increased total muscular force in males only (13.0%) and this change was greater than 
in females (10.4% difference).  IPC also induced different changes between sexes for average 
muscle O2 uptake, for example set 2: males 6.4%; females -16.7% and set 5: males 10.2%; females 
-40.4%, despite similar increases in muscle blood volume at rest and during recovery between sets 
of both sexes.  The initial IPC-induced increase in O2 delivery was also similar between sexes.   
The difference in response between sexes does not explain results of chapter 4 as no differences in 
performance were observed when males and females were analysed separately.  However, this 
may be explained by a single effort being performed in comparison to the repeated maximal efforts 
described in the study by Paradis-Deschênes et al. (2017) or consequence of different mechanisms 
underpinning performance when vascular occlusion is combined with exercise.  Opposing this, the 
difference in response between genders may explain some of the individual variations observed in 
chapter 5.  As highlighted, the split in male/female participants did not allow for separate analyses 
to be completed, however within swimming a decrease in O2 delivery could be detrimental to 
performance.  The physiological mechanisms required for performance of five sets of five maximal 
knee extensions will contrast to 100 and 200 m swimming and therefore results cannot be extracted 
from the study and applied to the current results.  However, this does highlight an important area 
for future research, identifying the difference in physiological response and performance between 
sexes if limb IPC is being considered for application in elite sport by performance scientists. 
 
Chapter 6 investigated the use of vascular occlusion as a recovery strategy in contrast to the 
previous two chapters examining its use as a pre-competition strategy.  Vascular occlusion applied 
as a recovery strategy did not influence any physiological or neuromuscular markers measured in 
the 2 h or 24 h after sprint exercise in professional academy rugby union players.  Moreover, no 
significant differences existed in hormone response to a physical stress test at 24 h, between 
conditions.  However, it is notable there was no detrimental effect on physiological or 
neuromuscular markers assessed, alleviating any concerns of impairment when using this strategy.  
The current study replicated the study design by Beaven et al. (2012), however our results oppose 
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those previously identified, where improved recovery of peak power, 24 h after occlusion (relative 
to a control) was observed.  Individualisation of cuff pressure was one methodological difference 
which may explain variability in results.  However as stated in Chapter 6, Northey et al. (2016) 
replicated the study by Beaven et al. (2012), including cuff pressure, and also found contrasting 
results.  Thus, training status of participants offered further explanation as discussed in chapter 6; 
variation in CK response between the current study and Page et al. (2017).  A review by Meneghel 
et al. (2013) indicated there is a reduction in the magnitude of indirect markers of muscle damage 
when the trained populations conduct repeated exercise sessions compared to untrained and/or 
sedentary participants (Chen et al. 2006).  Newton et al. (2008) supports this, the trained group 
showed significantly (p<0.05) smaller changes in the measured variables (MVC, CK and delayed 
onset muscle soreness) and faster recovery of muscle function when compared to the untrained 
group.  Research by Beaven et al. (2012) investigated healthy, non-sport participating males and 
found vascular occlusion improved recovery.  However, the current study, with focus on elite 
athletes, and Northey et al. (2016) both investigated the use of vascular occlusion for recovery in 
well trained athletes, suggesting training status may impact upon the success of this strategy. 
 
A novel approach to assess recovery following EIMD involved assessment of hormone response 
following the completion of a physical stress test to provide an indicator of readiness-to-train.  
Again, acknowledging the practical application for elite sport as a focus of this thesis, players are 
frequently required to return to training 24 h after a match.  Consequently, hormonal response to a 
physical stress test may indicate if players are adequately recovered and can return to training 
following research suggesting T is a stress biomarker and identified relationships between T 
concentration in response to a mid-week stress test and match outcome (Crewther et al. 2017).  
However, T increased pre-to post stress test in both conditions (Recovery: 21.58 ± 44.90 pg·ml-1, 
7 ± 17%, p=0.031; Con: 10.62 ± 36.57 pg·ml-1, 4 ± 13 %, p=0.178), but ΔT was not significantly 
different between conditions, suggesting Recovery in comparison to Con had no impact on 
hormonal response.  Further research is required into the application of vascular occlusion as a 
recovery strategy for elite athletes, determination of an optimal protocol is required.  However, 
performance scientists can be confident there are no detrimental effects on physiological and 
neuromuscular markers and can therefore be trialled with individuals to examine impact on 
recovery and subsequent performance.  Further research is required on the use of hormone response 
to a physical stress test as an indicator of recovery status and readiness to train. 
 
7.2 FUTURE RESEARCH 
Despite no improvements identified in athletic performance, the experimental chapters highlight 
key areas for future research to enable application in elite sport of vascular occlusion/limb IPC: 
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- Determination of cuff pressure in elite athletes, determining an optimal protocol with 
associated physiological and performance responses 
- Application of vascular occlusion with resistance exercise to increase muscle activation 
applied immediately prior to athletic performance 
- Replicate chapter 5, applying cuffs to the upper body to examine the late phase (24 h) of 
IPC on swimming performance 
- Determine a protocol for recovery regarding optimal cycles and length of occlusion 
- Determine physiological mechanisms causing variation in response between individuals 
to explain differences in performance 
- Further investigate the use of a physical stress test and hormone response as an indicator 
of readiness-to-train and success of a recovery strategy 
 
7.3 SUMMARY OF PRACTICAL IMPLICATIONS 
 
Summary of practical implications from experimental chapters: 
- Performance scientists, coaches and athletes can be confident vascular occlusion/IPC has 
no detrimental effect on physiological or performance measures when used as a pre-
competition or recovery strategy 
- Vascular occlusion combined with resistance exercise can increase T concentrations post 
exercise and reduce the decline over a 5 h period, found in both male and female athletes 
- Tolerance of vascular occlusion with resistance exercise should be trialled to optimise the 
balance between activation and fatigue in individuals 
- Variables such as cuff pressure, duration of occlusion and training status may be impacting 
effectiveness of vascular occlusion as a pre-competition or recovery strategy 
- Performance Scientists should be aware of the current limitations determining cuff 
pressure and individual responses associated with pre-competition strategies, individually 
monitoring athletes could identify those that have a positive response to using these 
strategies to implement as part of competition preparation or recovery. 
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7.4 CONCLUSION 
 
In conclusion, this thesis has successfully examined the use of vascular occlusion/limb IPC as a 
pre-competition and recovery strategy within elite athletes.  It is difficult to generalise and apply 
results from a healthy, untrained population into elite sport and therefore this thesis has discovered 
elite athletes’ response to vascular occlusion combined with resistance exercise, limb IPC and 
vascular occlusion for recovery.  Despite no performance improvements identified, more 
importantly this thesis has addressed some of the practical limitations of applying pre-determined 
protocols in sport and offered alternative protocols to be applied across a range of sports 
(strength/power, anaerobic, team sports) in areas which have not previously been investigated and 
provide clear practical implications and future research required to inform coaches and 
performance scientists how to effectively implement this ergogenic strategy to improve subsequent 
athletic performance, some of which are already being investigated and applied within the Welsh 
Institute of sport. 
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Appendix B: Participant information sheet 
 
 
 
 
Applied Sports Technology Exercise and Medicine Research Centre (A-STEM) 
Sport and Health Portfolio, College of Engineering 
 
 
 
 
 
 
 
PARTICIPANT INFORMATION SHEET 
(Version 1.1, Date: ) 
 
 
       
Project Title: 
The effect of morning exercise with and without occlusion on afternoon performance in elite athletes  
Contact Details: 
Miss Natalie Williams;  
 
1. Invitation Paragraph 
We would like to invite you to volunteer for this study that aims to identify if the use of exercise 
and exercise with blood flow restriction will help with physiological preparation and readiness 
for competition performance.  The study will be beneficial to you, aiming to improve performance 
as assessed through a countermovement jump and isometric mid-thigh pull that can be 
transferred into competition.  We would like to thank you for taking the time to read this 
information sheet and very much hope you decide to take part. 
 
2. What is the purpose of the study? 
The purpose of the study is to identify if the use of morning exercise both with and without blood 
flow occlusion, can be used as a pre-competition strategy to benefit your afternoon performance. 
 
3. Why have I been chosen?? 
You have been chosen to complete this study based upon the level and experience of competition 
performance, combined with your previous training history.  You will have the right to withdraw 
from the study at any time, without having to provide reasoning. 
 
4. What will happen to me if I take part? 
You will be required to attend 4 sessions; the sessions will require you to perform 4 conditions.  
These conditions involve morning exercise at 3RM, morning exercise combined with blood flow 
occlusion and occlusion only without exercise.  The first two conditions require you to complete 
maximal effort CMJ and isometric mid-thigh pull (IMTP), therefore participating in strenuous 
exercise. Several measures will be taken during the session including saliva samples, capillary 
blood samples, O2 saturation and blood pressure.  The exercise and occlusion will be performed 
in the morning and you will then be requested to return 4-6h post to complete the CMJ and IMTP. 
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5. What are the possible disadvantages of taking part? 
There are possible risks of the study.  Firstly, blood samples and saliva will be collected.  
Procedures of how both will be collected will be explained to you prior to taking the blood and 
saliva and you will have the right to withdraw at any stage.  The blood flow occlusion through use 
of blood pressure cuffs may cause discomfort, therefore you will be given the option not to 
participate if you are not comfortable and likewise have the right to withdraw if you experience 
any pain or discomfort such as light-headedness and nausea during the study.  You will also be 
expected to participate in strenuous exercise that may cause some slight discomfort, but should 
not be any different from your normal training and competition. 
 
6. What are the possible benefits of taking part? 
As a result of participating, you will gain valuable information on potential pre-competition 
strategies that can be used prior to competing and may be beneficial to your performance. 
 
7. Will my taking part in the study be kept confidential? 
All data will be kept confidential and results will not be accessible to anyone else, only the 
research team will have access to the information.  At the end of the study all data will be 
disposed of according to set guidelines. 
 
8. What if I have any questions? 
If you have any questions throughout the duration of this study, please do not hesitate to ask – 
contact details for the researcher are provided at the start of this document. 
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Applied Sports Technology Exercise and Medicine Research Centre (A-STEM) 
Sport and Health Portfolio, College of Engineering 
 
PARTICIPANT INFORMATION SHEET 
(Version 1.1: Date:) 
 
 
       
Project Title: 
The effect of early versus delayed IPC on swimming performance  
Contact Details: 
Miss Natalie Williams;  
 
1. Invitation Paragraph 
We would like to invite you to volunteer for this study that aims to measure response to 
a pre-competition strategy, aiming to improve swimming performance. As a swimmer, 
you will have the opportunity to try a pre-competition strategy called ischemic 
preconditioning, testing it at different time points before completing a 100 or 200m 
stroke specific time trial (TT).  We would like to thank you for taking the time to read this 
information sheet and very much hope you decide to take part. 
 
2. What is the purpose of the study? 
The purpose of the study is to monitor your response to a pre-competition strategy called ischemic 
preconditioning (IPC) and see how it affects your performance when it is used at different time points 
before a swimming time trial performance. 
 
3. Why have I been chosen? 
You have been chosen to complete this study based upon the level and experience of 
competition performance, combined with your previous training history.  You will have 
the right to withdraw from the study at any time, without having to provide reasoning. 
All information collected will be anonymous to practitioners and coaches and therefore 
your decision to participate or withdraw will not affect future squad/competition 
selection or access to sport science and coaching support.  
 
4. What will happen to me if I take part? 
Ischemic preconditioning involves the use of inflatable cuffs being wrapped around 
your thighs and being inflated and deflated.  Specifically, for this monitoring you will be 
required to complete 3 sessions, these will involve 2 trials when the cuffs are applied 
and inflated 2 h before a swimming time trial, the other session will involve having cuffs 
applied and inflated 24 h before a swimming time trial. 
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Once the cuffs are wrapped around your thighs, you will be asked to lie down and the 
cuffs will be inflated for 5 min and deflated for 5 min, repeated a total of 4 times (total 
time lying down will be 40 minutes). 
You will then be asked to rest according to the condition being complete (2h or 24h); 1 
h before swimming time trial, you will be asked to complete a swimming warm up, 
followed by 20 min rest.  A maximal effort swimming time trial (100 or 200 m stroke 
specific) will immediately follow and will be complete individually.  Your time trial will 
be videoed to allow for your stroke rate, stroke length, split times, time and distance 
underwater off the start and turns and total time to be recorded. 
No exercise is to be complete 24 h prior to testing and rest between the completion of 
cuff inflations and swimming time trial. 
 
Measures that you will be asked to complete, please note you can choose to opt out of 
any of these if you are not comfortable, however please be aware opting out of blood 
pressure measurement will prevent participation. 
 
Blood Pressure at rest – you will be asked to rest for 10 min.  Following this the 
procedure will be explained to you, including making you aware that there may be a 
tight feeling and very minor discomfort.  You will be asked to take a seat with the arm 
at heart level. You will be asked to have your feet on the floor, uncrossed and your back 
will be supported in the chair.  Once in this position, the cuff size will be checked and 
wrapped around your upper arm.  A blood pressure monitor will be used to measure 
your blood pressure.   
 
Capillary blood sample - Prior to any sample being taken you will be asked to be seated, 
the procedure will be explained to you and confirm you are happy to proceed.  The area 
of the finger will be cleaned with an alcohol wipe before a capillary blood sample is 
taken from your finger, a single use lancet will be used to puncture the tip of the finger 
in which a blood sample will be collected from.   
 
Heart Rate (HR) – this will be recorded using a polar heart rate monitor.  You will be 
asked to rest for 10min on arrival to record baseline HR and will be monitored and data 
collected throughout the whole session.   
 
You will also be asked your rating of perceived exertion on completion of the swimming 
time trial. 
 
5. What are the possible disadvantages of taking part? 
There are some possible disadvantages of taking part.  Firstly, capillary blood (from your 
finger) will be taken.  Procedures of how blood will be collected will be explained to you 
prior to taking any samples and you will have the right to withdraw at any time.  You may 
experience some discomfort from the cuffs such as pain, pins and needles and light 
headiness.  This will be explained to you before cuffs are wrapped around your legs 
inflated and you will be asked to let the researcher know immediately if you feel any 
symptoms when cuffs are inflated, researchers will continue to ask you throughout the 
protocol as well. If any symptoms are experienced the cuffs will be deflated and removed 
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immediately.  You will also be expected to participate in strenuous exercise, completing 
3 swimming time trials in total.  
 
6. What are the possible benefits of taking part? 
Because of participating, you will gain valuable information on a pre-competition strategy 
that may potentially improve performance.  
 
7. Will my taking part in the study be kept confidential? 
All data will be kept confidential and results will not be accessible to anyone else. You 
and your coach (Mark Rose or Mark Skimming) will receive group average results. At 
the end of the study all data will be disposed of after 5 years.  
 
8. What if I have any questions? 
If you have any questions throughout the duration of this study, please do not hesitate 
to ask – contact details for the researcher are provided at the start of this document. 
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Applied Sports Technology Exercise and Medicine Research Centre (A-STEM) 
Sport and Health Portfolio, College of Engineering 
 
 
 
 
 
 
 
PARTICIPANT INFORMATION SHEET 
(Version 1.1, Date:) 
 
       
Project Title: 
The use of intermittent lower-limb occlusion to enhance recovery after repeated sprint running 
performance 
Contact Details: 
Miss Natalie Williams;  
 
1. Invitation Paragraph 
We would like to invite you to volunteer for this study that aims to identify if the use of blood 
flow restriction, also termed occlusion, assists with recovery after completing repeated sprints.  
The study will be beneficial to you, aiming to improve your recovery as assessed through a 
countermovement jump and specific blood markers that indicate recovery following strenuous 
exercise.  We would like to thank you for taking the time to read this information sheet and very 
much hope you decide to take part. 
 
2. What is the purpose of the study? 
The purpose of the study is to identify if the use of blood flow occlusion can increase your 
recovery, to be used after training and/or competition to prepare for the next bout of exercise. 
 
3. Why have I been chosen?? 
You have been chosen to complete this study based upon the level and experience of 
competition performance, combined with your previous training history.  You will have the right 
to withdraw from the study at any time, without having to provide reasoning. All information 
collected will be anonymous to Sport Wales practitioners and coaches and therefore your 
decision to participate or withdraw will not affect future squad/competition selection or access 
to sport science support.  
 
4. What will happen to me if I take part? 
You will be required to attend 2 sessions; the sessions will require you to complete 2 
conditions.  Both conditions will involve providing baseline measures including saliva and 
capillary blood samples and completing maximal effort countermovement jump.  A repeated 
sprint protocol (15x30m) will then be complete prior to you being asked to lie down for 12 min 
and have blood pressure cuffs applied to the highest point of your thigh.  This will be inflated to 
15 mmHg or an individualized cuff pressure alternating between each leg for 3 min; the cycle 
will be repeated twice for a total of 12 min (total 6 min for each leg).  The cuffs will contain a 
pneumatic bag along its inner surface that is connected to a pressure gauge that will be 
manually inflated.  Following this baseline measures will be repeated again 2, 24 and 48 h post 
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cessation of exercise. Below provides you with information on the procedures involved in the 
measures being collected. 
 
 
Blood Pressure – this will be complete in a private room, you will be asked to rest for 10 min.  
Following this the procedure will be explained to you, including making you aware that there 
may be a tight feeling and very minor discomfort.  You will be asked to take a seat with the arm 
at heart level, the same arm will be used for measurement across both testing days, a pillow 
will be available to reduce any discomfort or change the height of the arm to ensure it is at the 
level of the heart.  You will be asked to have your feet on the floor, uncrossed and your back 
will be supported in the chair.  Once this position has been established, the cuff size will be 
checked and applied to your upper arm.  An automated blood pressure monitor will be used to 
determine your blood pressure: 2 readings will be taken.  Blood pressure measurements will 
also be taken after exercise and after occlusion. 
 
Capillary blood sample - Prior to any sample being taken you will be asked to be seated, the 
procedure will be explained to you and confirm you are happy to proceed.  The area of the 
finger will be cleaned with an alcohol wipe before a capillary blood sample is taken from your 
finger, a single use lancet will be used to puncture the tip of the finger in which a blood sample 
will be collected from.   
 
Saliva sample - you will be asked to provide a 2 ml sample of saliva into a sterile container 
before beginning, immediately after repeated sprints and also 2, 24 and 48 h post, these are the 
same time points as the blood samples.  This method is not invasive but the procedure will be 
explained to you and confirmation you are happy prior to providing a saliva sample. 
 
In addition to above measurements, you will be asked to complete a countermovement jump 
which will involve standing on a force platform, hands on your hips, before dipping to a self-
selected depth and then exploding upwards in an attempt to achieve maximum height. You will 
be required to complete 3 maximum jumps with 1.5 min rest between efforts.  You will also be 
asked to complete an Isometric Mid-thigh pull (IMTP) test, you will be asked to assume a body 
position similar to that of athletes completing the second pull of a power clean with a flat trunk 
position and shoulders in line with the bar. This position will allow you to maintain a knee angle 
of approximately 120–130º.  The bar height can be fixed at various heights above the force 
platform, to accommodate different heights, once the bar height is established, you will be 
instructed to pull as hard and as fast as possible on the bar for a period of approximately 5 
seconds. 
 
Participants will be asked to refrain from exercise and caffeine the morning prior to testing.  
Food consumption will also be controlled with no food or fluid consumption 2h prior to saliva 
samples.   
 
5. What are the possible disadvantages of taking part? 
There are possible risks of the study.  Firstly, blood samples and saliva will be collected.  
Procedures of how both will be collected will be explained to you prior to taking the blood and 
saliva and you will have the right to withdraw at any stage.  The blood flow occlusion through use 
of blood pressure cuffs may cause discomfort, therefore you will be given the option not to 
participate if you are not comfortable and likewise have the right to withdraw if you experience 
any pain or discomfort such as light-headedness and nausea during the study.  You will also be 
expected to participate in strenuous exercise that may cause some slight discomfort, but should 
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not be any different from your normal training and competition.  All results will be anonymous 
to Sport Wales and coaches and therefore if you decide not to participate or withdraw it will not 
influence further access to sport science support or selection for future squads/competitions.   
 
 
6. What are the possible benefits of taking part? 
As a result of participating, you will gain valuable information on potential recovery strategies 
that can be after training or competing.  
 
7. Will my taking part in the study be kept confidential? 
All data will be kept confidential and results will not be accessible to anyone else, only the 
research team will have access to the information. At the end of the study all data will be 
disposed of according to set guidelines.  
 
8. What if I have any questions? 
If you have any questions throughout the duration of this study, please do not hesitate to ask – 
contact details for the researcher are provided at the start of this document. 
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Appendix C: Consent form and health screening questionnaire 
 
Applied Sports Technology Exercise and Medicine Research Centre (A-STEM) 
Sport and Health Portfolio, College of Engineering 
 
 
 
 
 
PARTICIPANT CONSENT FORM 
(Version 1.1, Date:) 
 
 
Project Title: 
 
Contact Details: 
 
 
 
                    Please initial box 
 
1. I confirm that I have read and understood the information sheet dated 
  ....../……/…… (version number ……………………) for the above  
 study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected. 
 
3. I understand that sections of any of data obtained may be looked 
at by responsible individuals from the Swansea University or 
from regulatory authorities where it is relevant to my taking part in  
research.  I give permission for these individuals to have access to 
these records. 
 
4. I agree to take part in the above study. 
 
 
_____________________________ ________________ ________________________ 
Name of Participant   Date   Signature  
 
_____________________________ ________________ ________________________ 
Name of Person taking consent  Date   Signature  
 
_____________________________ ________________ ________________________ 
Researcher    Date   Signature  
 221 
 
 
 
 
 222 
Appendix D: Warm up for countermovement jump 
 
 
Exercise Reps/Time 
Light jog 4 
Skip 2 
Lunge and twist (jog back) 1 
Squat and turn (jog back) 1 
Side to side (1 forwards, 1 backwards) 2 
Double squat (jog back) 2 
Dynamic Stretches  
Spiderman 10 
Kneeling Rec Fem stretch 10 
Scorpions 10 
Side lunge 10 
Body weight squats (hands on hips) 5 
Body weight jump squats (hands on hips) 5 
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Appendix E: Warm up prior to swimming time trial performance 
 
 
Distance (m) Prescription 
1 x 600 Mixed stroke 
4 x 150 50 kick, 50 drill, 50 swim 
3 x 100 Descend 1-3 to 20/30bbm on 1.40 
12 x 50 Perfect stroke on 60 
15m fast on 60 
Descend 1-3 200 pace +2, 1, 0 on 60 
Steady on 60 
bbm – beats below max 
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Appendix F: Borg Scale 
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Appendix G: Perception of muscle soreness likert scale 
 
Please tick the sentence below that best describes your current muscle soreness during normal 
movement: 
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Appendix H: Perception recovery likert scale 
 
Please circle the sentence below that best describes your recovery status: 
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